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Maternal deaths in Australia 2006–2010 is the 15th report 
on women who die during pregnancy and childbirth. 
Although maternal deaths are rare in Australia, they are 
catastrophic events when they do occur and require 
monitoring and investigation. The report includes 
information about the women, pregnancy, and cause 
of death as well as good practice guidance points for 
clinicians to inform practice improvement.
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Summary 
Maternal deaths in Australia 2006–2010 provides a summary of statistics on maternal mortality 
in Australia to inform safety and quality of maternity care in Australia, and provides good 
practice guidance from members of the National Maternal Mortality Advisory Committee. 
Maternal mortality rates remained low for Australian women 
In 2006–2010 in Australia, there were 99 maternal deaths that occurred within 42 days of the 
end of pregnancy. The maternal mortality ratio (MMR) was 6.8 deaths per 100,000 women 
who gave birth. The MMR for 2003–2005 was 8.4 and 11.1 for 2000–2002. These data should 
be interpreted with caution due to the rarity of maternal deaths in Australia and the 
associated volatility of small numbers. 
There were 39 maternal deaths directly related to the pregnancy in 2006–2010. Fifty-seven 
deaths were indirect maternal deaths and due to non-pregnancy-related conditions. Women 
aged 40 and over, with higher parity, of Aboriginal and Torres Strait Islander origin, or with 
Remote or Very remote usual residence were among those at increased risk of maternal death. 
Australia’s MMR is lower than New Zealand and United Kingdom for comparable years but 
accurate comparisons are limited due to different maternal mortality review processes, 
classifications and ascertainment measures.  
Maternal mortality rates were higher for Aboriginal and Torres Strait Islander 
women 
Aboriginal and Torres Strait Islander women were almost 3 times as likely to die as  
non-Indigenous women, with a maternal mortality ratio of 16.4 deaths per 100,000 
Indigenous women giving birth. Sepsis and cardiac conditions were the leading causes of 
maternal death for Indigenous Australians. 
Key causes of direct and indirect maternal deaths in Australia in 2006–2010 
• The leading causes of direct maternal deaths were amniotic fluid embolism (9), 
thromboembolism (8), obstetric haemorrhage (7) and eclampsia (6), and, when 
combined, accounted for more than three-quarters of all direct maternal deaths.  
• There were 15 deaths due to cardiac disease, the leading cause of indirect maternal 
death. Preconception counselling and assessment for women with cardiac disease and 
referral to appropriate multidisciplinary tertiary services is essential.  
• There were 13 deaths due to psychosocial causes, including 9 due to suicide. Universal 
psychosocial screening is critical in identifying women at risk of psychosocial morbidity 
in the antenatal period, and clear referral guidelines and the treatment of significant 
maternal psychiatric morbidity important in preventing maternal deaths.  
• Five non-obstetric haemorrhage deaths resulted from rupture of a splenic artery 
aneurysm. 
• There were 3 deaths due to ectopic pregnancy in 2006–2010. Seven pregnant women died 
in motor vehicle accidents. Three women died from epilepsy. 
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1 Introduction 
The World Health Organization (WHO) estimates that worldwide 287,000 women die each 
year from complications of pregnancy and childbirth (Lee et al. 2012; WHO 2012). Each of 
these deaths is a tragedy for the women who die and the families they leave behind. 
Maternal mortality is rare in Australia and only a small portion of pregnancy-related 
morbidity. Nevertheless, it remains an important measure of maternity services and obstetric 
care. This is the 15th report published on maternal deaths in Australia. The purpose of the 
report is to identify trends in maternal mortality and to develop an evidence base for 
maternal deaths that can be used to inform maternity services policy and practice.  
Since Australia initiated the practice of reporting and subsequently publishing data on 
maternal mortality for the triennium 1964–1966, maternal deaths have decreased by nearly 
two-thirds. There are impressive examples of how maternal mortality reporting has 
influenced maternity services policy and planning, which has resulted in a decline in  
cause-specific maternal deaths (CMACE 2011). This was illustrated in the United Kingdom 
(UK) where there was a significant fall in the number of deaths from thromboembolism from 
41 deaths in 2003–2005 to 16 deaths in 2006–2008 following the publication of guidelines on 
the management of thromboprophylaxis during pregnancy, labour and after normal birth 
(CMACE 2011:57).  
1.1 Background to the report 
This report has been developed in the context of international and national actions to 
improve maternity care and outcomes for mothers and their babies.  
The United Nations Millennium Development Goals (MDGs) were developed as a 
framework for the international community to work together to improve the health of all 
people. The fifth MDG is ‘Improve maternal health’, and this improvement will be measured 
using 2 targets: 
1. Reduce the maternal mortality ratio by three-quarters, between 1990 and 2015.  
2. Achieve universal access to reproductive health by 2015.  
In 2008, a national review of maternity services was carried out in Australia, led by the 
Commonwealth Chief Nurse and Midwifery Officer. The findings were presented in 2009 in 
Improving maternity services in Australia: the report of the Maternity Services Review 
(Commonwealth of Australia 2009). The report aimed to identify key gaps in maternity care 
and to inform development of the first National Maternity Services Plan (Australian Health 
Ministers' Conference 2011).  
The National Maternity Services Plan 
The National Maternity Services Plan (the Plan) was launched in February 2011 and sets out 
a 5-year vision for maternity care that provides a strategic national framework to guide 
policy and program development across Australia (Australian Health Ministers' Conference 
2011). The purpose of the Plan is to maintain Australia’s high standard of maternity care 
while seeking to improve access to services and choice in care, which includes increasing and 
supporting the maternity workforce, strengthening infrastructure and building the evidence 
base of what works well in Australia (Australian Health Ministers' Conference 2011). In 
 2 Maternal deaths in Australia 2006–2010 
particular, the Plan’s priority areas are: to meet the needs of women and their families living 
in rural and remote areas; improving birth outcomes for Aboriginal and Torres Strait 
Islander people; and meeting the requirements of women who are vulnerable due to medical 
or other risk factors (Australian Health Ministers' Conference 2011). The Plan targets primary 
maternity services during the antenatal, intrapartum and 6-week postnatal period for both 
women and babies. In 2011, the then Australian Government Department of Health and 
Ageing provided funding for the National Maternity Data Development Project (NMDDP). 
National Maternity Data Development Project—Stage 1 
The NMDDP was set up in response to Recommendation 1 of the Improving maternity services 
in Australia: the report of the Maternity Services Review and Action Item 4.1.5 of the Plan to 
develop a nationally consistent and comprehensive maternal and perinatal mortality and 
morbidity data collection in Australia. The NMDDP is made up of a number of inter-related 
components (Figure 1.1).  
 
 
Figure 1.1: National Maternity Data Development Project—Stage 1 components  
The primary aims of the NMDDP are to develop a nationally consistent and comprehensive 
maternal and perinatal mortality and morbidity data collection in Australia. The availability 
of high-quality and nationally consistent data is required to assess the safety and outcomes 
of current and emerging models of maternity care in Australia. This will also enable the 
monitoring of disparities in health outcomes for population sub-groups compared with the 
general population. The publication, Foundations for enhanced maternity data collection and 
reporting in Australia: National Maternity Data Development Project Stage 1 reports on the 
progress and achievements of the first stage of the NMDDP from 2011–2013 (AIHW 2014). 
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National Maternal Mortality Advisory Committee 
The National Maternal Mortality Advisory Committee (NMMAC) was convened to provide 
guidance and national relevance to the development of the national maternal death report 
(refer to Appendix A for a list of members). It is a subcommittee of the NMDDP Advisory 
Group. The NMMAC provided expert advice to the project, including strategic advice, 
facilitation of data supply and provision of clinical commentary and good practice guidance.  
Two subcommittees of the NMMAC were convened to provide expert advice regarding 
clinical classification and interpretation of data, and to assist with specific components of the 
project: 
• National Maternal Mortality Advisory Committee–Report Working Group  
(NMMAC–RWG): to oversee the development of national data collection forms and a 
system of maternal death classification (refer to Appendix B for a list of members). 
• National Maternal Mortality Advisory Committee–Clinical Classifications Working 
Group (NMMAC–CCWG): for national classification of maternal deaths not previously 
classified by the State and Territory Maternal Mortality Committees (refer to Appendix 
C for a list of members). 
1.2 Purpose of this report 
The ‘maternal mortality’ component of the NMDDP specifically addresses the National 
Maternity Services Plan Priority Action 2.1, which recommends that a national maternal 
mortality review process be established and that national maternal mortality reports are 
produced (Australian Health Ministers' Conference 2011). This report details a national 
observation of 5 years of maternal deaths from 2006 to 2010.  
National data systems and processes can drive improved performance in both private and 
public maternity care settings. Internationally, maternal mortality is used in comparisons of 
maternal health outcomes across countries, and is also used as an indicator of society’s 
health-care services. Detailed examination and reporting of these deaths can inform policy 
and improve maternity care practices. 
1.3 Aims of this report 
• Provide an overview of maternal mortality from collated information on maternal deaths 
in Australia during the period 1 January 2006 to 31 December 2010. 
• Provide an evidence base to inform policy development. 
• Provide a platform to assist practitioners to reduce maternal mortality and counsel  
‘high- risk’ women who are considering pregnancy.  
• Inform national processes for classification of maternal deaths, providing a basis for 
consensus in the review of maternal deaths by State and Territory Maternal Mortality 
Committees and nationally. 
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Structure of this report 
Chapter 1 provides the background, including the policy context. 
Chapter 2 provides the definitions and classifications used in the report and the 
methodology and data used in measuring maternal mortality. 
Chapter 3 provides an overview of maternal deaths in Australia from 2006 to 2010. 
Chapter 4 provides detailed information on causes of direct and indirect maternal deaths. 
Chapter 5 provides detailed information on maternal deaths related to psychosocial 
morbidity. 
Chapter 6 provides detailed information on incidental maternal deaths. 
Chapter 7 provides detailed information on maternal deaths of Aboriginal and Torres Strait 
Islander women. 
Chapter 8 provides an overview of the role of the coroner in reporting of maternal deaths. 
Chapter 9 outlines the sources that provide review of maternal deaths. 
The report includes case summaries and good practice guidance points to make the report 
more accessible to clinicians working in maternity services. The aim of these is to provide 
educational opportunities for teaching and learning and practice improvement.  
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2 Definitions, classifications and 
methods 
2.1 Definitions and classifications 
Australia applies the standard international definition of maternal death. The WHO 
International statistical classification of diseases and related health problems, 10th edn (ICD-10) 
defines maternal death as ‘the death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration and the site of the pregnancy, from 
any cause related to or aggravated by the pregnancy or its management, but not from 
accidental or incidental causes’ (WHO 1992). Maternal deaths are subdivided into 2 
categories: direct and indirect deaths (Table 2.1). These categories divide the maternal deaths 
into those that result directly from complications of pregnancy or its management (direct) 
and those that are due to pre-existing or inter-current disease but where disease progression 
was influenced by pregnancy (indirect). Deaths considered to be unrelated to pregnancy are 
classified as ‘incidental’.  
Table 2.1: Definitions(a) of maternal death categories 
Type of death Definition 
Direct maternal deaths(a) Those resulting from obstetric complications of the pregnant state (pregnancy, labour and 
puerperium) from interventions, omissions, incorrect treatment or from a chain of events 
resulting from any of the above 
Indirect maternal deaths(a)  Those resulting from previous existing diseases or diseases that developed during pregnancy, 
and which were not due to a direct obstetric cause, but were aggravated by the physiologic 
effects of pregnancy 
Incidental maternal deaths Deaths from unrelated causes, which happen to occur in pregnancy or the puerperium 
Maternal death, not further 
classified 
Deaths considered to be related to the pregnancy or its management, but could not be further 
classified as either direct or indirect 
Unclassifiable maternal death Maternal death from unspecified or undetermined cause occurring during pregnancy, labour 
and delivery, or the puerperium 
(a)  Definitions are from the International statistical classification of diseases and related health problems, 10th edn, volume 2, section 5.8.1.  
The category ‘Maternal death, not further classified’ was applied where pregnancy was 
considered to have contributed to the death, but where jurisdictional or coronial 
investigation were not completed, and the death could not be classified as a direct or indirect 
maternal death.  
Deaths that were not classified by state or territory and were provided with insufficient 
information to assess cause of death were considered ‘unclassifiable’.  
Classification of deaths related to psychosocial morbidity 
Psychosocial illness is 1 of the leading causes of maternal death in Australia. Since the  
1997–1999 triennium, Australia has classified, for national reporting, maternal deaths among 
women with a pre-existing psychiatric illness or psychiatric illness that developed during 
pregnancy and was not due to direct obstetric causes as an indirect maternal death, and 
deaths deemed unrelated to the pregnancy due to ‘external causes’ as incidental. The 
classification practice for psychosocial deaths that occurred between 2006 and 2010 remained 
unchanged from the previous triennia.  
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2.2 Measuring maternal mortality 
The maternal mortality ratio (MMR) is used to measure maternal mortality. In line with 
international conventions (WHO 1992), the MMR is calculated using direct and indirect 
deaths combined, but excludes coincidental (termed ‘incidental’ in Australia) deaths (see Box 
2.1).  
The WHO definition specifies that the number of live births or the number of total births 
(live births plus fetal deaths) can be used as the denominator, and where both denominators 
are available, both calculations are made (WHO 1992). Internationally, there are a number of 
different denominators used for calculating maternal mortality, dependent upon the data 
available. The most appropriate denominator for estimating maternal mortality is the 
number of women at risk; that is, the number of pregnant or recently pregnant women. 
These data are not available in Australia, with the number of pregnancies ending before 
20 weeks gestation unknown. In Australia, accurate population data are available for the 
number of women who gave birth to at least 1 baby (either a live birth or a stillbirth) of 
20 weeks or more completed gestation or 400 grams or more birthweight and this is the 
denominator population used to calculate the MMR in this report.  
Box 2.1: Calculation of maternal mortality ratio (MMR) 
 
MMR = Number of direct and indirect maternal deaths(a)
Number of women who gave birth(a)
× 100,000 
 
(a) For a defined place and time. 
Australian maternal death reports before 1997–1999 included incidental deaths in the 
definition and calculation of the MMR. Caution must therefore be taken when comparing 
MMRs from triennia before 1997–1999 with MMRs from the 1997–1999 triennium onwards.  
Data for 2006–2010 maternal deaths 
Comprehensive review of maternal deaths and the comparison of outcomes across 
jurisdictions and internationally requires complete ascertainment and a consistent 
classification system (Allen et al. 2010). During the period 2006–2010, there were no 
recognised standard definitions or criteria that defined which causes of death should be 
counted as direct or indirect maternal deaths. Application of ICD-10 to deaths during pregnancy, 
childbirth and the puerperium: ICD-MM (WHO 2012) meets this need, but was not available for 
the entire 2006–2010 maternal death data collection period.  
There is a 2-tier arrangement for reviewing and classifying maternal deaths in Australia: the 
primary review is undertaken by states and territories and a subsequent review is 
undertaken by the NMMAC after collation of the data into the National Maternal Death 
Report Data Set. 
State and Territory Maternal Mortality Committees and subcommittees 
For the period 2006–2010, confidential enquiry was undertaken by 7 State and Territory 
Maternal Mortality Committees (STMMCs) or subcommittees. The Northern Territory did 
not convene a committee during this time period. The confidential enquiry process seeks to 
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identify and understand the individual circumstances surrounding each death, with a view 
to improving future maternity care and maternal and perinatal outcomes.  
Deaths are notified to the STMMCs by a wide variety of sources and professional groups, 
including clinicians, midwives, hospitals, health departments and coroners, and also via 
notifications from autopsy investigations, perinatal and hospital morbidity collections and 
from the Registrars of Births, Deaths and Marriages. The committees operate under legal 
privilege and are provided with clinical information and the results of autopsy investigations 
where available. This enables the STMMCs to agree on the causes of each death and assign 
the death to a maternal death category.  
The organisational and governance arrangements for STMMCs vary between jurisdictions. A 
more detailed review of these is provided in ‘Chapter 9 Quality of maternal death reviews in 
Australia’. 
National data collection form 
Collection of data for the 2006–2010 maternal deaths report was achieved using the National 
Maternal Death Reporting form 2006–2010 (NMDR form 2006–2010). This form was 
developed to standardise data collection from STMMCs and was developed in consultation 
with the NMMAC–Report Working Group (RWG). This form was based on the form used 
for previous reports and enhanced by a review of data items against the New Zealand 
retrospective maternal death reporting form, the UK’s maternal death surveillance form and 
from feedback from the NMMAC–RWG. In response to concerns about maternal death data 
availability and completeness, the form was shortened to reduce the burden on the 
jurisdictional health authorities, and to improve jurisdictional capacity to provide the data 
requested within the necessary timeframe. 
The NMDR form 2006–2010 was used to collect information across jurisdictions on all known 
deaths occurring during the period from 1 January 2006 to 31 December 2010. Information 
was requested about each death notified to STMMCs and the outcome of the confidential 
enquiry. 
National maternal death report database 
The information provided on the NMDR 2006–2010 form was checked and internal 
validation carried out before the data were compiled into the National Maternal Death 
Report Database 2006–2010 (NMDRD 2006–2010).  
Most jurisdictions returned completed NMDR 2006–2010 forms to the Australian Institute of 
Health and Welfare (AIHW) National Perinatal Epidemiology and Statistics Unit (NPESU) 
and the data were entered into the NMDRD 2006–2010. The New South Wales Ministry of 
Health provided an extract from their maternal deaths database that was used to enter 
information directly into the NMDRD 2006–2010. Ten per cent of records had dual entry to 
check for logical errors and validity of data.  
The database was updated in March 2013 when the Western Australian Department of 
Health supplied cause of death and classification of death from the Perinatal and Infant 
Mortality Committee of Western Australia. 
The NMDR form 2006–2010 requested limited information on the babies of the women who 
died. These data were incomplete and have not been included in this report.  
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A data quality statement for the NMDRD 2006–2010 is set out in Appendix D. The database 
was used to generate standard reports on deaths for review by the NMMAC and the final 
classifications were used to produce tabulations for this report.  
National review of maternal death classifications 
Details of the maternal deaths, including the preliminary cause of death and the 
classifications provided by STMMCs, were reviewed by the NMMAC Clinical Classifications 
Working Group subcommittee in October 2012 to ensure national consistency of 
classification.  
In most cases, the STMMC classification was applied. The NMMAC Clinical Classifications 
Working Group reviewed 21 cases of maternal death. Cases from some jurisdictions had not 
been assigned a classification of death. There were 8 deaths that the NMMAC Clinical 
Classifications Working Group was unable to classify fully. However, further 
correspondence with jurisdictions on a number of deaths occurred subsequently. The 
Department of Health in Western Australia subsequently supplied classifications of maternal 
deaths in March 2013. These classifications were used in the report. Seven maternal deaths 
were unable to be classified. Four complex cases had insufficient information to categorise 
the specific cause of maternal death and assign them as direct or indirect deaths. They were 
considered as maternal deaths, not further classified and included in the calculations for the 
MMR. One is considered in ‘Section 4.2 Non-obstetric haemorrhage’, 1 in ‘Section 4.7 Sepsis’ 
and the 2 other cases are included in ‘Section 4.10 Deaths due to other causes’. The remaining 
3 cases had inadequate information to determine whether a maternal death classification or a 
classification as an incidental death should be applied and were thus unclassifiable. These 
cases were not included in MMR calculations.  
Supplementary data 
Survey on jurisdictional maternal death reporting practices 
A survey on jurisdictional maternal death reporting practices was undertaken in June 2012. 
State and territory health authorities were asked to provide details about jurisdictional 
legislation and data collection practice and processing, and systems of review of material 
related to maternal deaths, in particular the process of referral to the coroner. This survey 
informed ‘Chapter 8 Coronial review’ and ‘Chapter 9 Quality of maternal death reviews in 
Australia’.  
The Australasian Maternity Outcomes Surveillance System 
Supplementary data were provided from the Australasian Maternity Outcomes Surveillance 
System (AMOSS) that conducts prospective, national population-based studies and 
surveillance of serious morbidity in pregnancy in nearly 300 maternity units across Australia 
and New Zealand. Research and support for translation of evidence-based practice and 
education for clinicians are carried out in conjunction with international collaborations with 
UK Obstetric Surveillance System (UKOSS) and International Network of Obstetric Survey 
Systems (INOSS). Selected information on the incidence, management and outcomes of 
severe and rare conditions in pregnancy has been gained through AMOSS studies, and were 
included in relevant chapters of this report from AMOSS studies on the H1N1 influenza 
pandemic and influenza A with admission to intensive care, and from 2010–2012, antenatal 
pulmonary embolism, amniotic fluid embolism, eclampsia, placenta accreta and peripartum 
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hysterectomy studies. The AMOSS project was funded by the National Health and Medical 
Research Council (NHMRC) Project Grant #510298 (2008–2012). 
Reporting maternal deaths 2006–2010 
The methodology used for this report is similar to previous reports. It includes 
epidemiological data on maternal deaths, the use of illustrative vignettes known as ‘case 
summaries’, clinical commentary and references to published guidelines for further 
education on specific clinical management, where available and relevant. A number of these 
components were out of scope for the previous maternal death report, Maternal deaths in 
Australia 2003–2005 (Sullivan et al. 2007), published in 2008, and have been re-introduced for 
this report following consultation with the NMMAC.  
Historically, data have been collected for 3-year reporting periods. For this report, 5 years of 
data were collected. The rationale for the longer reporting period is to aggregate larger 
numbers of deaths, which increases the capacity to identify trends, maintain privacy and 
improve the timeliness of reporting. 
Information related to the assessment of avoidable factors or preventability surrounding the 
deaths has not been included in this report. This was a decision of the NMMAC and was 
made due to the lack of a nationally consistent approach to assessment of preventability and 
the retrospective nature of the data collection. This information is not readily available or 
routinely collected in all jurisdictions. The most recent data available for inclusion in this 
report were from 2010. For some STMMCs, a number of deaths remain unreviewed as late as 
2012. These deaths were reviewed by the NMMAC–CCWG with all available information, 
and a classification of death was assigned if possible. Western Australia provided limited 
data for inclusion in the report due to legislative privacy restrictions on the sharing of data. 
Case summaries 
Case summaries or vignettes have been incorporated to provide opportunities for teaching 
and learning and practice improvement. The NMMAC–RWG developed a list of essential 
criteria for the case summaries, which were piloted by the Queensland Maternal and 
Perinatal Quality Council. Each jurisdiction was requested to prepare 2 case histories from 
deaths in their state or territory from the period 2006–2010 for potential inclusion in the 
maternal death report. The New South Wales Maternal and Perinatal Committee declined to 
provide case summaries, citing concerns regarding privacy. Case summaries were provided 
by Queensland Health, South Australia Health, the Department of Health, Victoria and the 
Department of Health, Tasmania. Care was taken to remove or change information that 
could potentially identify any individual. A decision was made by the NMMAC not to 
identify Aboriginal or Torres Strait Islander status in the case summaries and not to have any 
case summaries in the Aboriginal or Torres Strait Islander chapter. Perturbation, where a 
number of cases may have been combined, was used in the case summaries to prevent 
identification.  
Quality of maternal deaths review in Australia 
The method of maternal death reporting in Australia varies between states and territories. A 
review of the sources of maternal death notification, the supply and sharing of this 
information, confidential enquiries in Australia and internationally and the future of 
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reporting maternal deaths in Australia is discussed in ‘Chapter 9 Quality of maternal death 
reviews in Australia’. 
Confidentiality and small number reporting 
Maternal deaths are unexpected events and women who die are unable to provide consent 
for participation in research or inclusion in the national report. In many instances, there has 
been widespread reporting of the deaths in the public domain by the media or through the 
coronial processes. Nevertheless, it is essential that measures are taken to maintain privacy 
and limit reporting of identifiable information about individual women. Concurrent to this, 
it is also critical that information on these deaths is made available for review and learning 
purposes so that it can be used to inform prevention strategies, maternity policy, clinical 
audit and practice improvement, and education of future maternity-care providers. The use 
of data from rare occurrences raises critical issues with regards to the protection of 
individual privacy. There has been considerable discussion with regards to this issue 
throughout the development of this report.  
This report is an observational epidemiological report of all maternal deaths in Australia. 
The rationale for small number reporting is to provide, at a national level, information 
regarding the causes of maternal death, to be able to analyse and present data on the 
distribution of deaths, and to determine if there are modifiable factors for deaths that vary by 
different population groups, such as Aboriginal and Torres Strait Islander women. Although 
all available measures have been employed to prevent the identification of individual 
women, small numbers are unavoidable in this context and have been included in this report 
in accordance with ethical approval obtained from the relevant Human Research Ethics 
Committees (HRECs). Measures have been employed to prevent the identification of 
individual women and limit the range of information available through the use of 
perturbated case summaries and the application of broad categories for information other 
than cause of death.  
Maternal deaths are rare in Australia. The data should be interpreted with caution due to the 
volatility of small numbers and the different data collection practices of jurisdictions. 
Privacy 
Maternal deaths are rare events in Australia and women are potentially identifiable. 
Inadvertent identification or spontaneous recognition is a particular concern for Aboriginal 
and Torres Strait Islander women, who make up 3% of women giving birth in Australia. 
There has been extensive consultation and discussion with regards to the reporting of 
maternal deaths in Aboriginal and Torres Strait Islander women. The report aims to use the 
data collected in a way that maximises the potential for benefit while minimising the 
potential for harm. For this reason, detailed case summaries have not been included in 
‘Chapter 7 Aboriginal and Torres Strait Islander Women’.  
Aboriginal and Torres Strait Islander engagement 
University of New South Wales, with the support from the National Aboriginal Community 
Controlled Health Organisations (NACCHO), convened a National Aboriginal Perinatal 
Reference Group (members listed in Appendix E) to provide expert advice on matters 
relating to perinatal health at a national level, and sought their advice on ‘Chapter 7 
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Aboriginal and Torres Strait Islander Women’, which reports maternal mortality among 
Aboriginal and Torres Strait Islander women. 
Ethics approval 
Human research ethical approval for compilation of the research data set and Maternal deaths 
in Australia 2006–2010 report was obtained from the following HRECs: 
• Australian Institute of Health and Welfare Ethics Committee  
• University of New South Wales, Human Research Ethics Committee 
• Consultative Council on Obstetric and Paediatric Mortality and Morbidity (Victoria) 
• New South Wales Population Health Services Research Ethics Committee  
• Government of Western Australia, Department of Health, Human Research Ethics 
Committee 
• Government of South Australia, SA Health, Human Research Ethics Committee 
• Queensland Government, Queensland Health, Human Research Ethics Committee, 
Centre for Healthcare Improvement 
• University of Tasmania, Human Research Ethics Committee (Tasmania) Network  
• Human Research Ethics Committee of Northern Territory, Department of Health and 
Menzies School of Health Research  
• National Coronial Information System, Department of Justice, Human Research Ethics 
Committee  
• Australian Capital Territory, Department of Health, ACT Health Human Research Ethics 
Committee. 
In satisfaction of the conditions of the ethics approval from the Australian Capital Territory, 
it is noted that the Australia Capital Territory Health’s Directorate Human Research Ethics 
Committee approved this project on 8 February 2012. 
Aboriginal Health Ethics Committee approval was sought from states and territories where a 
separate committee or subcommittee was established. Approval was obtained from:  
• Aboriginal Health and Medical Research Council of New South Wales 
• Aboriginal Health Council of South Australia, Aboriginal Health Research Ethics 
Committee 
• Western Australian Aboriginal Health Ethics Committee 
• Northern Territory Department of Health and Menzies School of Health Research 
Aboriginal Ethics Sub Committee. 
Deaths related to anaesthesia 
Previous reports in the Maternal Deaths series have included specific chapters that describe 
deaths related to anaesthesia. For this reporting period, there were no deaths directly related 
to anaesthesia. Although 8 deaths occurred in theatre, there was insufficient information to 
provide a useful commentary on the circumstances of these deaths or the care provided. The 
new National Maternal Death Reporting form (see ‘Chapter 9 Quality of maternal death 
reviews in Australia’) will collect more detailed information on the details of anaesthetic 
treatment.  
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3 Maternal deaths in Australia 2006–2010 
Information about the deaths of 128 women that occurred during pregnancy or up to 42 days 
postpartum in Australia for the period 2006–2010 was provided to the AIHW NPESU. 
Following review by jurisdictional and national committees, 99 (77%) were classified as 
being directly or indirectly related to pregnancy.  
Figure 3.1 shows the distribution of maternal deaths between 2006 and 2010. Overall, 39 
(31%) were directly related to or aggravated by the pregnancy or its management and 
occurred while the woman was pregnant or within 42 days of the termination of the 
pregnancy. Fifty-seven (45%) were classified as indirect maternal deaths. These were 
considered to be due to non-pregnancy-related conditions that were aggravated by the 
pregnancy or its management. Three maternal deaths (2%) were considered to be related to 
the pregnancy or its management, but could not be further classified as either direct or 
indirect. Further information about deaths from these 3 categories is presented in this 
chapter and in ‘Chapter 4 Direct and indirect maternal deaths’ and ‘Chapter 5 Deaths related 
to psychosocial morbidity’.  
Twenty-six of the remaining 29 deaths, or 20%of all reported maternal deaths, were 
considered to be incidental to the pregnancy or its management. These deaths are reported in 
‘Chapter 6 Incidental deaths’. Of the remaining 3 (2%) deaths, there was insufficient 
information to classify them and they were categorised as unclassified deaths of women 
during pregnancy and the puerperium. No further information is presented about 
unclassified deaths in the report. Incidental and unclassified deaths are not included in the 
calculation of MMRs.  
 
Figure 3.1: The proportion of maternal deaths by classification, Australia, 2006–2010 
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3.1 Maternal mortality ratio 
There were 99 maternal deaths between 2006 and 2010. The maternal mortality ratio (MMR) 
is a proportion that uses the number of direct, indirect and maternal deaths not further 
classified in the numerator and the number of women who gave birth to babies of at least 400 
grams birthweight, or at least 20 weeks gestation in Australia, as the denominator. It is 
calculated over a defined time period. The MMR for the period 2006 to 2010 is 6.8 per 100,000 
women who gave birth (Table 3.1). 
Table 3.1: Maternal mortality ratio, Australia, 2006–2010 
Type of death Number of deaths Maternal mortality 
ratio(a)(b) 
Direct 39 2.7 
Indirect 57 3.9 
Maternal death not 
further classified 
3 0.2 
Total 99 6.8 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
The MMR for 2006–2010 is similar to the most recently reported MMR for the 2003–2005 
triennium and significantly lower than the MMR of 11.1 per 100,000 women who gave birth 
reported for the 2000–2002 triennium (Figure 3.2 and Table 3.2). However, the data should be 
interpreted with caution due to the rarity of maternal deaths in Australia and the associated 
volatility of small numbers. In particular, variability in ascertainment of maternal deaths 
may partially explain the lower MMR compared with the 2000–2002 triennium. Additionally, 
the processes for maternal death notification and review at a jurisdictional level were not 
standard, and, for some states and territories, the maternal mortality committees and 
subcommittees were not active for periods during 2006–2013 when the review of this report’s 
maternal deaths was expected to be undertaken. More detail is provided in ‘Chapter 8 
Coronial review’ and ‘Appendix D: Data Quality Statement’. These factors need to be 
considered when interpreting the data. Figure 3.2 and Table 3.2 present triennial reporting of 
the MMR in Australia from 1973 to 2005 and a 5-year reporting period, 2006–2010. Apart 
from the 2000–2002 triennium, the MMR in Australia has not significantly changed since 
1982–1984, and the fluctuations in the MMR over the period reflect the volatility of rare 
death reporting.  
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Note: 2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
Figure 3.2: Maternal mortality ratios, Australia, 1973–2010 
Table 3.2: Maternal mortality ratios, Australia, 1973–2010 
Triennium Direct 
deaths 
Indirect 
deaths 
Number of women 
who gave birth 
Maternal mortality 
ratio(a) 
1973–1975 60 32 726,690 12.7 
1976–1978 52 35 678,098 12.8 
1979–1981 54 34 682,880 12.9 
1982–1984 42 25 713,985 9.4 
1985–1987 32 30 726,642 8.5 
1988–1990 37 33 754,468 9.3 
1991–1993 27 22 769,253 6.2 
1994–1996 46 20 767,448 9.1 
1997–1999 34 30 758,030 8.4 
2000–2002 32 52 753,901 11.1 
2003–2005 29 36 773,248 8.4 
2006–2010(b)(c) 39 57 1,448,445 6.8 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
(c)  There are 3 unclassifiable maternal deaths included in the MMR calculation for the 2006-2010 reporting period. 
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3.2 State and territory maternal mortality ratio 
The MMR varied by state and territory of death (Table 3.3). For cases of transfer of care 
across jurisdictional borders, deaths were attributed to the state in which the death occurred, 
not the state of usual residence. The MMRs ranged from 3.2 deaths per 100,000 women who 
gave birth in Tasmania to 21.3 deaths per 100,000 women who gave birth in the Northern 
Territory, the least populous state in Australia. Fewer than 20,000 women gave birth in the 
Northern Territory between 2006 and 2010. The impact of the volatility of the small number 
of deaths indicates caution should be used when interpreting the state and territory MMRs.  
The Northern Territory has the highest proportion of Aboriginal and Torres Strait Islander 
mothers in Australia. During the period 2006–2010, 38.1% of women who gave birth in the 
Northern Territory were Aboriginal and Torres Strait Islanders. Aboriginal and Torres Strait 
Islander women have 3 times the risk of maternal death compared with other Australian 
women. More detailed information on maternal deaths of Aboriginal and Torres Strait 
Islander women is presented in ‘Chapter 7 Aboriginal and Torres Strait Islander Women’. 
These factors are not adjusted when reporting the state- and territory-specific MMR, and the 
MMRs should be interpreted with caution.  
Table 3.3: Maternal deaths by type of death, state and territory of usual residence, 2006–2010 
State and 
territory 
Number of women 
who gave birth 
Direct 
deaths(a) 
Indirect deaths(a) Direct and 
indirect deaths 
Unclassified Maternal 
mortality 
ratio(b) 
NSW and ACT 502,372 10 11 21 3 4.8 
Vic 348,854 8 22 30 0 8.6 
Qld 298,525 9 15 24 0 8.0 
WA(c) 149,956 4 5 9 0 6.0 
SA 96,688 5 1 6 0 6.2 
Tas 30,946 n.p. n.p. 1 0 3.2 
NT 18,739 3 1 4 0 21.3 
Total(d) 1,448,445 39 57 96 3 6.8 
(a)  Numbers may differ from those published in state and territory reports due to possible differences in the classification of maternal deaths by 
the NMMAC and the STMMC. 
(b)  Deaths per 100,000 women who gave birth. 
(c)  Includes1 woman who died in the NT. 
(d)  Includes 1 woman who died in Tasmania with unknown state of usual residence. 
n.p. Data not published to maintain confidentiality of small numbers 
Causes of direct deaths 
There were 39 direct maternal deaths, with an average of 8 deaths per year over the 5-year 
reporting period. The leading cause of direct deaths remained amniotic fluid embolism 
(AFE) followed closely by thromboembolism and obstetric haemorrhage, which together 
accounted for more than half of all direct maternal deaths (Table 3.4). The leading cause of 
direct maternal death in New Zealand was AFE for the period 2006–2009, which was the 
same as in Australia. In contrast, the leading cause of direct maternal death in the UK was 
genital tract infection (sepsis) for the 2006–2008 triennium. The number of deaths from 
infection fluctuated over the previous 3 reporting periods (5 deaths in the 2000–2002 
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triennium, 1 death in the 2003–2005 triennium and 5 deaths between 2006 and 2010), 
reflecting the inherent instability of small numbers for rare events such as deaths, and 
caution should be used when interpreting the data. Deaths due to sepsis are discussed in 
‘Section 4.7 Sepsis’. Of concern, were the 3 potentially preventable early pregnancy-related 
deaths due to ectopic pregnancy, which are discussed in ‘Section 4.9 Early pregnancy 
deaths‘. The MMR by cause of death is presented in more detail in Sections 4.1 to 4.10. 
Table 3.4: Causes of direct maternal deaths, Australia, 2006–2010 
Cause of death Number  % 
Amniotic fluid embolism 9 23.1 
Thromboembolism 8 20.5 
Obstetric haemorrhage 7 17.9 
Eclampsia 6 15.4 
Sepsis 5 12.8 
Early pregnancy death 3 7.7 
Non-obstetric haemorrhage 1 2.6 
Total 39 100.0 
Causes of indirect deaths 
There were 57 indirect maternal deaths between 2006 and 2010, with an average of 11 deaths 
per year. Cardiac deaths and deaths related to psychosocial morbidity remain the leading 
causes of indirect maternal death in Australia (Table 3.5). This was similar to the leading 
causes of indirect maternal death in New Zealand and the UK, which were pre-existing 
medical conditions and cardiac disease, respectively, and reflects the increasing age of 
mothers and increasing levels of obesity and other risk factors. Of note was the unusually 
high number of non-obstetric haemorrhage deaths (5) from rupture of a splenic artery 
aneurysm which are discussed in ‘Section 4.2 Non-obstetric haemorrhage’. There were 
3 deaths related to the 2009 H1N1 influenza pandemic. Caution should be used in 
interpreting these data. Further information on indirect deaths is presented in in ‘Chapter 4 
Direct and indirect maternal deaths’ and ‘Chapter 5 Deaths related to psychosocial 
morbidity’. 
Table 3.5: Indirect maternal deaths, Australia, 2006–2010  
Cause of death  Number % 
Cardiac 15 26.3 
Psychosocial 13 22.8 
Other 13 22.8 
Non-obstetric haemorrhage 10 17.5 
H1N1 influenza 3 5.3 
Sepsis 1 1.8 
Obstetric haemorrhage 1 1.8 
Early pregnancy death(a) 1 1.8 
Total 57 100.0 
(a) Includes 1 woman who died after termination of pregnancy for intractable intracerebral hypertension. 
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Sociodemographic and pregnancy factors  
Understanding the sociodemographic and pregnancy characteristics of women who die is 
essential to interpreting health statistics such as the MMR. This is because demographic 
factors, such as maternal age, social deprivation and Aboriginal and Torres Strait Islander 
status, are important determinants of health. For example, the incidence of cardiac disease in 
women between 30 and 45 years of age is higher than in women aged under 30. Therefore, a 
woman aged 45 is theoretically at a higher risk of cardiac morbidity before pregnancy than a 
woman aged 20. Similarly, a woman who lives in a remote area, with perhaps more limited 
access to health care, is potentially at higher risk of mortality than a woman living in a major 
city who would have easier access to tertiary health-care services. In order to calculate and 
interpret the MMR accurately and plan services appropriately, an understanding of the 
context in which maternal deaths occur and the characteristics of the women who died is 
required. 
Age 
Table 3.6 shows maternal deaths between 2006 and 2010 by age group. The age of the women 
who died ranged between 17 and 45. Mothers aged 40 or older have the highest risk of 
mortality, with an MMR of 25.7 per 100,000 women who gave birth (Table 3.6). The highest 
number of deaths (27.3%) occurred in the 35–39 years age group and this group accounted 
for almost 1 in 5 women who gave birth in Australia. The MMR was lowest for women aged 
25–29 at 3.3 women per 100,000 who gave birth. 
Table 3.6: Maternal deaths(a) by age group and percentage of women who gave birth by age group, 
Australia, 2006–2010  
Age group 
(years) 
Number of 
deaths(a) 
Percentage of 
deaths 
Number of women who 
gave birth 
Percentage of total 
number of women 
who gave birth MMR(b) 
<20 4 4.0 59,198 4.1 6.8 
20–24 17 17.2 208,840 14.4 8.1 
25–29 13 13.1 391,036 27.0 3.3 
30–34 22 22.2 463,254 32.0 4.7 
35–39 27 27.3 271,169 18.7 10.0 
≥40 14 14.1 54,525 3.8 25.7  
Total(c) 99 100.0 1,448,445 100.0 6.8 
(a)  Direct, indirect and maternal deaths not further classified. 
(b)  Deaths per 100,000 women who gave birth. 
(c)  Includes about 2.1% of deaths where maternal age is not stated. 
Age-standardised death rates for direct and indirect deaths between 2006 and 2010 are 
presented in Tables 3.7 and 3.8. The numbers of deaths are small and reflect the volatility of 
the rates over time by age groups. For direct maternal deaths, women aged 35 and older had 
the highest rates of maternal mortality. For indirect deaths, however, there was no obvious 
trend. For both direct and indirect deaths, the overall age-standardised rate for maternal 
mortality was the lowest reported since the 1973–1975 triennium. Note that the age-
standardised rates are expressed per 100,000 female population, in contrast to the crude 
MMRs, which are expressed per 100,000 women who gave birth. 
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Table 3.7: Age-specific and age-standardised maternal mortality rates: direct 
maternal deaths, Australia, 1973–2010 
Triennium 
Direct 
deaths 
Aged  
15–19  
Aged  
20–24  
Aged  
25–29  
Aged  
30–34  
Aged  
35–39  
Aged  
40–44  
Age- 
standardised 
 rate(a) 
1973–1975 66 0.25 1.10 1.14 0.42 0.57 1.00 0.74 
1976–1978 52 0.22 0.58 0.70 0.80 0.41 0.73 0.58 
1979–1981 54 0.17 0.80 0.60 0.74 0.39 0.54 0.54 
1982–1984 42 0.11 0.75 0.62 0.23 0.45 0.08 0.37 
1985–1987 32 0.20 0.25 0.40 0.52 0.27 0.00 0.28 
1988–1990 37 0.05 0.35 0.52 0.59 0.26 0.06 0.31 
1991–1993 27 0.00 0.09 0.44 0.28 0.34 0.16 0.22 
1994–1996 46 0.11 0.33 0.48 0.69 0.47 0.10 0.37 
1997–1999 34 0.00 0.20 0.27 0.37 0.58 0.14 0.27 
2000–2002 32 0.10 0.05 0.38 0.45 0.36 (b)0.13 0.25 
2003–2005 29 0.10 0.15 1.00 0.22 0.40 0.13 0.34 
2006–2010(c) 39 0.06 0.13 0.16 0.16 0.28 0.23 0.17 
(a)  Directly age-standardised to the Australian female population aged 15–44 at 30 June 2001.  
(b)  Includes 1 woman aged over 44. 
(c)  2006–2010 is a 5-year period; previously 3-year reporting periods were used.  
Note: Rates expressed per 100,000 female population. 
Table 3.8: Age-specific and age-standardised maternal mortality rates: indirect 
maternal deaths, Australia, 1973–2010 
Triennium 
Indirect 
deaths 
Aged  
15–19  
Aged  
20–24  
Aged  
25–29  
Aged  
30–34  
Aged  
35–39  
Aged  
40–44  
Age-standardised 
 rate(a) 
1973–1975 30 0.06 0.42 0.57 0.31 0.53 0.19 0.35 
1976–1978 35 0.11 0.64 0.53 0.27 0.25 0.46 0.37 
1979–1981 34 0.17 0.39 0.65 0.36 0.30 0.09 0.33 
1982–1984 25 0.11 0.27 0.34 0.29 0.32 0.00 0.22 
1985–1987 30 0.30 0.20 0.75 0.16 0.11 0.00 0.25 
1988–1990 33 0.05 0.20 0.52 0.54 0.26 0.06 0.27 
1991–1993 21 0.15 0.09 0.24 0.32 0.15 0.05 0.17 
1994–1996 20 0.00 0.10 0.19 0.55 0.09 0.00 0.16 
1997–1999 (b)28 0.16 0.05 0.41 0.37 0.27 0.05 0.22 
2000–2002 52 0.15 0.26 0.75 0.90 0.22 0.13 0.41 
2003–2005 36 0.15 0.24 0.34 0.48 0.31 0.13 0.28 
2006–2010 (c)57 0.06 0.32 0.19 0.40 0.38 0.13 0.25 
(a)  Directly age-standardised to the Australian female population aged 15–44 at 30 June 2001. 
(b)  Data do not include 2 indirect deaths in the 1997–1999 triennium that were notified or amended after the 1997–1999 report was published.  
(c)  Includes 1 woman aged over 44. 
Notes 
1.  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
2.  Rates expressed per 100,000 female population. 
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Parity 
Table 3.9 shows the direct maternal deaths by parity and age group. Parity is the number of a 
woman’s previous pregnancies that result in a live birth. Fifteen per cent of the women who 
died had 4 or more previous births. Only 3.9% of the women who gave birth in 2006–2010 
had 4 or more previous births, indicating that women of high parity are at greater risk of 
mortality.  
Table 3.9: Direct maternal deaths by parity and age group, 
Australia, 2006–2010 
Age group 
Parity (number) 
0 1 2 3 ≥4 Total 
<25 3 2 2 0 0 7 
25–29 1 3 1 1 0 6 
30–34 2 1 1 0 2 6 
35–39 2 2 2 3 2 11 
≥40 1 3 1 2 2 9 
Total 9 11 7 6 6 39 
Remoteness 
In Australia, remoteness is an important demographic variable that can be used as a proxy 
for access to health care. Data on area of usual residence were supplied as a postcode. 
Postcode is not designed as a geographical instrument, and in some cases can be inaccurate 
as an indicator of usual residence. These postcodes have been mapped to levels of 
remoteness using the Australian Bureau of Statistics (ABS) Australian Standard 
Geographical Classification (ASGC) Remoteness Area structure. Postcode was not reported 
in 35.6% of maternal deaths. This reflected largely the non-supply of that data by 1 
jurisdiction. Over the period 2006–2010, 69.6% of births and 41.4% of maternal deaths 
occurred in Major Cities (Table 3.10). However, 2.8% of births occurred in Remote/Very remote 
areas, 5.1% of direct and 1.8% of indirect deaths occurred in Remote/Very remote areas. Some 
women, especially those with identified chronic or pregnancy-related diseases who are 
residents in Remote areas, are relocated to cities to give birth and have their temporary, rather 
than usual, address recorded. As a result, the actual number of women resident in Very 
remote areas is understated.  
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Table 3.10: Number and percentage of women who gave birth by remoteness area of usual 
residence and type of death, Australia, 2006–2010 
Remoteness area 
of usual residence 
Number of 
women who 
gave birth 
Percentage of 
total number 
of women 
who gave 
birth 
Percentage of 
direct deaths 
Percentage of 
indirect 
deaths MMR(a) 
Total 
(%) 
Major cities 1,008,628 69.6 48.7 35.1 4.1 41.4 
Inner regional 260,271 18.0 15.4 10.5 4.6 12.1 
Outer regional 134,966 9.3 5.1 10.5 5.9 8.1 
Remote/Very 
remote 41,121 2.8 5.1 1.8 7.3 3.0 
Not stated  2,891 0.2 25.6 42.1 .. 35.4 
Total(b) 1,448,445 100.0 100.0 100.0 6.8 100.0 
(a) Deaths per 100,000 women who gave birth 
(b) Includes a non-Australian resident. 
Country of birth 
For this report, only maternal country of birth was collected; information on ethnicity is not 
routinely collected in perinatal data collections. No information on whether women were 
new migrants or refugees was available. The NMMAC has recognised that more detailed 
information is needed on these groups of women and the new National Maternal Death 
Reporting (NMDR) form intended for implementation in 2015 includes this information.  
Maternal country of birth was unknown in 12 (12%) of the 99 maternal deaths (Table 3.11). 
Of the 87 women where country of birth was known, 64 (73.6%) were born in Australia. 
There were 23 maternal deaths of women whose country of birth was other than Australia 
and these women were born in 18 countries. The proportion of deaths to women born 
outside of Australia (26.4%, where country of birth was known) was similar to the 
proportion (25.5%) of births to these women between 2006 and 2010. Women born in New 
Zealand accounted for 2.7% of women who gave birth in Australia and 7 (7.1%) of the 
maternal deaths in Australia between 2006 and 2010. There were 2 maternal deaths of 
women born in the UK. The small number of deaths over the 5-year period limits further 
analysis by country of birth.  
Table 3.11: Maternal deaths by country of birth, Australia, 2006–2010 
 
Total number of 
women who gave 
birth 
Percentage of total 
number of women 
who gave birth 
Number of 
maternal deaths 
MMR 
 
Australia 1,071,065 73.9  64 6.0 
Other 368,947 25.5  23 6.2 
Unknown 8,433 0.6  12  .. 
Total 1,448,445 100.0  99 6.8 
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Gestation of pregnancy at time of death  
The number of maternal deaths relative to the gestation of pregnancy is presented in Table 
3.12. Two-thirds of maternal deaths (65.7%) occurred after the pregnancy had ended  
(post-pregnancy, 65 deaths), 27.3% occurred during pregnancy (antepartum, 27 deaths) and 
7.1% occurred during childbirth (intrapartum, 7 deaths).  
The pregnancy associated with a maternal death could end with the death of the baby as a 
miscarriage or induced abortion before 20 weeks gestation, or with a birth (live or stillborn) if 
the gestation is 20 or more weeks. In total, 29 (29.3%) maternal deaths occurred in women 
who had not given birth at the time of death. These included all 27 of the antepartum deaths 
and 2 of the 7 intrapartum deaths (Table 3.12). There were 19 maternal deaths that occurred 
on the day of giving birth or termination of pregnancy. A further 14 maternal deaths 
occurred over the next 2 days. After this time, deaths became increasingly sporadic, with 25 
deaths between day 1 and day 20 postpartum and a further 9 deaths between day 21 and day 
42. In 3 cases, the interval between the end of pregnancy and the time of maternal death was 
not known. 
Gestational age was measured as completed pregnancy duration. Gestational age was 
identified for all but 1 of the 34 maternal deaths that occurred during pregnancy or 
childbirth, but for only 32 of the 65 maternal deaths that occurred after the pregnancy had 
ended (Table 3.12). Among the 65 maternal deaths with known pregnancy gestation, 
43 (66.2%) followed pregnancies with gestational age of less than 37 weeks and 22 (33.8%) 
with gestations of 37 or more weeks. The type of maternal death differed by known 
pregnancy gestation. Whereas 74.4% of maternal deaths associated with pregnancies with a 
gestational age of less than 37 weeks were due to indirect causes, maternal deaths associated 
with pregnancies of 37 or more weeks’ gestational age were predominantly due to direct 
causes (63.6%). However, caution is required when interpreting the data in view of the large 
number of cases for which gestational age was not available. 
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Table 3.12: Maternal deaths by gestation and type of death, Australia, 2006–2010 
Time of death by gestation (weeks) Direct Indirect Not classified Total 
Antepartum deaths     
<20(a) 3 7 1 11 
20–27 1 3 1 5 
28–36 n.p. n.p. 0 5 
≥37 2 3 0 5 
Not stated 1 0 0 1 
Total antepartum – – – 27(b) 
Intrapartum deaths     
<20(d) 0 0 0 0 
20–27 0 0 0 0 
28–36 n.p. n.p. 0 1 
≥37 4 2 0 6 
Not stated 0 0 0 0 
Total intrapartum – – – 7(c) 
Post-pregnancy deaths(d)     
<20(d) 1 6 0 7 
20–27 1 1 0 2 
28–36 2 10 0 12 
≥37 8 3 0 11 
Not stated 15 17 1 33 
Total post-pregnancy    65 
Total 39 57 3 99 
(a) Birth is defined as gestation of greater than 20 weeks and/or 400 grams birthweight  
(b) All these maternal deaths occurred in women who were pregnant at the time of death 
(c) Two of the 7 maternal deaths occurred in women who were pregnant at the time of death 
(d) Deaths following a pregnancy of 20 or more weeks gestation are referred to as postpartum deaths 
n.p. not published (data cannot be released due to quality issues, confidentiality or permission not granted) 
Mode of birth 
Of the 65 women whose pregnancies ended during or after childbirth, 7 died during 
childbirth and 58 died in the postpartum period (Table 3.12). Table 3.13 shows that 41 of the 
65 women (63.1%) who gave birth had a caesarean section. This compares with 31.2% of 
women who gave birth and subsequently died by caesarean section in Australia in  
2006–2010. The UK’s Royal College of Obstetricians and Gynaecologists (RCOG) 
classification of caesarean section was used to categorise the urgency of the caesarean 
section, with the addition of the ‘peri or post mortem’ category of fetal retrieval. There was 
limited information on the indications for the classification at the national level or if there 
was morbidity associated with the procedure. There was no such information for 9 (22.0%) 
women. Sixteen caesarean sections (39.0%) were performed because of an immediate threat 
to life of the mother or baby. In contrast, 11 (26.8%) were performed with no immediate 
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threat to the life of the mother or baby. Five caesarean sections (12.2%) were performed peri- 
or post-mortem. 
Table 3.13: Maternal deaths by type of death and urgency of caesarean section, Australia, 
2006–2010 
 Type of death 
Urgency of caesarean section Direct Indirect Total 
Immediate threat to life of mother or baby  8 8 16 
Maternal or fetal compromise with no immediate threat to life 4 3 7 
No maternal or fetal compromise but needs early delivery 1 1 2 
Delivery timed to suit woman or staff  2 0 2 
Peri- or post-mortem 1 4 5 
Not stated 4 5 9 
Total 20 21 41 
Where the women died 
For the first time, information is presented on the type of hospital department, unit or service 
within the hospital setting the woman was admitted to at the time of death. This information 
was available for 70 deaths that occurred in hospital. Table 3.14 shows that the majority of 
the women who died in hospital did so outside of the maternity setting, which reflects that 
the women had access to multidisciplinary care in a variety of hospital settings. The most 
common place of death was in an intensive care unit (ICU) (37.1%). Among direct deaths, the 
main causes of death were amniotic fluid embolism, pulmonary embolism, obstetric 
haemorrhage and eclampsia, with almost two-thirds of deaths occurring in the ICU or 
theatre. In contrast, for indirect deaths where the main causes of death were cardiac disease 
or psychosocial morbidity, one-third occurred in the ICU, with only 2.7% in theatre. The 
place of death has implications for the identification and reporting of maternal deaths. 
Routine notification of maternal deaths from ICUs should be encouraged. These data 
provide a snapshot of where women who suffer catastrophic events and severe morbidity 
are managed and can inform the planning of maternity services. 
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Table 3.14: Maternal deaths by location and setting of death in hospital and type of death, 
Australia, 2006–2010 
 
Number 
Direct 
(%) 
Indirect 
(%) 
Unclassified 
(%) 
Total hospital 
deaths 
(%) 
Maternity setting 4 6.7 2.7 33.3 5.7 
Intensive care unit 26 40.0 37.8 0.0 37.1 
High-dependency unit 0  0.0 0.0 0.0 0.0 
Emergency department 5 3.3 8.1 33.3 7.1 
Coronary care unit 0 0.0 0.0 0.0 0.0 
Psychiatric unit 2 0.0 5.4 0.0 2.9 
Theatre 8 23.3 2.7 0.0 11.4 
Other 10 6.7 21.6 0.0 14.3 
Unknown 15 20.0 21.6 33.3 21.4 
Total 70 100 100 100 100 
In summary 
The MMR for 2006–2010 was 6.8 per 100,000 women who gave birth in Australia. Amniotic 
fluid embolism, pulmonary embolism and obstetric haemorrhage remained the leading 
causes of direct maternal deaths in Australia, while cardiac deaths and deaths related to 
psychosocial morbidity continued to be the leading causes of indirect maternal deaths. Older 
women of higher parity were at higher risk of pregnancy-related mortality.  
Australia and New Zealand 2006–2009 
The MMR for Australia for the 4-year period 2006–2009 was 7.1 per 100,000 women giving 
birth. It is significantly lower than the New Zealand MMR of 19.2 per 100,000 women giving 
birth (maternities) for the same time period (PMMRC 2011). The higher MMR associated 
with the pregnancy-related H1N1 influenza pandemic in New Zealand in 2009 (4 deaths) has 
partially contributed to the higher MMR reported in New Zealand. Different denominators 
were used in the calculation of the MMRs for the 2 countries. The New Zealand denominator 
for calculating the MMR termed ‘maternities’ is defined as all live births plus fetal deaths at 
20 weeks or beyond, or weighing 400 grams or more if gestational age was unknown. This 
does not explain the difference in rates because there would be minimal impact on the rates 
with the Australian denominator defined as the number of women who gave birth to at least 
1 or more live born or stillborn baby of at least 20 weeks gestation or at least 400 grams 
birthweight. 
The validity of the comparison of the MMRs between Australia and New Zealand is 
compromised by the different maternal mortality review processes, classification and 
ascertainment measures used in New Zealand. The higher MMR for New Zealand may 
reflect the enhanced surveillance and centralised maternal mortality review established in 
2006 under the auspices of the Perinatal and Maternal Mortality Review Committee, and the 
volatility of small numbers. Further, there are differences in the process for identifying 
maternal deaths in New Zealand. Although some maternal deaths are identified through the 
death certificate, the majority of deaths are identified by clinicians.  
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Australia and the United Kingdom 2006–2008 
The MMR for Australia for the 3-year period 2006–2008 was 6.8 per 100,000 women giving 
birth at ≥24 weeks gestation, which was significantly lower than the UK’s MMR of 11.4 per 
100,000 maternities (CMACE 2011). As for New Zealand, the validity of the comparison of 
Australian and the UK’s MMRs is limited by the different review processes, classification 
and ascertainment measures between the countries. Conversely, the UK has the advantage of 
more accurate denominator data, including both live births at any gestation or stillbirths 
occurring at or after 24 completed weeks of gestation that are required to be notified by law. 
The difference in the review process is discussed further in ‘Chapter 9 Quality of maternal 
death reviews in Australia’ of this report. 
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4 Direct and indirect maternal deaths 
This chapter presents the findings related to direct and indirect maternal deaths by grouped 
causes of death. Sections are presented in order of frequency of the conditions that caused 
the death. The most common cause of death, ‘Cardiac disease’, is presented first and the least 
common cause of death, ‘Deaths due to early pregnancy’, is presented last. The NMMAC 
decided that deaths related to psychosocial morbidity should be discussed in a separate 
chapter in order to give prominence to the condition. 
For each of the grouped causes of death presented in this chapter, a standard set of 
information is presented. This includes an introduction to the topic, an introduction to 
morbidity data for the same condition (where available) and an overview of the information 
on the women who died. Good practice guidance highlights areas of clinical relevance that 
have been selected by relevant experts in the field of perinatal health. The good practice 
guidance includes key findings, reference to published guidelines or position statements and 
clinical guidance.  
4.1 Cardiac disease 
Good practice guidance 
• All women with high-risk pregnancies due to cardiovascular disease should be 
referred to appropriate multidisciplinary tertiary services, which provide access to 
cardiac investigations and cardiologists and/or physicians with expertise in this area.  
• Women with known cardiovascular disease should have access to pre-pregnancy 
counselling. This should ideally be offered at the onset of menarche and should 
include appropriate contraceptive advice.  
• Autopsy should be advocated on women where the cause of death may be cardiac- 
related. 
• Shortness of breath, palpitations, presyncope and syncope, chest pain and oedema may 
be symptoms of cardiac disease in a pregnant woman and should be assessed 
appropriately and referred for physician review if necessary.  
• Women with severe chest or abdominal pain must be investigated with appropriate 
thoracic or abdominal imaging. 
Sources: RCOG 2011a; NMMAC review of cases 
It is estimated that 5% of Australian women aged under 45 have cardiovascular disease 
(AIHW 2011). To date there has been no national study on severe maternal morbidity from 
cardiac causes and the incidence of cardiovascular disease in pregnancy is unknown. The 
UKOSS undertook a study of acute myocardial infarction (AMI) in pregnancy between 2005 
and 2010, which gave an estimated incidence of 0.7 non-fatal MIs per 100,000 women giving 
birth to 1 or more live or stillborn infants at 24 weeks gestation or more. 
Rheumatic heart disease (RHD) is a rare condition with high morbidity and mortality. The 
increased cardiac demands of pregnancy are often accompanied by the appearance of cardiac 
symptoms in women with RHD, even if they have been well and without symptoms before 
pregnancy. Although cases of RHD have mostly disappeared in Australia, Aboriginal and 
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Torres Strait Islander women have among the highest documented rates of RHD in the 
world (AIHW 2004). The AMOSS commenced a national study of RHD in pregnancy in 2012. 
This study aims to provide an evidence base to improve clinical care and associated maternal 
and perinatal outcomes for women with RHD in pregnancy. 
Deaths from cardiac disease in 2006–2010 
There were 15 indirect maternal deaths from cardiac-related causes between 2006 and 2010, 
making cardiovascular disease the most common cause of maternal death for this period. 
The MMR for cardiac-related deaths for 2006–2010 was 1.0, compared with 1.7 in 2003–2005 
(Table 4.1).  
Table 4.1: Deaths from cardiac disease, 
rates per 100,000 women, Australia,  
2000–2010 
  Number MMR(a) 
2000–2002 12 1.6 
2003–2005 13 1.7 
2006–2010(b) 15 1.0 
(a)  Deaths per 100,000 women who gave birth. 
(b) 2006–2010 is a 5-year period; previously 3-year 
reporting periods were used. 
The mortality rate for cardiac disease in Australia is similar to comparable countries 
internationally such as the UK (MMR 2.31 cardiac deaths per 100,000 women giving birth to 
1 or more live or stillborn infants at 24 weeks gestation or above) (CMACE 2011). In 2008, a 
New South Wales-based study linking birth records to death records not only provided 
additional evidence showing that cardiovascular disease was the leading cause of indirect 
maternal death, but also showed that many of the deaths identified were late deaths. The 
current reporting system in Australia does not routinely collect information on late maternal 
deaths; therefore, given the New South Wales linkage study, the burden of cardiac disease 
contributing to all maternal deaths may be higher than recorded in this report (Cliffe et al. 
2008). These statistics show that women who die in pregnancy are more likely to die from a 
cardiac condition than from any other cause.  
Risk factors contributing to cardiac deaths in pregnancy include: increasing maternal age; 
increasing adverse lifestyle factors—obesity, smoking, poor diets and alcohol; increased 
diagnosis of inherited disorders pre-pregnancy, such as inherited cardiomyopathy; and 
increasing numbers of women with pre-existing congenital heart disease surviving into 
adulthood due to improved medical treatment and embarking on pregnancies (Lupton et al. 
2002). Women are giving birth at older ages, with almost 23% of women who gave birth in 
2010 being over the age of 35 (Li et al. 2012). Older mothers have higher rates of 
comorbidities including obesity, diabetes and hypertension, which increase their risk of 
developing cardiovascular disease. It is reasonable to expect that with this reproductive 
trend towards older pregnant women with complex medical problems and more risk factors, 
the incidence of cardiovascular disease in pregnant women is going to continue to increase. 
The NMMAC recommends that clinicians understand that cardiovascular diseases in 
pregnancy are no longer seen as one-off events, but should be recognised as part of a larger 
spectrum of maternal morbidity and mortality.  
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There were 4 deaths due to ischaemic heart disease (IHD), 3 due to dissection of the aorta 
and 3 due to congenital heart disease. The 4 deaths from IHD were caused by myocardial 
infarction and atherosclerosis. There were 2 deaths from other cardiac causes: 1 from acute 
bacterial endocarditis and 1 from Takayasu arteritis. There were 3 other deaths where the 
cause of death could not be determined, one in the absence of autopsy. This death is reported 
as ‘cardiac failure’ because the woman had known pulmonary hypertension as a sequela of 
RHD. The other 2 deaths that were undetermined were both sudden deaths where the 
coroner concluded a cardiac cause was likely. Table 4.2 compares the causes of indirect 
deaths due to cardiac disease between 2006 and 2010 with the previous 2 reporting periods.  
Table 4.2: Indirect maternal deaths due to cardiovascular disease by 
cause, Australia, 2000–2010 
Cause of death  2000–2002 2003–2005 2006–2010(a) 
Myocardial infarction 2 .. 2 
Atherosclerosis 1 .. 2 
Congenital heart disease 3 3 3 
Aortic dissection 2 3 3 
Cardiac failure 2 1 1 
Undetermined .. 1 2 
Peripartum cardiomyopathy 1 1 0 
Primary pulmonary 
hypertension diagnosed 
at autopsy .. 1 .. 
Takayasu arteritis .. .. 1 
Endocarditis   1 
Total 11 10 15 
(a)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
Note: Three late maternal deaths were also reported, but not included in this table for the 2000–2002 
triennium. Three direct maternal deaths due to peripartum cardiomyopathy were reported but 
are not included in this table for the 2003–2005 triennium.  
There were 2 deaths reported in other chapters of the report where cardiac conditions 
contributed to the death: 1 from H1N1 influenza on a background of corrected Tetralogy of 
Fallot, and 1 in a woman with massive haemorrhage on a background of IHD. There was 1 
death from hypertensive cardiomyopathy which was classified as an incidental death and is 
reported in ‘Chapter 6 Incidental deaths’.  
Table 4.3 shows the cause of death, age group, parity and timing of death for the 15 women 
who died from cardiac causes. The timing of the deaths range between 11 and 40 weeks 
gestational age, with more occurring in the third trimester and in the postpartum period. The 
median maternal age of the women who died due to cardiac disease was 34. The median age 
of women giving birth in Australia in 2010 was 30 (Li et al. 2012). Of the 15 women who 
died, 2 died during the antepartum period, 1 died intrapartum at term and 12 died 
postpartum (Table 4.3).  
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Table 4.3: Maternal deaths due to cardiac disease by cause, woman’s age, parity, 
timing of death and gestational age, Australia, 2006–2010 
Age group  Principal cause of death Parity(a) Timing of death 
Gestational age 
at birth or death 
(weeks)  
20–24 Pulmonary hypertension M Postpartum 29 
20–24 Cardiac ischaemia M Postpartum Unknown 
20–24 Acute bacterial 
endocarditis 
Not 
stated 
Within 24 hours of 
giving birth Unknown 
25–29 Ruptured aortic aneurysm N Intrapartum 40 
30–34 Intracerebral 
haemorrhage  
(Takayasu arteritis) N Postpartum Unknown 
30–34 Acute myocardial 
infarction 
Not 
stated 
Within 24 hours of 
giving birth 11 
30–34 Mitral valve prolapse N Antepartum 15 
30–34 Ruptured dissection of  
thoracic aorta 
N Within 24 hours of 
giving birth 
Unknown 
35–39 Type A aortic aneurysm N Postpartum 32 
35–39 Undetermined M Postpartum 18 
35–39 Atrial and ventricular  
septal defect M Postpartum 35 
35–39 Cardiac  N Postpartum Unknown 
35–39 
Cardiac disease M 
Within 24 hours of 
giving birth 38 
≥40 Coronary artery 
atherosclerosis M 
Within 24 hours of 
giving birth 25 
≥40 
Unascertained 
Not 
stated Antepartum 37 
(a) N = nullipara; M = multipara. 
The NMMAC noted that early multidisciplinary care, including cardiology referral, is 
recommended for pregnant women with cardiac disease. Limited details on the pregnancy 
for the women discussed here was available and it is not known whether they were referred 
for specialist care earlier in pregnancy. 
For the 15 women who died of cardiac disease, comorbidities and lifestyle factors such as 
body mass index (BMI), smoking status, hypertension and diabetes were inadequately 
reported. In 40% to 66.7% of cases, these risk factors were not reported to the NPESU and 
therefore data are not presented in this report.  
Thirteen of the 15 women who died were referred to the coroner and 12 had an autopsy. In 1 
case, the family did not consent to an autopsy. An autopsy allows clarification of the cause of 
death because numerous medical conditions may present with similar symptoms. There are 
also a number of cardiac diseases causing sudden cardiac death with a genetic basis, which 
may have implications for family members.  
Congenital heart disease  
There were 3 deaths in women with congenital heart disease: 1 woman had myocarditis in 
prolapsed mitral valve; 1 had an undiagnosed atrial ventricular septal defect (AVSD); and 1 
where the cause was undetermined at the time of publication but a past history of significant 
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congenital heart disease was noted in the data collected and at NMMAC review. One woman 
died from a respiratory infection on a background of corrected Tetralogy of Fallot and is not 
reported in this chapter. The women who died were aged between 33 and 39. Two women 
presented with the morbid event near term and 1 early in the second trimester. One died 
before admission to hospital and 2 had pulmonary hypertension at initial investigation and 
deteriorated rapidly with death occurring within days of the reported onset of symptoms.  
Case summary 
A multiparous woman who presented to the emergency department late in second 
trimester gestation was complaining of shortness of breath for 2 hours. CT pulmonary 
angiogram findings were consistent with severe pulmonary hypertension. An 
echocardiogram showed a previously undiagnosed atrial ventricular septal defect, severe 
right ventricular dilatation and dysfunction and severe pulmonary hypertension. The 
woman gave birth to a live born infant by caesarean section. Her cardiac condition 
deteriorated 10 days post-operatively leading to a cardiac arrest. Cause of death: atrial 
ventricular septal defect and pulmonary hypertension.  
Women with known heart disease should be properly assessed pre-conception. For those 
with congenital heart disease, discussions around pregnancy should be carried out at the 
onset of menarche and before pregnancy is planned. Counselling should be offered that 
includes discussion and advice on appropriate methods of contraception. It is unknown 
whether this occurred for the women presented in this chapter.  
Ischaemic heart disease 
There were 4 deaths from ischaemic heart disease. Two of the deaths were due to acute 
myocardial infarction (AMI) in late pregnancy and 2 were due to atherosclerotic disease, 
with associated comorbidities listed as contributing factors. There was 1 death that is 
reported in ‘Section 4.8 Influenza in pregnancy’ where a known background of IHD 
contributed to the death. The women who died were aged between 24 and 45. All of the 
women had known risk factors for cardiovascular disease, including hypertension, obesity 
and diabetes mellitus.  
Shortness of breath 
Three of the 15 women discussed in this chapter were investigated for symptoms of 
shortness of breath in pregnancy. For 1 of the women reported here, and for others reported 
in previous maternal death reports, an initial diagnosis of pulmonary embolus was recorded 
on the death certificate. Cardiac ischaemia was later discovered at autopsy. It is an important 
clinical point to note that symptoms of shortness of breath and oedema in a pregnant woman 
require consideration of cardiac disease as the diagnosis, as well as considering pulmonary 
embolism.   
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Case summary 
A multiparous woman aged over 35 with previously uncomplicated pregnancies gave birth 
spontaneously. She re-presented a couple of days postpartum to hospital with signs of 
presumed acute sepsis and underwent investigation for persistent hypotension and 
tachycardia. An echocardiogram revealed dilated ventricles indicative of cardiomyopathy. 
On intubation to provide life support, cardio-respiratory arrest occurred; resuscitative 
measures, including cardio-pulmonary bypass and open cardiac massage, were 
unsuccessful. Cause of death: acute congestive cardiac failure with pulmonary oedema in 
association with myocardial ischaemia. 
Aortic dissection 
There were 3 deaths from aortic dissections in ruptured aortic aneurysms. All dissections 
were Type A (ascending aorta); 1 occurred at greater than 30 weeks gestation and the other 2 
at term. The women who died were aged between 26 and 36. In 1 of the cases, the pathologist 
did not comment on the cause of the aneurysm. In another, the pathologist commented on 
the possibility of an underlying connective tissue disorder such as Marfan’s syndrome. For 
the third case, the autopsy report was not available. During 2006–2010, there were 6 maternal 
deaths from ruptured splenic artery aneurysms, which are reported in ‘Section 4.2 Non-
obstetric haemorrhage’, and 1 death of a woman with Barlow’s syndrome (valvular disease, 
which is common but very rarely associated with Marfan’s syndrome). It is noteworthy that 
women with underlying connective tissue disease are at risk of aortic dissection in 
pregnancy, as are those with bicuspid aortic valve. In addition, pregnant women who had 
previous normal pregnancies may also suffer this complication. The UK Saving mothers’ lives: 
Reviewing maternal deaths to make motherhood safer, 2006–2008 report recommends that women 
with severe chest or abdominal pain requiring opiate analgesia must be investigated with 
appropriate imaging such as computed tomography chest scan, magnetic resonance imaging, 
transthoracic or transoesophageal echocardiogram (CMACE 2011).  
Other deaths 
There was 1 death from cardiac failure as a sequela of RHD. There was 1 death from infective 
endocarditis and 1 from the sequelae of Takayasu arteritis. The 2 deaths of undetermined 
cause were sudden unexpected deaths. Both of these cases were reviewed by the coroner and 
were determined to be due to suspected ‘cardiac causes’, although the exact cause of death 
could not be determined.  
Summary 
Cardiac disease represented the largest cause of indirect maternal deaths between 2006 and 
2010 in Australia and accounted for 15% of maternal deaths overall and 26% of indirect 
deaths. This proportion will likely rise given the increasing cardiovascular risk factors 
including smoking, increasing maternal age, obesity, diabetes and hypertension. This may 
result in an increase in women with acquired cardiac disease such as IHD embarking on 
pregnancy, as well as the increasing number of women with known congenital heart disease 
embarking on pregnancies. The true burden of pregnancy-related cardiovascular morbidity 
and mortality in Australia has not been fully characterised, with some of the current research 
suggesting under-reporting.  
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Clinicians caring for pregnant women need to be aware of the increasing burden of 
cardiovascular disease in Australia. Consideration needs to be given to pre-existing or new 
onset heart disease in pregnant women who present with cardiovascular symptoms, and 
these patients should be referred for appropriate and timely cardiovascular investigation and 
management. This management may involve referral to a multidisciplinary tertiary hospital 
where there is expertise in the management of cardiac disease occurring in pregnancy 
(RCOG 2011a). Future research should be aimed at facilitating improvements in the 
recognition, prevention and treatment of cardiac disorders and providing the evidence base 
for effective planning of maternity services in Australia.  
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4.2 Non-obstetric haemorrhage 
Good practice guidance 
• Ruptured splenic artery aneurysm (SAA) should be considered in the differential 
diagnosis of a pregnant woman with severe and unexplained abdominal pain, 
regardless of whether pain or shock is the most prominent feature at the time of 
evaluation (Selo-Ojeme & Welch 2003). 
• Neurological symptoms in pregnant women suggest an urgent review and cerebral 
imaging if indicated (CMACE 2011). 
Severe non-obstetric haemorrhage related maternal morbidity 
Splenic artery aneurysm (SAA) is a rare condition and the published literature mainly 
consists of single case reports and literature reviews. The research discussed in this report is 
limited in its statistical power. There have been no major studies on SAA and the prevalence 
is unknown and difficult to determine because most cases are asymptomatic. One study 
found that splenic artery aneurysms were found incidentally on 0.78% of angiograms  
(Selo-Ojeme & Welch 2003).  
It is known that SAA is more frequent in women, with up to 58% of cases occurring in 
women of child-bearing age and up to 95% during pregnancy (Ha et al. 2009). Although 
rupture can occur at any time during pregnancy and in the immediate postpartum period, 
most occur in the third trimester (Selo-Ojeme & Welch 2003). Pregnancy leads to increased 
blood volume, compression of the aorta and iliac vessels from the uterus (which increases 
proximal blood flow) and hormonal changes, which affect arterial wall structure. These 
combined effects stress the vessel wall, and the splenic artery is progressively weakened by 
successive pregnancies, leading to an increased incidence of SAA, and also increased 
frequency of rupture with increased parity (Ha et al. 2009; Hillemanns et al. 1996; Selo-Ojeme 
& Welch 2003). Mortality in pregnancy is reported at a disproportionately high rate. In the 
non-pregnant population, mortality following rupture has been reported to be 
approximately 25%. Rupture during pregnancy is associated with a maternal mortality rate 
of 70% and a fetal mortality rate of 90% (Hillemanns et al. 1996). 
Deaths from non-obstetric haemorrhage between 2006 and 2010 
There were 12 maternal deaths due to non-obstetric haemorrhage between 2006 and 2010, 
giving an MMR of 0.8 per 100,000 women who gave birth (Table 4.4). For the purposes of this 
report, non-obstetric haemorrhage is defined as haemorrhage occurring from sites other than 
the genital tract. Ten of the deaths were classified as indirect maternal deaths, 1 was 
classified as a direct death and another death required further classification. There were 5 
deaths from ruptured splenic artery aneurysm and 7 deaths from intracerebral haemorrhage. 
In previous reporting periods, there were 5 deaths due to non-genital tract haemorrhage 
between 2003 and 2005 and 9 deaths between 2000 and 2002 (Table 4.4).  
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Table 4.4: Deaths from non-obstetric 
haemorrhage, Australia, 2000–2010 
Reporting period Number MMR(a) 
2000–2002 9 1.2 
2003–2005 5 0.6 
2006–2010(b) 12 0.8 
(a) Deaths per 100,000 women who gave birth. 
(b) 2006–2010 is a 5-year period; previously 3-year reporting 
periods were used. 
There were 12 deaths from non-obstetric haemorrhage between 2006 and 2010—five from 
ruptured splenic artery aneurysm and 7 from intracerebral haemorrhage. There were 
2 deaths from cerebral infarcts reported in ‘Section 4.10 Deaths due to other causes’. Of the 7 
deaths from intracerebral haemorrhage, 1 was due to a spontaneous acute intracranial 
haemorrhage, 2 were due to spontaneous haemorrhage from an arteriovenous malformation 
and 4 were due to subarachnoid haemorrhage including 3 from a ruptured Berry aneurysm. 
The age group, parity and gestation of the women who died are shown in Table 4.5. The 
majority of women who died were aged over 30 (10 of 12). Parity ranged between 0 and 4, 
and 10 of the 12 women who died were more than 20 weeks gestation or postpartum at the 
time of death.  
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Table 4.5: Deaths from non-obstetric haemorrhage, by cause, 
age group and parity, Australia, 2006–2010 
Cause of death 
 Ruptured splenic 
artery aneurysm 
Intracerebral 
haemorrhage 
Total 
Age group    
<20 0 0 0 
20–24 0 1 1 
25–29 1 0 1 
30–34 2 3 5 
35–39 1 3 4 
≥40 1 0 1 
Parity    
0 1 1 2 
1 2 4 6 
2 1 0 1 
3 1 1 2 
≥4 0 0 0 
Not stated 0 1 1 
Gestational age group    
Antepartum/Intrapartum    
< 20 weeks 0 1 1 
≥20 weeks  1 2 3 
Postpartum 3 4 7 
Not stated 1 0 1 
Total 5 7 12 
Ruptured splenic artery aneurysm 
The 5 cases of ruptured splenic artery aneurysm that occurred during 2006–2010 are 
significantly more than the 1 case reported during the 2003–2005 triennium and only 
1 reported in the UK during 2006–2008. Splenic artery aneurysm rupture is a rare and  
life-threatening condition. The majority of cases are asymptomatic until rupture, although 
prodromal signs of rupture, such as intermittent epigastric pain, left-side pain or chest pain 
radiating to the left arm do occur in some cases. Three of the women who died reported a 
sudden onset of abdominal pain, which was followed by circulatory collapse.  
Rupture is often misdiagnosed with other common maternity emergencies such as placental 
abruption, uterine rupture or amniotic fluid embolism, as well as other conditions such as 
pulmonary thromboembolism, cholecystitis, appendicitis or perforated peptic ulcer disease 
(Selo-Ojeme & Welch 2003). 
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Case summary 
A multiparous woman in her early 20s collapsed at home at over 30 weeks gestation after 
complaining of abdominal pain. She was admitted to a regional hospital where an initial 
diagnosis of AFE was made. On transfer to a tertiary hospital she was found to have a 
haemoglobin level of 3 g/dL. She suffered a cardiopulmonary arrest and resuscitation was 
unsuccessful. Autopsy: ruptured splenic artery aneurysm. 
In the emergency setting, adequate resuscitation is essential. Management of an SAA or SAA 
rupture requires surgery. The mortality rate for ruptured splenic artery aneurysm in 
pregnancy is approximately 70%. A review of reported cases of SAA rupture in pregnancy 
found that involvement of a general or vascular surgeon was found to be a protective factor 
for mortality (Ha et al. 2009). There were 5 deaths in 13 patients reported where a general 
surgeon wasn’t involved, compared with no deaths in the 9 patients reported that had 
involvement of a general surgeon.  
Intracerebral haemorrhage 
Six of the 7 maternal deaths due to intracerebral haemorrhage between 2006 and 2010 were 
classified as indirect. For the seventh death, there was insufficient information to classify the 
death, and it has been included based on the reported cause of death. There were 
5 spontaneous acute intracranial haemorrhages, 3 of these from ruptured Berry aneurysms. 
There were 2 deaths secondary to rupture in an arteriovenous malformation. Age at death 
ranged between 24 and 38, with a median age of 33. Parity ranged between 0 and 4 (for 1 
woman it was unknown) (Table 4.5). One of the women was at less than 20 weeks gestation 
and 2 were at more than 20 weeks gestation and 4 were postpartum when the haemorrhage 
occurred. None of the haemorrhages were associated with labour. Three of the women died 
before giving birth and 4 died postpartum. One woman underwent a caesarean section 
before the cessation of medical treatment and 1 had a peri-mortem caesarean section. Four of 
the women died in hospital, 1 died at home and for 1 woman the place of death was 
unknown. All of the women who were known to have died in hospital died in an ICU.  
The women who died either collapsed suddenly at home or presented to hospital with a 
headache and in some cases other neurological symptoms and subsequently lost 
consciousness.  
Case summary 
A nulliparous woman at 26 weeks gestation collapsed at home in the bath shortly after 
physical activity. She had no known history of cerebrovascular disease or hypertension. 
Autopsy: ruptured Berry aneurysm leading to subarachnoid haemorrhage.  
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Case summary 
A nulliparous woman at 36 weeks gestation presented to hospital conscious and 
complaining of severe headache. She was noted to be hypertensive. Her conscious state 
gradually deteriorated and she was transferred by ambulance to a regional hospital where a 
CT scan revealed intracerebral haemorrhage. A caesarean section was performed and a live 
born infant delivered. She suffered a cardiac arrest shortly after. Autopsy: ruptured 
aneurysm in the left basal ganglion.  
 
Case summary 
A 32-year-old woman who was in the second trimester of pregnancy developed a severe 
headache with slurred speech and general weakness. She suffered a cardiac arrest in the 
ambulance en route to hospital. On arrival at the hospital a CT scan showed intracerebral 
haemorrhage. She never regained consciousness and was declared brain dead 13 days after 
her admission. Life support was later withdrawn. Autopsy: haemorrhage in anterior-
inferior cerebellar artery. 
The UK report, Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer, 2006–
2008, noted 11 deaths from intracerebral haemorrhage between 2006 and 2008. There were 6 
cases of sudden collapse or rapid deterioration; 4 of these were asymptomatic. In many 
instances reported in Australia and in the UK, women present to hospital in pregnancy with 
potentially serious neurological symptoms. The UK report recommends that ‘women with 
new and potentially serious neurological symptoms in pregnancy must be seen early by a 
specialist who understands that all imaging modalities can be used in pregnancy if 
necessary, and the implications of headache and unilateral weakness or numbness’ (CMACE 
2011).  
Summary 
There were an unusually high number of deaths due to splenic artery aneurysm reported 
between 2006 and 2010. Rupture most commonly occurs in multiparous women in the third 
trimester of pregnancy. Splenic artery rupture is a rare but catastrophic condition and should 
be included in the differential diagnosis for any pregnant women presenting with severe 
abdominal pain. Multidisciplinary care, specifically the involvement of a general surgeon 
may improve chances of survival. Six women died from an intracerebral haemorrhage. The 
majority of the women who died presented to hospital with neurological symptoms. Women 
with potentially serious neurological conditions should be investigated in a timely manner 
and with appropriate imaging. 
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4.3 Amniotic fluid embolism 
Good practice guidance 
• The immediate management of women with suspected amniotic fluid embolism (AFE) 
is prompt cardio-pulmonary resuscitation and coagulation support by a 
multidisciplinary team, and should be undertaken in the same manner as for any other 
cause of collapse with coagulation failure (RCOG 2011b).  
• Autopsy should be advocated in all deaths suspected of being caused by AFE.  
Severe amniotic fluid embolism-related maternal morbidity 
Diagnosis of AFE is difficult and often based on a process of exclusion. The difficulties with 
identifying AFE and the small number of cases mean that it is challenging to study and there 
is limited information available about this disease. The first national population-based 
AMOSS study of AFE was undertaken in Australia and New Zealand for the period 2010–
2012. Preliminary data from the AMOSS study for 2010–2011were used to estimate an 
incidence of 4.1 cases per 100,000 women giving birth to a baby of at least 20 weeks gestation 
or at least 400 grams birthweight (95% CI 2.9–5.6 per 100,000 women giving birth). The 
AMOSS AFE study had a case fatality of 14%. A study in New South Wales, where one-third 
of births in Australia occur, found that 35% (7 out of 20 identified cases) of women with AFE 
died, and in Victoria between 2000 and 2008, 43% (6 out of 14 identified cases) of women 
with AFE died (Knight et al. 2012).  
Although about two-thirds of women and their babies survive AFE, studies show that many 
of these women go on to develop serious morbidity (Knight et al. 2012; Roberts et al. 2010). 
Cerebral injury was noted in 6% of women with AFE in the UK, and cerebral infarction 
occurred in 20% of women in New South Wales (Knight et al. 2012). There is, however, 
limited information available on the long-term effects on women who survive. In Australia, 
the AMOSS AFE study is ongoing to collect national information on all cases of AFE. All 
suspected cases should be reported via the AMOSS online reporting system.  
Deaths from amniotic fluid embolism between 2006 and 2010 
AFE is a rare, but often fatal, condition of pregnancy and occurs when amniotic fluid enters 
the maternal circulation. Fetal skin cells or meconium in the amniotic fluid cause platelet 
thrombi to form, blocking the pulmonary vessels (Medforth et al. 2011). In Australia, the 
death rate from AFE has remained relatively stable over the last 3 triennia (Table 4.6). There 
were 9 deaths due to AFE between 2006 and 2010, giving an MMR of 0.6 per 100,000 women 
who gave birth. All of these deaths were classified as direct maternal deaths.  
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Table 4.6: Direct deaths from AFE, Australia,  
2000–2010  
 Reporting period Number MMR(a) 
2000–2002 10 1.3  
2003–2005 8 1.0 
2006–2010(b) 9 0.6 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year periods were 
used. 
The 9 women who died were aged between 21 and 42, with a median age of 35. Parity 
ranged between 0 and 3. All of the women who died with known gestational age were over 
36 weeks gestation at the time of their death, and 3 women died postpartum. There has been 
a suggested link between induction of labour and AFE (Roberts et al. 2010). Four of the 
women who died had an induction of labour and for 1 woman there were no details of the 
birth event available. All of the women whose labour was induced had prostaglandins for 
this purpose. Table 4.7 shows the type of labour and type of birth for the women who died 
from AFE. 
Table 4.7: Deaths from amniotic fluid 
embolism by type of labour and birth, 
Australia, 2006–2010 
Type of labour Type of birth 
Induced  Caesarean section 
Induced  Caesarean section  
Induced  Caesarean section 
Induced Caesarean section 
No labour Did not give birth 
No labour Caesarean section 
Spontaneous Instrumental vaginal 
Spontaneous Instrumental vaginal 
Not stated Not stated 
The diagnosis of AFE is difficult and often one of exclusion or identified at the autopsy 
(Knight et al. 2012; Roberts et al. 2010; Tuffnell 2002). However, despite the difficulties, in 
many cases a characteristic series of events is highly suggestive of the diagnosis.  
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Box 4.1: Characteristics of AFE 
• Most are likely to occur during labour and birth 
• Signs and symptoms include: 
o dyspnoea 
o restlessness, panic, feeling cold, paraesthesia 
o sudden unexpected collapse 
• Findings on investigation 
o disseminated intravascular coagulation 
o chest X-ray: pulmonary oedema, adult respiratory distress syndrome, right atrial 
enlargement, prominent pulmonary artery 
Source: NMMAC 
Case summary 
A 39-year-old woman in her third pregnancy with a past history of 1 caesarean section at 32 
weeks was treated with aspirin, prednisone and progestins during this pregnancy. The 
placenta was known to be encroaching on lower uterine segment and a repeat caesarean 
section had been booked for 38 weeks. She suffered one episode of vaginal bleeding 
estimated at 500 mL at 37 weeks, and a small episode of further vaginal bleeding 2 days 
before death. She collapsed at home 1 day before the booked caesarean section date 
following a spontaneous rupture of membranes. Resuscitation by the woman’s family 
failed. Autopsy: major placenta praevia (placenta completely covered cervical os) and 
extensive amniotic fluid embolism. 
Early recognition and immediate resuscitation of women with suspected AFE are essential to 
survival. Prompt caesarean section following collapse may be required to facilitate adequate 
cardio-pulmonary resuscitation.  
Diagnosing AFE 
All of the 9 women who died of AFE had an autopsy. AFE was confirmed at autopsy in 7 of 
the cases, all by the presence of fetal squames in the maternal pulmonary circulation. 
Insufficient information was available in the other cases to determine the grounds on which 
the diagnosis was made.  
It is important that consistent and complete information can be collected on rare disorders 
such as AFE. Rare diseases require comprehensive and lengthy surveillance (so that enough 
cases can be collected) to generate sufficient information to guide changes in policy or 
practice (Kayem et al. 2011). An international review of AFE incidence, risk factors and 
outcomes found that reported incidence of AFE in comparable countries such as the UK and 
Australia varied (Knight et al. 2012). It is suggested that these differences in the number of 
cases are due to variation or inconsistencies in the way cases of AFE are identified and 
analysed, rather than actual differences in the number of women who develop an AFE 
(Knight et al. 2012). For example, in the UK, cases of AFE are identified based upon clinical 
diagnosis with strict exclusion criteria. In Australia, where incidence is much higher, cases 
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were identified by suspicion with no formal exclusion criteria. The review also found that the 
available information did not allow an assessment of any potential relationships between 
management and outcome (Knight et al. 2012).  
As discussed in Chapter 9, an inability to make assessments on preventability or the 
standard of care provided limits the usefulness of any data collected. Recommendations 
have been published that highlight the need for a single method of identifying or diagnosing 
AFE (Knight et al. 2012). It is intended that this ‘will allow for valid international 
comparisons and may permit pooling of data to provide more reliable information on 
associated factors, management and outcomes, thus allowing for development of 
preventative and treatment strategies to improve outcomes’ (Knight et al. 2012), and 
potentially prevent deaths and serious morbidity. The AMOSS study may contribute to the 
development of such uniform diagnostic definitions. 
Summary  
AFE, the most common cause of direct maternal death in Australia, remains a poorly 
understood cause of maternal deaths. The persistence of AFE as a leading cause of direct 
maternal death is unlikely to change in light of current knowledge. Given the unexpected 
nature of AFE, it would be wise for maternity services to ensure that they have readily 
accessible guidelines for immediate management, and that they regularly undertake AFE 
management training. A high index of suspicion of AFE should be considered if there are 
signs of respiratory distress, restlessness and altered behaviour indicative of cerebral 
hypoxia. Early and aggressive resuscitation provides the best chance of survival. Autopsy is 
the gold standard of diagnosis in fatal AFE, and should be sought whenever maternal death 
follows unexpected collapse.  
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4.4 Thromboembolism 
Good practice guidance 
• Identification of at-risk women and thromboprophylaxis use saves lives: all women 
should undergo a documented assessment of risk factors for venous thromboembolism 
(VTE) in early pregnancy or before pregnancy. This assessment should be repeated if 
the woman is admitted to hospital for any reason or develops other inter-current 
problems (McLintock et al. 2012; RCOG 2009). 
• Institutions should have guidelines on the management of obesity in pregnancy and 
women requiring thromboprophylaxis should be placed on doses appropriate to their 
weight. 
• Where the cause of death is not clearly known, autopsy should be advocated to 
establish the cause of death. 
Severe thromboembolism-related maternal morbidity 
There is currently no reliable information available in Australia on the number of women 
who experience antenatal pulmonary thromboembolism or their outcomes. The first national 
population-based AMOSS study of antenatal pulmonary embolism was undertaken in 
Australia and New Zealand for the period 2010–2012 and has recently finished data 
collection. Preliminary results for 2010–2011 showed an incidence of 1.2 cases per 10,000 
women giving birth to a baby of at least 20 weeks gestation or at least 400 grams birthweight. 
There were no maternal deaths from the 104 antenatal pulmonary embolism cases in the 
AMOSS study. This is in keeping with a prospective national case-control study of antenatal 
pulmonary embolism undertaken through the UKOSS between 2005 and 2006 that reported 
an incidence of 1.3 cases per 10,000 women giving birth to 1 or more live or stillborn infants 
at 24 weeks gestation or above. Of the women who had an antenatal pulmonary embolism, 
3.5% died (CMACE 2011). Information is available on some risk factors that are associated 
with an increased risk of VTE in pregnancy. These include obesity, older age, smoking and 
operative delivery. These risk factors are prevalent in Australia.  
The prevalence of morbid obesity has risen dramatically in Australia over recent years. The 
AMOSS undertook a prospective national population-based cohort study between 1 January 
and 31 October 2010. Extremely obese pregnant women were defined as BMI > 50 and/or 
weight over 140 kilograms. The study identified 370 extremely obese women with a 
prevalence of 2.14 per 1,000 women giving birth (n = 171,289 women giving birth) (Sullivan 
et al. 2011). In 2010, the proportion of women who smoked during pregnancy was 13.5% 
nationally. There were 93,157 caesarean sections performed the same year, which equates to 
31.6% of all the women who gave birth in Australia in 2010. 
There is no published information on thromboprophylaxis use in pregnancy across 
maternity units in Australia. These data are collected in some states as a requirement for 
hospital accreditation but are not available on a national basis.  
Deaths from thromboembolism between 2006 and 2010 
There were 9 maternal deaths due to thromboembolism between 2006 and 2010. Venous 
thromboembolism is the obstruction of a blood vessel, usually a large vein, with thrombotic 
material carried in the blood from its site of origin (usually the deep veins of the leg) to block 
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another vessel (Medforth et al. 2011). The MMR for thromboembolism for 2006–2010 is 0.6 
per 100,000 women who gave birth, which is unchanged from the 2003–2005 triennium 
(Table 4.8). Pulmonary thromboembolism is a known complication of pregnancy and 
historically has been a leading direct cause of maternal death in Australia and other 
developed nations across the world. It appears that this trend is improving, with the 
proportion of maternal deaths attributable to pulmonary thromboembolism decreasing in 
comparable countries such as the UK and New Zealand. In the UK, where monitoring of 
cases of antenatal pulmonary embolism is more reliable than in Australia, this fall is 
attributed to improved identification of at-risk women and the more widespread use of 
thromboprophylaxis (CMACE 2011). Since the publication of the guidelines, 
Thromboprophylaxis during pregnancy, labour and after normal vaginal delivery (RCOG 2004), the 
UK has reported its lowest mortality rate from thromboembolism to date. This suggests that 
adherence to these guidelines has resulted in improved recognition and management of 
obstetric patients at risk of VTE and has saved lives. 
Table 4.8: Deaths from 
thromboembolism, Australia,  
2000–2010 
Reporting period Number MMR(a) 
2000–2002 3 0.4  
2003–2005 5 0.6  
2006–2010(b) 9 0.6 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year 
reporting periods were used. 
There were 9 deaths in Australia from thromboembolism between 2006 and 2010. Data on 
contributing factors were poorly reported. All of the women died from pulmonary 
thromboembolism. Eight of the deaths were classified as direct and 1 was classified as 
indirect. The indirect death occurred in a woman with a retroperitoneal tumour. Table 4.9 is 
a summary of all maternal deaths in which pulmonary embolism was a principal or 
contributory cause that have been documented in Australia since maternal death reporting 
began in 1964. Pulmonary embolism was previously a leading cause of direct maternal death 
in Australia, ranging from 18% of deaths in 1967–1969 to 9% for 2006–2010. When reviewed 
in conjunction with the UK research, this downward trend in the number of maternal deaths 
from thromboembolism is likely to reflect improved identification and management of  
at-risk women during the antenatal period.  
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Table 4.9: Maternal deaths in which pulmonary embolism was a principal and contributory cause 
by reporting period, Australia, 1964–2010 
Reporting 
period 
During 
pregnancy 
After 
miscarriage/ 
termination of 
pregnancy 
After 
ectopic 
pregnancy 
After 
vaginal 
birth 
After 
caesarean 
section Total  
Total 
number 
of 
deaths 
Percentage 
of total 
1964–1966 3 6 0 22 13 44 275 16.0 
1967–1969 15 0 0 23 5 43 237 18.1 
1970–1972 5 2 1 10 4 22 244 9.0 
1973–1975 4 0 0 6 1 11 137 8.0 
1976–1978 7 0 0 3 3 13 106 12.2 
1979–1981 1 0 0 1 6 8 98 8.1 
1982–1984 1 0 0 1 1 4 94 4.2 
1985–1987 2 0 0 3 2 7 86 8.1 
1988–1990 3 1 0 3 5 12 96 12.5 
1991–1993 2 0 1 2 4 8 84 9.5 
1994–1996(a) 2 0 1 2 4 9 100 9.0 
1997–1999 3 0 0 1 2 6 90 6.7 
2000–2002 2 0 0 2 2 6 84 7.1 
2003–2005(b) n.a. n.a. n.a. n.a. n.a. 5 90 5.6 
2006–2010(c) 2 0 0 3 4 9 99 9.0 
(a)  The total number of deaths includes 9 deaths where the timing of death was unknown. 
(b)  The total number of deaths includes 5 deaths where the timing of death was unknown. 
(c)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
n.a. not applicable 
The women who died due to thromboembolism between 2006 and 2010 were aged between 
18 and 41, with a median age of 28. Parity ranged between 0 and 4. Seven of the deaths 
occurred postpartum, 1 in the immediate postpartum period, 1 occurred in the week 
following birth and 5 died between 7 and 42 days postpartum. There was 1 death with 
sudden collapse in the second trimester of pregnancy. There was 1 death in the first trimester 
of pregnancy in a woman with a complex medical and obstetric history. Table 4.10 is a 
summary of the timing of deaths from pulmonary thromboembolism in relation to 
pregnancy over previous reporting periods.  
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Table 4.10: Direct deaths from pulmonary thromboembolism by timing of death, Australia,  
1994–2010 
Reporting 
period 
Died before 
giving birth 
Died within 24 hours of 
birth or termination of 
pregnancy 
Death 2–6 days 
postpartum 
Death 7–42 days 
postpartum 
Total 
1994–1996 2 1 1 4 8 
1997–1999 3 1 1 1 6 
2000–2002 1 0 1 1 3 
2003–2005(a) n.a. n.a. n.a. n.a. 5 
2006–2010(b) 2 1 1 5 9 
(a)  Information not reported for 2003–2005. 
(b)  2006–2010 is 5-year period; previously 3-year reporting periods were used. 
n.a. not available 
The data collected for these women were of variable quality and adequate details of death 
were only provided for 3 of the 9 women described here. For the other 6 women, it is not 
known whether any of them experienced respiratory symptoms before the morbid event, 
because this information was incomplete at the national level. Additionally, details of the use 
of thromboprophylaxis is not currently collected on the national reporting form used to 
populate this report, so this information was unavailable for many of the women who died. 
 Case summary 
A nulliparous woman aged under 25 with a BMI >35, known smoker and a previously 
uncomplicated pregnancy collapsed at home following a spontaneous birth. On arrival to 
hospital she was found to be asystolic with non-reactive pupils. Resuscitation was 
unsuccessful. Autopsy: pulmonary thromboembolism.  
Risk factors for pulmonary thromboembolism were also inadequately documented, but some 
information can be drawn from the available data. All of the women who died had an 
identifiable risk factor. Four of the women who died had 2 or more risk factors for 
thromboembolism and 3 women had more than 2 risk factors. Four of the 7 women who 
gave birth had their babies by caesarean section. All of the caesarean sections were 
undertaken for factors related to maternal or fetal wellbeing. Three of the 9 women were 
aged over 35. In the 3 women where BMI was known, 2 were morbidly obese (BMI≥40). Of 
the 8 women where smoking status was known, 5 were smokers. One woman had conceived 
through assisted reproductive technology and had a multiple pregnancy. One woman had a 
retroperitoneal malignancy and recent admission to ICU, 1 had pre-eclampsia and 1 had 
gestational diabetes. Table 4.11 provides information on the known risk factors such as BMI, 
parity, mode of birth and smoking status.  
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Table 4.11: Direct deaths from thromboembolism by cause and known risk factors, Australia,  
2006–2010 
Age 
group  Parity(a) Principal cause of death Mode of birth BMI(b) Smoking 
25–29 M Pulmonary embolus Caesarean section Not stated Smoker 
≥40 N Pulmonary embolus Before giving birth Not stated Not stated 
25–29 M Pulmonary embolus Caesarean section Normal Non-smoker 
≥40 M Pulmonary thromboembolism 
Non-instrumental 
vaginal Not stated Non-smoker 
30–34 M Pulmonary thromboembolism 
Non-instrumental 
vaginal Not stated Smoker 
25–29 M Large pulmonary embolus 
Non-instrumental 
vaginal Not stated Smoker 
<20 M 
Pulmonary thromboembolism from inferior 
vena cava and pelvic thromboses Before giving birth 
Morbidly 
obese Smoker 
35–39 GM Pulmonary embolism Caesarean section 
Morbidly 
obese Smoker 
25–29 M Pulmonary embolism Caesarean section Not stated Non-smoker 
(a) N = nullipara; M = multipara; GM = grand multipara. 
(b) BMI = body mass index. 
Risk assessment 
In the UK, publication of the 3 RCOG guidelines on thromboprophylaxis in pregnancy—the 
1995 RCOG guideline on thromboprophylaxis after caesarean section (RCOG 1995); the 2004 
RCOG thromboprophylaxis guideline (RCOG 2004), and the updated guideline that includes 
weight-specific advice on thromboprophylaxis in pregnancy (RCOG 1995, 2009)—have been 
associated with a significant decline in pulmonary embolism deaths in pregnancy (CMACE 
2011). All women should undergo a documented assessment of risk factors for 
thromboembolism in early pregnancy or before pregnancy. Women are at risk of VTE 
throughout pregnancy and into the postpartum period, and this assessment should be 
repeated if the woman is admitted to hospital for any reason or develops other inter-current 
problems. 
Over 2 in every 1,000 women giving birth in Australia are extremely morbidly obese 
(Sullivan et al. 2011). Obesity remains a significant risk factor for VTE in pregnancy. 
Maternity service providers should ensure they have current guidelines/protocols on 
thromboprophylaxis in pregnancy including weight-specific advice on thromboprophylaxis. 
Table 4.12 describes risk factors for thromboembolism in pregnancy. 
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Table 4.12: Risk factors for venous thromboembolism in pregnancy  
Time frame  Factors 
Pre-existing Previous venous thromboembolism 
Thrombophilia—heritable: 
Antithrombin deficiency 
Protein C deficiency 
Protein S deficiency 
Factor V Leiden 
Prothrombin gene G20210A 
Thrombophilia—acquired (antiphospholipid syndrome): 
Persistent lupus anticoagulant 
Persistent moderate/high-titre anticardiolipin antibodies or β2 glycoprotein 1 antibodies 
Medical comorbidities (e.g. heart or lung disease, systemic lupus erythematosus(a), cancer, inflammatory 
conditions (inflammatory bowel disease or inflammatory polyarthropathy), nephrotic syndrome 
(proteinuria > 3 g/day), sickle cell disease, intravenous drug user 
Age > 35 
Obesity (BMI > 30 kg/m2) either pre-pregnancy or in early pregnancy 
Parity ≥ 3 
Smoking 
Gross varicose veins (symptomatic or above knee or with associated phlebitis, oedema/skin changes) 
Paraplegia 
Obstetric  
 
Multiple pregnancy 
Assisted reproductive therapy 
Pre-eclampsia  
Caesarean section 
PPH (> 1 litre) requiring transfusion  
Prolonged labour 
Mid-cavity rotational operative delivery 
New-onset/transient Surgical procedure in pregnancy or puerperium (e.g. evacuation of retained products of conception, 
appendectomy, postpartum sterilisation) 
Potentially reversible hyperemesis, dehydration 
Ovarian hyperstimulation syndrome 
Systemic infection (requiring antibiotics or admission to hospital), e.g. pneumonia, pyelonephritis,  
postpartum wound infection 
Long-distance travel (> 4 hours) 
Note: Systemic lupus erythematosus may develop at later stages in gestation than the initial risk assessment, or may resolve and therefore 
continuing individual risk assessment is important. 
Source: RCOG 2004. 
Autopsy 
Of the 9 women who died of thromboembolism, 8 had autopsies. In the cases of sudden 
death, all of these autopsies resulted in the cause of death being identified. In 1 case, the 
cause of death was diagnosed before death. In the other cases, the cause of death was 
diagnosed at death on clinical grounds and confirmed at autopsy. In any case, where the 
cause of death is not clearly known it is necessary to proceed to autopsy to establish the 
cause of death. 
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Summary 
Thromboembolism still remains a leading cause of maternal death in Australia. Of the 
women who died, there was a significant number with known risk factors, and in some cases 
these were multiple risk factors. Women are at risk of thromboembolism throughout 
pregnancy and into the postpartum period. All women should undergo a documented 
assessment of risk factors for thromboembolism in early pregnancy or before pregnancy. 
Institutions should ensure they have current guidelines/protocols on thromboprophylaxis in 
pregnancy and ensure that clinicians looking after pregnant women are aware of these 
guidelines and undertake risk assessments of pregnant women, because this has been shown 
to save mothers’ lives.  
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4.5 Obstetric haemorrhage 
Good practice guidance 
• An antenatal ultrasound should be recommended to all pregnant women in order to 
determine the placental location. Appropriate recognition, preparation and 
management of women with placenta praevia or suspected morbidly adherent 
placentation is crucial, because these conditions are associated with increased risk of 
catastrophic haemorrhage and maternal mortality (RANZCOG 2011c). 
• Active management of the third stage of labour (use of prophylactic oxytocics and 
controlled cord traction) decreases the risk of postpartum haemorrhage (PPH) and 
blood transfusion and should be recommended to all women (RANZCOG 2011b).  
• Assessment of ongoing blood loss is an essential aspect of postpartum care. Visual 
estimation of blood loss is notoriously unreliable and often underestimates true blood 
loss. More accurate measures such as weighing drapes, pads and swabs can also be 
used. Clinical signs of shock or tachycardia should prompt a thorough assessment of 
the mother, including an accurate appraisal of blood loss, both concealed and revealed 
(RANZCOG 2011b).  
• Delays in recognising the severity of haemorrhage can lead to morbidity and death. 
Severe obstetric haemorrhage-related maternal morbidity 
There are no national data on massive obstetric haemorrhage requiring rapid blood 
transfusion in pregnancy. However, based on earlier studies, it has been estimated that 
adjusted rates for PPHs during the birth admission increased from 8.3% in 1994 to 10.7% in 
2002, with a sixfold increase of transfusion following birth (1.9% to 11.7%) (Cameron et al. 
2006). This suggests that PPH is increasing in frequency and severity in Australia. A new 
AMOSS study will provide data concerning massive obstetric haemorrhage events requiring 
rapid blood transfusion, including information on the women, clinical features, transfusion 
requirements and complications. An AMOSS study on peripartum hysterectomy was 
completed in 2012 in Australia and New Zealand. Preliminary analysis from 2010–2011 
estimated the incidence of peripartum hysterectomy to control haemorrhage to be 6.0 per 
10,000 women giving birth to a baby of at least 20 weeks gestation or at least 400 grams 
birthweight (95% CI 5.5–6.5). The earlier UKOSS study undertaken between February 2005 
and February 2006 estimated the incidence of peripartum hysterectomy to control 
haemorrhage to be 4.1 per 10,000 women giving birth to 1 or more live or stillborn infants at 
24 weeks gestation or above (95% CI 3.6–4.5) (Knight et al. 2008). Less than 1% of the women 
who had hysterectomies died. A similar finding was found in the AMOSS study. Thirty-nine 
per cent of the women had a morbidly adherent placenta, and the main documented risk 
factor was previous caesarean delivery (adjusted odds ratio 3.52, 95% CI 2.35–5.26) (CMACE 
2011). In 2010, there were 93,157 caesarean sections performed in Australia, which was 31.6% 
of all births (Li et al. 2012).  
Deaths from obstetric haemorrhage between 2006 and 2010 
Obstetric haemorrhage remains a major cause of mortality in Australia and worldwide. It 
can be defined as bleeding from the genital tract with an estimated blood loss of > 1,000 mL 
or a blood loss which causes clinical signs of shock (Medforth et al. 2011). Other non-
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obstetric causes of major bleeding (such as splenic artery aneurysm rupture) may also occur 
during pregnancy and the postpartum period, and these are reported in ‘Section 4.2  
Non-obstetric haemorrhage’. There were 8 deaths due to obstetric haemorrhage between 
2006 and 2010, giving an MMR of 0.6 per 100,000 women who gave birth. Seven of these 
deaths were classified as direct maternal deaths and 1 as an indirect maternal death because 
it occurred following blunt trauma to the abdomen. Between 1997 and 2005, obstetric 
haemorrhage was the second most common direct cause of maternal mortality in Australia 
(Sullivan et al. 2007). For this reporting period, it is the third most common cause of direct 
maternal deaths, behind amniotic fluid embolism and thromboembolism. Table 4.13 shows 
the MMR for deaths due to obstetric haemorrhage for the last 3 reporting periods. Although 
death rates appear to be relatively stable, obstetric haemorrhage is the leading cause of 
severe maternal morbidity in many developed countries and evidence suggests that the 
number of cases of obstetric haemorrhage is increasing. A recent population-based study in 
New South Wales found that the incidence of severe maternal morbidity is increasing by 4% 
each year, with nearly all of the increase due to the increasing occurrence of obstetric 
haemorrhage (Roberts et al. 2009). 
Table 4.13: Deaths from obstetric 
haemorrhage, Australia, 2000–2010 
Reporting period  Number MMR(a) 
2000–2002 9 1.2 
2003–2005 4 0.5 
2006–2010(b) 8 0.6 
(a) Deaths per 100,000 women who gave birth. 
(b) 2006–2010 is a 5-year period; previously 
3-year reporting periods were used. 
There were 8 deaths due to obstetric haemorrhage. There were 4 due to postpartum 
haemorrhage and 4 due to antepartum haemorrhage. Four of the 8 women had at least 1 
previous caesarean section. Parity ranged between 1 and 7. The median age at death was 33. 
Table 4.14 shows details of the women who died from obstetric haemorrhage, including age 
group, parity, BMI and mode of birth in 2006–2010.  
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Table 4.14: Death from obstetric haemorrhage by age and parity, BMI, mode of birth, Australia, 
2006–2010 
Age 
group  Principal cause of death 
Contributing cause 
of death Parity(a) BMI(b) Mode of birth 
30–34 Obstetric haemorrhage 
Ischaemic heart 
disease GM Not stated Caesarean section 
≥ 40 
Massive intra and postpartum 
haemorrhage 
Spontaneous uterine 
rupture; grand 
multiparity GM Obese Instrumental vaginal 
25–29 Postpartum haemorrhage 
Multi-system organ 
failure; coagulopathy M Not stated Caesarean section 
35–39 Postpartum haemorrhage None M Not stated Caesarean section 
30–34 Postpartum haemorrhage None M Obese Caesarean section 
25–29 Haemorrhage: placenta accreta None M Morbidly obese Caesarean section 
25–29 
Placental laceration and 
haemorrhage 
Motor vehicle 
accident and blunt 
trauma M Not stated Before giving birth 
35–39 Placenta percreta Placenta praevia GM Obese Caesarean section 
(a) M = multipara; GM = grand multipara 
(b) BMI = body mass index 
Of the 8 women who died, 1 had an undiagnosed placenta praevia, 3 had a confirmed 
placenta accreta or percreta and 2 women died following uterine rupture. One woman died 
from placental laceration as the result of a car accident and 1 from a postpartum 
haemorrhage of unspecified cause. 
Antepartum haemorrhage 
One of the reported women died near term due to placental laceration following blunt 
trauma to the abdomen sustained in a motor vehicle accident. The other 3 women who died 
due to an antepartum haemorrhage were all of high parity (4 or more) and 2 had a history of 
3 or more previous caesarean sections. One woman required a subtotal hysterectomy, 1 had 
embolisation of the internal iliac arteries and for the other, the surgical history was not 
provided. 
Case summary 
A woman in her early 30s with 5 previous pregnancies and 4 previous caesarean sections 
presented to hospital at 28 weeks gestation with an antepartum haemorrhage. Four 
previous pregnancy ultrasounds had not identified that the placenta was praevia. An 
emergency caesarean section was performed and there was heavy intraoperative bleeding 
due to placenta praevia accreta. A subtotal hysterectomy was undertaken and was followed 
by a cardiac arrest. She was successfully resuscitated and transferred to a tertiary hospital. 
A second arrest occurred during transfer. On arrival, further intervention including 
embolisation of the internal iliac arteries was unsuccessful and she died from multi-organ 
failure.  
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Postpartum haemorrhage 
All 4 women who died from postpartum haemorrhage (PPH) were of parity greater than 2. 
One of the women who died gave birth by caesarean section because of a known placenta 
praevia, 1 was found to have a placenta percreta at caesarean section, and 1 presented to the 
hospital following uterine rupture. Both women with percreta and uterine rupture had a 
history of 2 previous caesarean sections. The fourth woman had an unspecified PPH 
following a normal vaginal birth. 
Definitions of PPH vary, but the one used by the World Health Organization is ‘blood loss of 
500 mL or more during or following birth, or any amount of blood loss post-partum that 
causes haemodynamic instability’ (Lalonde et al. 2006). It can be difficult to predict the 
occurrence of bleeding and, once this occurs, the situation can change rapidly with women 
deteriorating quickly. 
Case summary 
A woman with a history of 2 previous caesarean sections underwent an elective caesarean 
section at term. Approximately 10 minutes after the birth of the baby there was a fall in 
blood pressure and rise in heart rate. Heavy bleeding from the placental bed was observed 
and a manual removal of the placenta attempted. The placenta was found to be morbidly 
adhered to the uterine wall. Manual removal continued and cross-matched blood was 
ordered. The uterus began to bleed profusely with a drop in blood pressure, which 
responded to vasopressors. The uterus was exteriorised and with manual compression the 
bleeding settled. The abdomen was closed. Thirty minutes later in recovery light flow of 
vaginal blood loss was noted. Doctors administered misoprostol, undertook bimanual 
compression of the uterus and an intra-uterine balloon insertion. The bleeding appeared to 
slow. There was a total estimated blood loss of 3 L in a woman of small stature. The woman 
suffered a cardiac arrest in recovery. Resuscitation was successful and she was returned to 
theatre for a hysterectomy. After the hysterectomy she was transferred to ICU with multiple 
organ failure, likely secondary to ischaemia suffered during the cardiac arrest. Shortly after, 
treatment was withdrawn.  
According to Welsh et al. (2008), while ‘certain factors for obstetric haemorrhage can be 
identified in the antenatal period, for the most part when it occurs it is unpredictable, sudden 
and often catastrophic and may result in serious morbidity or death’. It is understood that 
delay in recognising the severity of haemorrhage and delay in referring for appropriate 
treatment are contributing factors to maternal death in the UK (Knight et al. 2009). Similarly, 
a United States (US) study found that ‘human and service provider factors’ were responsible 
for women progressing along the severe maternal morbidity–mortality continuum, 
contributing to women having more severe disease (Geller et al. 2004). 
A Cochrane review showed that active management of the third stage, when compared with 
physiological management, decreases the risk of PPH and blood transfusion (Prendiville et 
al. 2003). Active management includes the administration of prophylactic oxytocics and 
controlled cord traction (RANZCOG 2011b). 
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Placenta accreta 
Morbid adherence of the placenta to the uterine wall is a potentially life-threatening 
condition. The first national population-based AMOSS study of placenta accreta was 
undertaken in Australia and New Zealand for the period 2010–2012 and has recently 
finished data collection. Preliminary results for 2010–2011 demonstrate an incidence of 
4.2 cases per 10,000 women giving birth to a baby of at least 20 weeks gestation or at least 400 
grams birthweight. Less than 1% of the women who had a placenta accreta died. The 
AMOSS study will report on complications and outcomes. Morbidly adherent placentation 
can be difficult to diagnose, but may be suspected when there is a placenta praevia in a 
woman with a history of caesarean section or other uterine surgery (Armstrong et al. 2004; 
Miller et al. 1997). With the rising caesarean section rate and increasing maternal age, the 
incidence of placenta accreta has significantly increased (Miller et al. 1997). The Royal 
Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG) has 
released the following statement on the management of placenta accreta.  
Good practice guidance regarding placenta accreta 
• Where there is suspected or known placenta accreta, delivery should occur in a place 
with the necessary medical facilities and expertise to manage these high-risk cases. It is 
important to be cognisant of the risk of placental growth to the serosa of the uterus, 
and into adjacent organs such as the bladder in extreme circumstances. 
• Such facilities would include: access to ‘cellsaver’, an ability to cope with high-volume 
blood transfusion, availability of other blood products (e.g. platelets, clotting factors) 
and appropriate specialised expertise (e.g. neonatal, senior obstetric and anaesthetic, 
haematological and intensive care). A multidisciplinary approach is required, 
including possible prior consultation with other medical specialists such as urologists, 
gynaecological oncologists, vascular surgeons, intensivists and interventional 
radiologists. 
• As with all women at risk of major obstetric haemorrhage, those with suspected 
placenta accreta should be encouraged to remain close to the planned hospital of 
confinement for the duration of the third trimester of pregnancy. An emergency 
contingency plan is strongly recommended. 
• The timing of the caesarean section should consider the desirability of performing it as 
an elective rather than an emergency procedure. The caesarean section should 
therefore usually be undertaken at an earlier gestation than that for uncomplicated 
elective caesarean births or uncomplicated placenta praevia. 
Three surgical management choices may be considered according to available expertise, 
geographical and individual circumstances: 
1. Delivery of the baby and attempted delivery of the placenta. This is associated with a 
high likelihood of hysterectomy but not invariably so. If this option is chosen, the surgeon 
must be prepared to proceed promptly to hysterectomy if needed and the anaesthetist 
prepared for massive transfusion as bleeding may be considerable while the hysterectomy 
is being undertaken. 
2. Delivery of the baby via a uterine incision distant from the placenta, quick repair of the 
uterus and en bloc hysterectomy.  
OR 
(continued)  
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Good practice guidance regarding placenta accrete (cont.) 
3. Delivery of the baby via a uterine incision distant from the placenta, trimming of the cord 
close to insertion site, full repair of the uterus and conservative management. About two-
thirds of women will avoid a hysterectomy, one-third will still require a hysterectomy 
because of uncontrollable bleeding, which may be delayed up to several weeks, and this 
approach also has a significant risk of infectious morbidity. In addition, uncertainty as to 
the time of onset of secondary bleeding can tax available resources. This has serious 
implications if the patient is returning to a remote area with little facility to cope with 
sudden severe haemorrhage. 
• Retrospective studies of pregnancy following conservative management of placenta 
accreta have reported reasonably good fertility rates and pregnancy outcomes but with 
an increased rate of recurrent placenta accreta (17–29%).  
• Consideration of ureteric stenting should be made particularly when there is a 
suspicion of placenta percreta. 
• Interventional radiology can be life-saving and uterine-sparing for the treatment of 
massive postpartum haemorrhage. It can be useful in the management of haemorrhage 
from abnormal placentation after delivery. The role of radiological placement of 
balloon catheters before delivery in placenta accreta requires further evaluation. 
Source: RANZCOG 2011b.  
Summary 
Obstetric haemorrhage remains a key cause of maternal mortality and severe morbidity. 
Identification of placentae encroaching on the lower uterine segment, especially in women 
who previously gave birth by caesarean section, is critical. Maternity units should have well-
rehearsed protocols for team management of catastrophic obstetric haemorrhage. 
  
 Maternal deaths in Australia 2006–2010 55 
4.6 Hypertensive disorders of pregnancy 
Good practice guidance 
• The significance of hypertension in pregnancy should not be underestimated and any 
woman who presents with signs or symptoms that are possibly due to pre-eclampsia 
should undergo a full clinical and laboratory assessment and early referral to a 
consultant obstetrician at a hospital of a service capability level suitable to manage 
high-risk pregnancies.  
• The management of women with pre-eclampsia between gestational ages of 24 and 32 
weeks should be undertaken in those centres of an appropriate service capability level 
with corresponding experience and expertise (SOMANZ 2008). 
• The major cause of death in women with hypertension in pregnancy is intra-cerebral 
haemorrhage. Systolic blood pressure of 170 mmHg or above or diastolic blood 
pressure of 110 mmHg or above is a medical emergency and requires urgent in-patient 
assessment and management in a specialist maternity service. 
Severe hypertensive-related maternal morbidity 
Eclampsia is a rare complication of pregnancy and birth and the associated incidence of 
severe morbidity is unknown in Australia. Preliminary findings from the 2010–2011 AMOSS 
eclampsia study identified an Australia and New Zealand incidence of eclampsia of 2.2 cases 
per 10,000 women giving birth to a baby of at least 20 weeks gestation or at least 400 grams 
birthweight. These findings were similar to an earlier UKOSS eclampsia study, which 
identified a UK incidence of 2.7 cases per 10,000 births. UK data estimate a case fatality rate 
from eclampsia to be 3.1% (CMACE 2011) . There were no maternal deaths in the AMOSS 
eclampsia study. 
The UK’s Confidential Enquiries into Maternal Deaths persistently show substandard care in 
a significant percentage of deaths (CMACE 2011). Information as to the standard of care in 
Australia has not been routinely collected and is outside the scope of this report. However, 
internationally there has been a demonstrated reduction in severe maternal morbidity due to 
improved treatment of pre-eclampsia and it is known that timely identification and 
treatment can save women’s lives. 
The extent to which Australasian clinicians have adopted the treatment recommendations for 
eclampsia since publication of the major international trials is unknown. The Society of 
Obstetric Medicine of Australia and New Zealand (SOMANZ) publishes national guidelines 
for the diagnosis and management of pre-eclampsia and eclampsia, and it recommends that 
‘each Unit should develop protocols for the management of hypertension and regularly 
monitor and audit their outcomes’ (SOMANZ 2008).  
Deaths from hypertensive disorders of pregnancy in 2006–2010  
Hypertension in pregnancy affects up to 10% of pregnancies (AIHW 2012b), making it one of 
the most common pregnancy complications and a leading cause of maternal death around 
the world for many years (Sullivan et al. 2007). There a number of definitions relating to 
hypertensive disorders of pregnancy, depending on the underlying cause. The SOMANZ 
defines hypertension in pregnancy as systolic blood pressure greater than or equal to 
140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg (SOMANZ 
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2008). There were 6 maternal deaths related to hypertensive disorders of pregnancy between 
2006 and 2010.  
Hypertension in pregnancy may be due to a number of conditions: pre-eclampsia and 
eclampsia are the most common causes and are potentially harmful conditions to both 
mother and baby. All of the deaths caused by hypertensive disorders of pregnancy between 
2006 and 2010 were due to pre-eclampsia or eclampsia. All deaths were classified as direct. 
The MMR during 2006–2010 for hypertensive disorders of pregnancy was 0.4 per 100,000 
women who gave birth compared with 0.8 in 2003–2005 (Table 4.15). Although these figures 
do show a potential fall in the rate of deaths from hypertensive disorders of pregnancy, such 
statistics should be interpreted with caution due to the small numbers of maternal deaths.  
Table 4.15: Deaths from 
hypertensive disorders, Australia, 
2000–2010 
Reporting period Number MMR(a) 
2000–2002 5 0.7 
2003–2005 6 0.8  
2006–2010(b) 6 0.4  
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 
3-year reporting periods were used. 
All 6 maternal deaths related to hypertensive disorders of pregnancy between 2006 and 2010 
were due to sequelae of pre-eclampsia or eclampsia. Intracerebral haemorrhage was the most 
commonly reported cause of death (4 women), although the majority suffered multiple 
complications and organ failure. One woman died as a result of a hepatic rupture and for 
another woman the cause of death was reported as ‘eclampsia’.  
The women who died were aged between 17 and 41, with a median age of 34. Parity ranged 
between 0 and 2. All of the women who died were at greater than 37 weeks gestation. Five 
presented with symptoms of fitting or pre-eclampsia in the antenatal period, and 1 presented 
postpartum following an uncomplicated birth by elective caesarean section. All 6 women 
had given birth before their death: 4 by caesarean section, 1 by vaginal birth after induced 
labour and 1 by vaginal birth after spontaneous labour. All women died between 2 and 26 
days postpartum. Table 4.16 details deaths from hypertensive disorders of pregnancy by 
cause in Australia from 1997 to 2010. 
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Table 4.16: Deaths from hypertensive disorders of pregnancy, by cause, 
Australia, 1997–2010 
Cause of death  1997–1999 2000–2002 2003–2005 2006–2010(a) 
Hypertension .. 1 .. .. 
Cerebral 
Intracranial 
haemorrhage 1 .. 3 4 
Subarachnoid 
haemorrhage 1 .. 1 .. 
Infarct 1 .. .. .. 
Pre-eclampsia  2 .. .. 
Eclampsia 1 1 .. 1 
Cardiac 
Arrhythmia 1 .. .. .. 
Hepatic 
Rupture .. .. .. 1 
Other 1 1 1 .. 
Total 6 5 5 6 
2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
.. not applicable 
All of the women who died developed multiple complications of pre-eclampsia and 
eclampsia, such as hepatic rupture, adult respiratory distress syndrome and disseminated 
intravascular coagulation, and all were admitted to an ICU before their deaths.  
Women who develop organ failure require intensive monitoring and medical management, 
either within a high dependency or intensive care setting. The SOMANZ recommends that 
the management of women with pre-eclampsia between gestational ages of 24 and 32 weeks 
should be restricted to those centres with appropriate experience and expertise (SOMANZ 
2008).  
Pre-eclampsia and eclampsia 
Case summary 
A nulliparous woman with a booking blood pressure of 105/65 mmHg presented to 
hospital at 37 weeks gestation with minimal facial oedema and a mild headache. Urinalysis 
was normal and she was discharged home with a follow-up midwifery home visit the next 
day. She next presented in spontaneous labour at term. In labour, investigations revealed 
proteinuria +++ and blood pressures of 130/85–90 mmHg. No further documentation. She 
was found unconscious at home by her husband 2 days postpartum. A CT scan showed 
cerebellar haemorrhage and acute hydrocephalous. She died on the day of her collapse. 
Cause of death: Intracerebral haemorrhage. 
It is essential that the significance of hypertension in pregnancy is recognised early. Systolic 
blood pressure greater than or equal to 140 mmHg and/or diastolic blood pressure greater 
than or equal to 90 mmHg (Korotkoff 5) requires referral to a specialist and multidisciplinary 
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team involvement. As in this case summary, a woman with a low booking blood pressure 
(105/65) and signs of pre-eclampsia (proteinuria +++) may be at substantial risk, even with 
borderline elevated blood pressures (130/85–90). Continued careful postnatal observation of 
previously diagnosed pre-eclampsia is necessary because the disease does not necessarily 
resolve after birth and many complications can occur at this time. 
Box 4.2: Identification of pre-eclampsia 
• Regular blood pressure monitoring should be undertaken at all antenatal visits past 20 
weeks gestation. The NMMAC recommends that urine testing be undertaken at all 
antenatal visits past 20 weeks gestation; at minimum, urine testing should be 
undertaken at all antenatal visits past 20 weeks gestation in women who are at 
particular risk of pre-eclampsia and in all women where a raised blood pressure is 
found.  
• Systolic blood pressure greater than or equal to 140 mmHg and/or diastolic blood 
pressure greater than or equal to 90 mmHg (Korotkoff 5) requires referral to an 
obstetric specialist. 
• Systolic blood pressure of 170 mmHg or above or diastolic blood pressure of 110 
mmHg or above is a medical emergency and requires urgent in-patient assessment and 
management in a specialist maternity service.  
• Treatment should be considered at lower blood pressures in women who have low 
blood pressure at booking visits.  
• Continued postnatal observation is necessary. 
Source: SOMANZ 2008. 
Summary 
Early recognition and appropriate management of pre-eclampsia saves women’s lives. 
Women with signs and symptoms of pre-eclampsia should be referred early for care by a 
specialist obstetrician. Each maternity unit should develop/adopt protocols for the 
management of hypertension in pregnancy and regularly audit their outcomes. Pre-
eclampsia does not necessarily resolve after birth and complications can occur at this time. 
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4.7 Sepsis  
Good practice guidance 
• Diarrhoea and/or vomiting in pregnant women may be serious signs of sepsis and an 
indication for commencing antibiotic therapy. 
• Early investigation of non-specific symptoms in pregnant women is necessary to 
exclude serious infection. 
• Where an autopsy is performed, blood cultures should be taken for all cases as soon as 
is possible. 
Source: NMMAC 
Severe sepsis-related maternal morbidity 
There is currently limited available information on sepsis in pregnancy. In the UK, a 
prospective UKOSS study on all severe infection in pregnancy has commenced, which is 
intended to assist in the development of management guidelines. 
Deaths from sepsis between 2006 and 2010 
The diagnosis of septic shock during pregnancy, labour or the puerperium may depend on 
careful observation and be associated with a range of clinical symptoms, and can be defined 
as collapse due to failure of the woman’s circulatory system (Medforth et al. 2011). Overall, 
there were 10 maternal deaths due to sepsis between 2006 and 2010, giving an MMR of 0.7 
maternal deaths per 100,000 women who gave birth. This compares with an MMR of 0.6 
deaths per 100,000 women due to sepsis in women who gave birth between 2003 and 2005 
(Table 4.17). In the UK, sepsis was the leading cause of direct maternal death for the  
2006–2008 triennium, and has risen from 0.85 deaths per 100,000 women giving birth to 1 or 
more live or stillborn infants at 24 weeks gestation or above in 2003–2005 to 1.13 deaths in 
2006–2008 (CMACE 2011). In Australia, for the 2003–2005 triennium, there was 1 direct 
maternal death due to sepsis. For 2006–2010, there were 5 direct deaths due to sepsis. The 10 
deaths, including 3 deaths due to H1N1 influenza infection, have been included here and 
reported separately in ‘Section 4.8 Influenza in pregnancy’. 
Table 4.17: Deaths from sepsis, 
Australia, 2000–2010 
Reporting period Number MMR(a) 
2000–2002 15 2.0 
2003–2005 5 0.6 
2006–2010(b) 10 0.7 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year 
reporting periods were used. 
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Deaths due to sepsis can be grouped or classified in a number of ways. For this report, they 
have been grouped into obstetric and non-obstetric infections. Differences in the 
circumstances of each case and classification method used across jurisdictions mean that the 
classification of direct versus indirect varies within these groups. Table 4.18 shows the 
number of direct and indirect maternal deaths due to sepsis and the cause of these deaths 
including the organisms identified from 2000 to 2010.  
Table 4.18: Deaths from sepsis, Australia, 2000–2010 
Reporting 
period Number of deaths Principal causes Contributing cause Organisms 
  Direct Indirect   
2000–2002 5 10 Pneumonia 
Meningitis 
Epidural abscess 
Group A beta haemolytic 
streptococcus 
Intra-abdominal sepsis following 
caesarean section 
Influenza 
Septicaemia 
 
Asthma 
Thromboembolism 
Pre-eclampsia 
Adult respiratory 
distress syndrome 
Multi-organ failure 
  
  
  
E. coli 
Group A beta 
haemolytic 
streptococcus 
Staphylococcus 
aureus 
Herpes simplex 
Malaria 
Cryptococcus 
neoformans 
Streptococcus 
pneumoniae 
Pseudomonas 
aeruginosa 
2003–2005 1 4 Unknown Unknown Unknown 
2006–2010(a) 5 5 H1N1 influenza 
Meningitis 
Pneumonia 
Puerperal sepsis/chorioamnionitis 
Intra-abdominal sepsis 
Group A streptococcal septicaemia 
Cholecystitis 
Congenital heart 
disease 
Psychosocial factors  
  
  
  
  
  
Pneumococcus  
E. coli 
H1N1 influenza A 
Group A beta 
haemolytic 
streptococcus  
Gram negative 
organism 
(a) 2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
Group A beta haemolytic streptococcus (GAS), also known as Streptococcus pyogenes, is the 
most common pathogen associated with maternal mortality (Nicoll et al. 2012). In Australia, 
there were 4 deaths due to GAS between 2006 and 2010, and 3 between 2000 and 2002. 
Between 2005 and 2008, 50% of direct maternal deaths due to sepsis in the UK were caused 
by GAS infection.  
There were 5 direct maternal deaths due to sepsis. These women died from the following 
causes: endometritis, chorioamnionitis, postpartum puerperal sepsis, cholecystitis and 
pneumonia. There were 4 indirect deaths and 1 unclassified death due to sepsis. The 4 
indirect deaths included 3 from H1N1 influenza and 1 from pneumococcal meningitis 
infection. Table 4.19 shows the causes of direct and indirect maternal death from sepsis, any 
contributing factors, organisms identified and the age group of the women who died 
between 2006 and 2010.  
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Table 4.19: Deaths from sepsis by cause, Australia, 2006–2010 
Age 
group 
Principal cause of death Contributing cause of death Comments/organism 
Direct deaths 
≥40 Endometritis  None Group A beta haemolytic 
streptococcal septicaemia 
35–39 Chorioamnionitis None Unknown 
20–24 Toxic shock-like syndrome, Acute cholecystitis None Group A beta haemolytic 
streptococcus and 
Staphylococcus aureus in 
caesarean section wound. 
No blood culture results 
reported  
20–24 Lobar pneumonia E. coli  E. coli 
35–39 Puerperal sepsis Unknown Group A streptococcus 
sepsis 
Indirect deaths 
35–39 H1N1 influenza Congenital heart disease Influenza A 
≥40 Respiratory failure due to H1N1 influenza None Influenza A 
20–24 Complications of H1N1 influenza None Influenza A 
35–39 Pneumococcal meningitis None  
Not stated Sepsis None Group A streptococcus 
The age at death ranged from 20 to 42 with a median age of 38. The parity ranged between 0 
and 4. Eight of the women who died were postpartum at the time of their death, 1 died 
during labour and 1 died near term before giving birth. Three of the women were smokers, 3 
women did not smoke, and for the remaining women smoking status was unknown. Two 
women had a BMI over 35, 1 had a BMI less than 30, and for the others BMI was not 
recorded. Table 4.20 shows deaths from sepsis by smoking status, BMI, country of birth and 
remoteness of usual residence.  
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Table 4.20: Deaths from sepsis, by smoking, BMI and country of birth, Australia, 2006–2010 
Age group  Principal cause of death Contributing cause 
of death 
Smoking BMI(a) Country of 
birth 
Remote-
ness 
35–39 H1N1 influenza Congenital heart 
disease 
Not stated Not 
stated 
Australia Not stated 
20–24 Lobar pneumonia E. coli  Not stated Not 
stated 
Not stated Not stated 
20–24 Complications of H1N1 
influenza 
None Non- 
smoker 
Not 
stated 
Australia Major 
cities 
35–39 Pneumococcal meningitis None Smoker Not 
stated 
Australia Major 
cities 
Not stated Puerperal sepsis None Not stated Not 
stated 
Not stated Not stated 
≥40 Respiratory failure due to 
H1N1 influenza 
None Non- 
smoker 
Obese Timor Leste Outer 
regional 
≥40 Group A streptococcal 
septicaemia 
None Not stated Obese Australia Not stated 
35–39 Chorioamnionitis None Smoker Not 
stated 
Australia Inner 
regional 
20–24 Sepsis None Smoker Over-
weight 
Australia Inner 
regional 
35–39 Group A streptococcus sepsis Unknown Non- 
smoker 
Not 
stated 
Australia Major 
cities 
(a)  BMI = body mass index. 
Obstetric infections 
Most obstetric infections occur postpartum and may relate to genital tract infection, mastitis, 
thrombophlebitis, episiotomy and perineal tear infections, caesarean section wound 
infection, gastric acid aspiration or post-general anaesthesia pneumonia. Antepartum 
infections include chorioamnionitis, which may follow prolonged premature rupture of 
membranes (PPROM) and prolonged labour. Endometritis is a spectrum of endometrial, 
myometrial and parametrial infections. Three of the women who died between 2006 and 
2010 died from obstetric-related infections. Two of these women died from postpartum GAS 
uterine infection. One developed septicaemia following Gram negative infection in retained 
placental tissue after a second trimester miscarriage. All of these deaths were classified as 
direct maternal deaths.  
Case summary 
A multiparous woman aged over 35 developed vomiting and diarrhoea 10 days following 
spontaneous vaginal birth of a live born infant. The same day she attended her GP and was 
documented to have been ‘treated’ and returned home (the details of treatment are 
unknown). On day 11 she presented to a health-care centre with vomiting, diarrhoea and 
hypothermia. On day 12 she was brought to a health centre unconscious with an 
unrecordable blood pressure. Resuscitation attempts failed and she died the same day. 
Autopsy: postpartum—puerperal sepsis; streptococcus group A septicaemia. 
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For all of the women who died from obstetric-related infections, the course of events 
described showed a rapid deterioration from mild onset of symptoms to death within hours 
or days. Sepsis can present at any time before, during or following giving birth and it is 
important to recognise and treat it early. Mothers often present with vague symptoms and 
signs.  
Non-obstetric infections 
Physiological and immune changes occur in pregnancy, making women more susceptible to 
infections (Logan & Price 2011). Additionally, pregnancy can lead to delay in investigation, 
diagnosis and treatment of systemic infections. For these reasons, deaths due to non-genital 
tract infection, such as meningitis, are considered related to pregnancy and classified as 
indirect maternal deaths. Seven women died as a result of non-obstetric related (non-genital 
tract sepsis) infections. Six of these deaths were classified as indirect maternal deaths: 3 
deaths were from H1N1 influenza; 1 from pneumococcal meningitis; 1 from subdural 
empyema and purulent meningitis with Group A beta haemolytic streptococcal sinusitis; 
and 1 from cholecystitis following complicated recovery from a caesarean section. One death 
was unable to be classified. 
Two deaths from non-obstetric related infection were classified as direct maternal deaths: 
1 death from pneumonia was complex in nature and related to other obstetric and 
psychosocial factors; another from a toxic shock-like syndrome where the pathogenesis of 
disease could not be accurately established but was possibly due to acute cholecystitis. As 
with obstetric-related infection, early investigation of non-specific symptoms in pregnant 
and early-postnatal women is necessary to exclude serious infection.  
Group A beta haemolytic streptococcus 
There were 4 deaths identified as due to GAS infection, accounting for 36% of all maternal 
deaths due to sepsis between 2006 and 2010. GAS is a community-acquired bacterium and 
up to 30% of individuals are asymptomatic carriers of GAS, whether in the throat or on the 
surface of the skin (Nicoll et al. 2012). Clinical signs of systemic GAS infection and 
management of severe sepsis are described in Box 4.3.  
Box 4.3: Clinical signs of GAS sepsis 
• pyrexia, but normal temperature does not exclude sepsis 
• hypothermia may be a sign of sepsis 
• diarrhoea is a common presenting symptom of women with pelvic sepsis 
• tachycardia 
• fetal distress or fetal death without placental abruption may be a presenting symptom 
of sepsis and should always be considered 
• abdominal pain 
• tachypnoea 
• vaginal discharge/abnormal lochia 
• blanching erythema. 
(continued)  
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Box 4.3 (cont.): Clinical signs of GAS sepsis 
Management of severe sepsis 
• Start antibiotics within 1 hour. 
• Take blood cultures, vaginal swabs, urine and any other relevant tissue or discharge 
cultures. If prolonged premature rupture of membranes (PPROM), take amniotic fluid 
culture. 
• Take a throat swab if any history of sore throat in patient or family members. 
• Senior obstetric clinician involvement as soon as possible and have a low threshold for 
admission to high dependency unit or intensive care unit and for involvement of an 
infectious disease specialist. 
• Fluid challenge cautiously due to the risk of pulmonary oedema. 
Source: Nicoll et al. 2012 
Serious maternal morbidity from acquired infection during pregnancy is rare and 
consequently awareness among health professionals and pregnant women of the potential 
severity of infection is low (Nicoll et al. 2012). The Australian national maternal death 
reporting system does not support a commentary on the standard of care provided in 
individual cases. However, in the UK, where these types of assessments are made, ‘failure to 
recognise severity’ is identified as a contributing factor in a high proportion of cases 
(CMACE 2011). A high index of suspicion is required to the successful identification of GAS 
infection.  
Risk factors for GAS infection are hard to define. The UK Saving mothers’ lives: Reviewing 
maternal deaths to make motherhood safer, 2006–2008 report has shown a correlation between 
GAS infection and seasonal flu between December and March and concurrent upper 
respiratory tract infection (CMACE 2011). Evidence has shown that in developed countries 
there is an association with obesity, invasive antenatal and intrapartum procedures, 
premature rupture of membranes, retained placental tissue and medical comorbidities such 
as diabetes (Nicoll et al. 2012; Sriskandan 2011). Globally, possible reasons for the observed 
increase in deaths due to sepsis, and in particular GAS infection, include decreased 
awareness by clinicians of maternal morbidity and mortality associated with obstetric 
infection, a hyper-virulent strain of GAS, and an increase in vulnerable populations 
(Sriskandan 2011). The UK Saving mothers’ lives: Reviewing maternal deaths to make motherhood 
safer, 2006–2008 report advocates education of women regarding perineal hygiene and hand-
washing in the period following childbirth as a public health intervention (CMACE 2011).  
Data collection  
The current Australian maternal death data collection does not provide enough information 
to contribute towards an evidence base for GAS or other rare obstetric infections. It cannot 
inform guidelines on management of pregnancy-associated infection because clinical details 
including results of laboratory testing, clinical observations and relevant comorbidities are 
not consistently reported. This report relied heavily on second-hand clinical summary 
information and coroners’ data. In a number of cases, the clinical details and course of events 
were difficult to determine. The National Maternal Death Reporting (NMDR) form intended 
for implementation in 2015 will collect more detailed information on microbiology results, 
infection markers and pre-existing disease. It is anticipated that this will improve the 
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capacity to accurately establish the cause of death in individual cases and to compare cases at 
the national level. It should be advocated that all women who die due to infection during 
pregnancy or in the postpartum period be referred for autopsy to accurately establish the 
cause of death. The UK Royal College of Pathologists (RCPATH) maternal death autopsy 
guidelines recommend that ‘on admission to the mortuary take blood cultures (aerobic and 
anaerobic) from a sterile upper body site on all cases, unless another cause of death is 
already evident’ (RCPATH 2010).  
Summary 
Overall, there were 10 maternal deaths due to sepsis between 2006 and 2010, giving an MMR 
of 0.7 per 100,000 women who gave birth. This compares favourably to the UK where sepsis 
was the leading cause of direct maternal death for the 2006–2008 triennium and had risen 
from 0.85 deaths in 2003–2005 to 1.13 deaths per 100,000 women giving birth to 1 or more 
live or stillborn infants at 24 weeks gestation or above in 2006–2008 (CMACE 2011). Group A 
beta haemolytic streptococcus was the most common pathogen associated with mortality in 
both Australia and the UK. All of the women who died deteriorated rapidly from mild onset 
of symptoms to death with hours or days. Early investigation of non-specific symptoms in 
pregnant women is necessary to exclude serious infection. 
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4.8 Influenza in pregnancy 
Good practice guidance 
• Pregnant women, particularly in the second half of pregnancy, were more likely than 
non-pregnant women to develop critical illness associated with the 2009 H1N1 
influenza. Current recommendations are that pregnant women should be vaccinated 
(RANZCOG 2011a). 
• The risk of transmission of novel H1N1 through breast milk is unknown. Use of 
antiviral medication for H1N1 treatment or chemoprophylaxis is safe for use in 
breastfeeding women (RACS 2011).  
• The use of extracorporeal membrane oxygenation for severe adult respiratory 
distress syndrome in pregnant and postpartum women was associated with a 66% 
survival rate (Logan & Price 2011; NZIC Influenza Investigators & AMOSS 2010). 
• Intensive management for maternal hypoxia, including caesarean section and 
extracorporeal membrane oxygenation, led to better than expected outcomes 
(ANZIC Influenza Investigators & AMOSS 2010). 
Severe influenza-related maternal morbidity 
During 2009, AMOSS and the Australian and New Zealand Intensive Care Society (ANZICS) 
undertook a collaborative study of H1N1 influenza in pregnant women leading to ICU 
admission in Australia and New Zealand. This population-based cohort study demonstrated 
that pregnant women, particularly in the second half of pregnancy, were more likely than 
non-pregnant women to develop critical illness associated with the 2009 H1N1 influenza. For 
women who developed critical illness, there were poorer outcomes, including the death of 
the mother or baby (ANZIC Influenza Investigators & AMOSS 2010).  
Compared with non-pregnant women of child-bearing age, pregnant women with a 
gestation of greater than 20 weeks or more had a 13-fold greater risk of admission to an ICU 
as a result of the 2009 H1N1 infection (relative risk 13.2). The relative risk for postpartum 
women was 6.4 and for women with gestation of less than 20 weeks the relative risk was 2.4 
(ANZIC Influenza Investigators & AMOSS 2010). In 2009, in Australia and New Zealand, 57 
women who were pregnant or in the postpartum period were found to have a confirmed 
diagnosis of H1N1 influenza, and were subsequently admitted to an ICU. Six women (11%) 
died of H1N1 influenza in Australia and New Zealand (ANZIC Influenza Investigators & 
AMOSS 2010). A UK comparison study identified a maternal death rate of 6.9 deaths due to 
H1N1 infection per 100,000 women giving birth to 1 or more live or stillborn infants at 24 
weeks gestation or above (95% CI 2.6–15.1) (Knight et al. 2011). 
The AMOSS/ANZICS study was repeated in 2010 during the flu season (June to December) 
to also examine medical and obstetric management and maternal and infant outcomes 
related to critical illness following influenza A in pregnancy. It studied the impact of 
immunisation on the incidence and severity of influenza A in Australia and New Zealand. 
Preliminary analysis of the Australian data identified only 1 woman (from 36 cases) who was 
immunised for influenza A (NPESU 2012).  
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Deaths from influenza between 2006 and 2010 
In previous Australian maternal death reports, all deaths due to infection were reported in 
the same chapter. For this report, deaths due to influenza virus and deaths due to other 
infections are reported in separate sections. Maternal deaths due to H1N1 influenza and the 
impact of the 2009 pandemic on the Australian obstetric population will be discussed in this 
chapter. Maternal deaths from other infections including obstetric and non-obstetric 
infection (such as puerperal sepsis or pneumonia) are reported in ‘Section 4.7 Sepsis’. There 
were 3 reported deaths due to H1N1 influenza virus: all occurred during the 2009 H1N1 
influenza pandemic.  
There were 3 reported deaths from H1N1 influenza in 2009–2010. The women who died 
were aged from their early 20s to early 40s. Parity ranged between 0 and 3. BMI was 
unknown for all women. Both of the women whose smoking status was known were  
non-smokers. One of the women who died had a background of significant congenital heart 
disease (corrected Tetralogy of Fallot); there were no reported comorbidities for the other 2 
women. All deaths were classified as indirect.  
The collaborative AMOSS/ANZICS study identified 6 maternal deaths in Australia and New 
Zealand during the 2009 H1N1 pandemic (ANZIC Influenza Investigators & AMOSS 2010);  
3 of these deaths occurred in Australia and were identified through the national maternal 
death reporting system.  
Some clinical symptoms of H1N1 influenza are included in Box 4.4.  
Box 4.4: Clinical symptoms of H1N1 influenza  
Patients typically present with symptoms of acute respiratory illness including: 
• cough 
• sore throat 
• rhinorrhoea 
• fever  
• headache 
• fatigue 
• body aches 
• vomiting 
• diarrhoea.  
Clinical presentation can be complicated by development of a secondary bacterial 
infection (such as pneumonia).  
Symptoms commonly develop within 1 week of exposure, and patients are contagious 
for approximately 8 days thereafter (Novel Swine-Origin Influenza A (H1N1) Virus 
Investigation Team 2009). 
For the 2009–2010 H1N1 pandemic, it was established that pregnancy is a risk factor for 
critical illness, leading to maternal morbidity and mortality (ANZIC Influenza Investigators 
& AMOSS 2010). Following the 2009–2010 pandemic, the national H1N1 vaccination 
program is known to have contributed to better than expected impact of influenza on the 
Australian population in 2010 (Commonwealth of Australia 2011). It is not known whether 
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any of the women discussed in this report were vaccinated, although the AMOSS/ANZICS 
study reported that none of the women in the study had been vaccinated, despite established 
recommendations that pregnant women should be vaccinated. No Aboriginal or Torres Strait 
Islander women are reported in this chapter. However, international studies have shown 
that indigenous women and women with pre-existing morbidity had a higher risk of critical 
illness or death (Knight et al. 2011; ANZIC Influenza Investigators & AMOSS 2010). The 
ANZICS study also identified obesity as a risk factor for critical illness due to H1N1 
influenza during pregnancy or postpartum. A key observation from the study was the need 
for emergency caesarean section because the mother could not be ventilated (and most did 
well). It is an important finding that preterm delivery of a baby can be of major benefit to 
mother and safe for the baby in women with influenza. These findings contribute 
significantly with respect to appropriate planning of a public health response to influenza 
and any future pandemics (Knight et al. 2011).  
Summary 
A global pandemic of H1N1 influenza occurred during this 2006–2010 reporting period. It is 
known that pregnancy is a risk factor for critical illness following infection and that pregnant 
or postpartum women suffered higher rates of morbidity and mortality than non-pregnant 
women. In Australia and New Zealand, 11% of pregnant or postpartum women who were 
admitted to an ICU with H1N1 influenza died (ANZIC Influenza Investigators & AMOSS 
2010).  
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4.9 Early pregnancy deaths 
Good practice guidance 
• An early pregnancy ultrasound that fails to identify an intrauterine sac in the presence 
of a positive serum human chorionic gonadotropin (hCG) titre should stimulate active 
exclusion of tubal pregnancy (NICE 2012). 
• The first clinical sign of an ectopic pregnancy may be a catastrophic collapse.  
• All maternity units including those in rural settings are recommended to have 
established guidelines for the management of a collapse associated with the ectopic 
pregnancy. Such guidelines should include access to blood products to assist 
resuscitation of associated severe haemorrhage. 
Severe early pregnancy maternal morbidity 
Information on early pregnancy loss is difficult to capture because information on these 
pregnancies is not routinely collected in the perinatal or hospital administrative data 
collections. At the national level, the National Perinatal Data Collection contains information 
on births of at least 20 weeks gestation (or greater than 400 grams birthweight) only.  
There is no national data collection on the conditions relating to termination of pregnancy. 
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists is 
supportive of the monitoring and collection of statistics relating to termination of pregnancy, 
including the occurrence of complications of these procedures. Non-availability of 
termination of pregnancy services has been shown to increase maternal morbidity and 
mortality in population studies (WHO 2004). In Australia, legislation regarding termination 
of pregnancy varies across jurisdictions.  
Early pregnancy deaths between 2006 and 2010 
For the purpose of this report, an early pregnancy death is defined as a maternal death 
during the first 14 weeks of pregnancy. Fifteen deaths occurred in the first 14 weeks of 
pregnancy between 2006 and 2010. Eleven of these deaths are reported and counted in other 
chapters. These deaths included 5 deaths related to psychosocial morbidity, including 3 
suicides, 1 homicide and 1 drug overdose. There were 2 deaths from cardiac disease: 1 due to 
ischaemic heart disease and 1 in a woman with dilated cardiomyopathy that was 
unclassifiable. There was 1 death from thromboembolism in a woman with an early IVF 
pregnancy and 1 due to intracerebral haemorrhage. There were 2 further deaths at less than 
14 weeks gestation also reported in ‘Section 4.10 Deaths due to other causes’ where the cause 
of death could not be determined.  
Three women died following an ectopic pregnancy and 1 died following a termination of 
pregnancy. These 4 women will be reported in this chapter. Table 4.21 shows the deaths in 
early pregnancy by cause over the previous 3 reporting periods.  
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Table 4.21: Deaths in early pregnancy by cause, Australia,  
2000–2010 
Cause of death 2000–02 2003–05 2006–10(a) 
Ectopic pregnancy 1 1 3 
Psychosocial 0 2 5 
Cardiac 1 2 2 
Non-genital tract haemorrhage 1 0 1 
Thrombosis and thromboembolism 0 0 1 
Epilepsy 0 1 0 
Other 1 0 3 
Total 4 6(b) 15 
(a)  2006–2010 is a 5-year period; previously 3-year reporting periods were used.  
(b) Number reported differs from those reported in Maternal deaths in Australia 2003–2005 
due to differences in definitions used to determine an early pregnancy death. 
The MMR for all deaths occurring in the first 14 weeks of pregnancy (15) is 1.0 per 100,000 
women who gave birth. The MMR for early pregnancy deaths not reported elsewhere (4) is 
0.3 per 100,000 women who gave birth. Table 4.22 shows the MMR from early pregnancy 
deaths between 2000 and 2010 and earlier reporting periods.  
Table 4.22: Deaths from early 
pregnancy loss, Australia,  
2000–2010 
  Number MMR(a) 
2000–2002 4 0.5 
2003–2005 6 0.8 
2006–2010(b) 15 1.0 
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 3-year 
reporting periods were used. 
Three women died following an ectopic pregnancy and 1 following a termination of 
pregnancy. The median age of the women who died was 30. Parity was unknown in 1 case. 
All of the other women had previously given birth. Two of the women died from rupture of 
an ectopic pregnancy and 1 died from complications of the associated laparoscopic surgery. 
Insufficient information was available at the national level to accurately establish the 
circumstances of the fourth death and the cause of death was recorded as ‘intractable 
cerebral hypertension’ following a termination of pregnancy. In the UK, 6 women died from 
ruptured ectopic pregnancies between 2006 and 2008 and overall, care was considered to be 
substandard in 54% of cases of early pregnancy death (CMACE 2011). Commentary on the 
standard of care provided is not undertaken at the national level in Australia.  
Two of 3 women reported had a sudden and catastrophic collapse before a diagnosis of 
ectopic pregnancy being made. The third woman presented to her GP, and later the hospital, 
with increasingly severe abdominal pain. The cases reported here and a number of cases 
reported in the UK demonstrate that, in cases of ectopic pregnancy, the pregnancy is often 
unknown to the woman and her family before the catastrophic collapse, or she may be very 
ill when first contact is made with medical services. Due to the small number of deaths, 
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details of cases cannot be reported here. However, a number of learning points were 
identified on expert clinical review and are included in the good practice guidance at the 
beginning of this section.  
Summary 
Although ectopic pregnancies are rare, they are potentially fatal. Women who do not know 
they are pregnant may present to medical services with a catastrophic collapse. An early 
pregnancy ultrasound that fails to identify an intrauterine sac in the presence of a positive 
serum human chorionic gonadotropin (hCG) titre should stimulate active exclusion of tubal 
pregnancy; the presence of a small intrauterine sac does not exclude ectopic pregnancy. 
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4.10 Deaths due to other causes 
Good practice guidance 
• Women with epilepsy should be provided with advice regarding the risks of the use of 
baths.  
• Pregnant women with symptoms and/or signs suggestive of potentially serious 
conditions should undergo appropriate investigations.  
Source: NMMAC 
There were 13 maternal deaths due to ‘other’ causes between 2006 and 2010 that have not 
been reported in other chapters, giving an MMR of 0.9 per 100,000 women who gave birth 
(Table 4.23). This included 12 indirect maternal deaths. One death was deemed unclassifiable 
by the NMMAC as insufficient information was available.  
Table 4.23: Deaths from other causes, 
Australia, 2000–2010 
  Number MMR(a) 
2000–2002 12 1.6  
2003–2005 10 1.3  
2006–2010(b) 13 0.9  
(a)  Deaths per 100,000 women who gave birth. 
(b)  2006–2010 is a 5-year period; previously 
3-year reporting periods were used. 
There were 3 deaths from epilepsy, 2 deaths from cancer and 1 in a woman with a 
phaeochromocytoma. Two women died following a cerebral infarction. In 3 cases, the cause 
of death was undetermined and 2 women died of other miscellaneous causes. Table 4.24 
shows causes of death and classification of deaths from ‘other’ causes between 2006 and 
2010. 
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Table 4.24: Maternal deaths by other causes and classification, Australia, 2006–2010 
Age group  Principal cause of death 
Contributing cause of 
death 
Gestational 
age 
Type of 
death 
30–34 Dilated cardiomyopathy None 14 Unclassified 
20–24 Hypoxic ischaemic brain Injury Epilepsy 28 Indirect 
30–34 
Intra-abdominal haemorrhage due to ruptured 
liver tumour None 38 Indirect 
25–29 
Stroke; midbrain infarction and haemorrhagic 
transformation None 40 Indirect 
20–24 Cardiorespiratory arrest—uncertain origin None 12 Indirect 
35–39 Drowning Epilepsy Unknown Indirect 
20–24 Drowning Epilepsy 40 Indirect 
35–39 Hodgkin’s lymphoma None 31 Indirect 
<20 Brain stem infarction Basilar artery thrombosis 40 Indirect 
20–24 Undetermined None 32 Indirect 
≥40 Undetermined 
Mastitis, obesity, sleep 
apnoea 6 Indirect 
25–29 Phaeochromocytoma Unknown Unknown Indirect 
35–39 
Acute renal failure resulting from postpartum 
coagulation defects and acquired haemolytic 
anaemia Unknown 35 Unclassified 
Epilepsy 
Three women died from epilepsy: all were classified as indirect maternal deaths. Two of the 
women died while pregnant and 1 in the postpartum period. All of the women were known 
to have epilepsy and all were on anticonvulsant therapy. Two of the women died from 
drowning in the bath and 1 presented in the second trimester with intractable seizures.  
Case summary 
A multiparous woman with a known history of epilepsy was being closely monitored 
during her pregnancy. She was found unconscious in shallow water in the bathtub at home. 
She was transferred to a regional hospital where she was pronounced dead shortly after 
arrival. Autopsy: Carbamazapine levels were found to be within therapeutic range. 
The most recent UK Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer, 
2006–2008 report found that 14 women had died of epilepsy during pregnancy or the 
puerperium. One of these women also died while bathing. The bathing deaths of women 
with epilepsy demonstrates the importance of women with epilepsy being advised regarding 
the risks of the use of baths (CMACE 2011). 
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Cerebral infarction 
One woman died of basilar artery thrombosis and brain stem infarction, and another from a 
cerebral infarction diagnosed on imaging and no autopsy was performed to establish the 
cause. Both of these deaths were classified as indirect maternal deaths.  
The risk factors for basilar artery thrombosis are the same as those seen generally in stroke 
and the prognosis is poor. The guidelines endorsed by the Royal Australian and New 
Zealand College of Obstetricians and Gynaecologists (McLintock et al. 2012) and the 
NHMRC (NHMRC 2009) on the use of anticoagulation in pregnancy and the puerperium are 
summarised in Box 4.5.  
Box 4.5: Anticoagulation in pregnancy and the puerperium 
• Therapeutic doses of low molecular weight heparins (LMWH) may be used for the 
management of acute thrombotic events in pregnancy, unless the shorter half-life of 
intravenous unfractionated heparin (UH) and predictable reversibility by protamine 
are important. 
• Treatment should be continued up until the birth of the baby and into the puerperium. 
• Pregnant women who have had an acute thrombotic event should give birth under the 
care of a specialist maternity team.  
• In the case of recent thrombosis, the birth of the baby should be planned and the time 
during which anticoagulation therapy is ceased around the time of birth should be 
minimised. 
• Therapeutic doses of LMWH contraindicate the use of regional anaesthesia, and a 
switch to intravenous UH before birth is due may allow greater flexibility in this 
regard. 
• Prophylactic doses of LMWH can be used to reduce the risk of recurrent 
thromboembolic events in pregnancy. The regimen used will depend on the previous 
history, the family history and the presence of risk factors, including the genetic and 
acquired causes of thrombophilia. 
• Women with mechanical heart valves are at high risk during pregnancy and require 
therapeutic anticoagulation throughout pregnancy under the direction of experienced 
cardiological and haematological specialists (Hague et al. 2001). 
Cancer in pregnancy 
Cancer is a leading cause of death of women during reproductive years, although the 
number of pregnancy-associated cancers remains low. A New South Wales study identified 
499 cancers that were diagnosed during pregnancy between 1994 and 2008, and 1,299 cancers 
that were diagnosed during the first year after pregnancy (Lee et al. 2012). This gave a crude 
incidence for pregnancy-associated cancers (defined as a diagnosis of cancer during 
pregnancy or within 12 months of giving birth) of 191.5 per 100,000 women giving birth to 1 
or more live or stillborn infants at 24 weeks gestation or above (p < 0.001) (Lee et al. 2012). 
The most common pregnancy-associated cancers identified were melanoma (33.3%) and 
breast cancer (21.0%). In 2013, the AMOSS commenced the first national Australian study on 
gestational breast cancer. 
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Two women reported here died from cancer during pregnancy and 1 from a tumour of the 
right adrenal gland (phaeochromocytoma). One of the women was diagnosed with a relapse 
of cancer, having been in remission before becoming pregnant. One woman had 
undiagnosed cancer before her death and she died from intra-abdominal bleeding due to a 
ruptured liver tumour in the antenatal period. There was insufficient information available 
to establish the circumstances surrounding the death of the third woman. These deaths were 
classified as indirect maternal deaths. 
Although pregnancy-associated cancers remain rare, it is an important clinical point to note 
that pregnant women should undergo appropriate investigations for potentially serious 
conditions. Studies have shown that women and their health-care providers may incorrectly 
attribute cancer-related symptoms to the physiologic changes of pregnancy and that there is 
reluctance to perform radiographs or invasive procedures during pregnancy (Smith et al. 
2003). These factors may lead to delayed diagnoses of cancer during pregnancy. Evidence 
has shown that less aggressive tumours are more likely to remain undetected until after the 
woman has given birth (Smith et al. 2003). The New South Wales cancer in pregnancy study 
concluded that ‘pregnancy-associated cancers have increased, and this increase is only 
partially explained by increasing maternal age. Pregnancy increases women’s interaction 
with health services and the possibility for diagnosis, but may also influence tumour growth’ 
(Lee et al. 2012).  
Deaths from undetermined causes 
There were 3 indirect maternal deaths where the cause of death could not be determined. Of 
these 3 deaths, 2 of the women had an autopsy examination, but the other was not referred to 
the coroner and the reason for this was not documented at the national level. One woman 
died from respiratory causes but the exact cause of death could not be determined at autopsy 
examination. Another woman died antenatally from an undetermined cause after 
complaining of swelling of the hands and feet but remained normotensive and the cause was 
not determined at autopsy examination. One woman who was being treated for mastitis, and 
was known to have multiple comorbidities, collapsed at home and died postpartum.  
Summary 
‘Other’ causes of maternal death included epilepsy, cerebral infarction and cancer. The cause 
of death was undetermined in a number of cases because an autopsy was not performed or 
was inadequate. Although it is accepted that the death of a woman in association with 
pregnancy is a very difficult occurrence for all involved, it is important that health 
professionals always seek consent for specialist pathologist autopsy.  
Pregnant women who present with symptoms of serious disease should be fully investigated 
and relevant clinical specialists consulted.  
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5 Deaths related to psychosocial 
morbidity 
Good practice guidance 
• The antenatal period presents an opportunity to monitor women’s psychosocial 
wellbeing and provide access to appropriate mental health services. 
• Antenatal psychosocial screening has been introduced throughout Australia as part of 
the National Perinatal Depression Initiative 2008–2013. 
• Antenatal and postnatal screening programs, with clear referral guidelines and 
treatment of significant maternal psychiatric morbidity should be routine practice in 
maternity services, general practice and child and family health services (Austin et al. 
2011). 
5.1 Severe psychosocial maternal morbidity 
The most common mental health problem related to pregnancy is depression. Research 
shows that the period prevalence (over the 9-month gestation) for major depression is 12.7%, 
while the period prevalence for major depression is 7.1% in the first 3 months postpartum 
(Gaynes et al. 2005). The National Perinatal Depression Initiative (NPDI) 2008–2013 is an 
Australia-wide initiative that has a specific focus on psychiatric illness in pregnancy and the 
postpartum period. The NPDI identifies maternal mental health and wellbeing as an 
essential part of a holistic approach to maternity health care. For the first time in Australia, 
guidelines have been developed and implemented for the detection and treatment of 
depression and related conditions during pregnancy and up to the first year after birth. The 
NPDI, underpinned by the Australian Clinical practice guidelines for depression and related 
disorders-anxiety, bipolar disorder and puerperal psychosis- in the perinatal period (Austin et al. 
2011), aims to improve the prevention and early detection of antenatal and postpartum 
depression and to provide better care, support and treatment for pregnant women, new 
mothers and their families. 
Deaths from psychosocial morbidity between 2006 and 2010 
For this report, the term ‘psychosocial morbidity’ describes deaths in which a psychiatric 
condition contributed to the cause of death, and encompasses the wider issues of domestic 
violence and substance misuse. There were 13 maternal deaths from causes related to 
psychosocial morbidity between 2006 and 2010. Psychosocial morbidity was the second 
leading cause of indirect maternal death in Australia, behind cardiac causes. The MMR due 
to psychosocial morbidity for 2006 to 2010 is 0.9 deaths per 100,000 women who gave birth, 
compared with 1.2 deaths per 100,000 women who gave birth in 2003–2005 (Table 5.1). 
Previous Australian maternal death reports have shown similar findings with ‘psychiatric 
deaths’ (the term used in previous Australian maternal death reports) reported as the 
leading cause of death in the previous 3 triennia (Table 5.1). The very small number of deaths 
increases volatility and limits the interpretation of the data, so caution should be used when 
interpreting these results. 
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Table 5.1: Deaths related to 
psychosocial morbidity, ratio per 
100,000 women who gave birth, 
Australia, 2000–2010 
Reporting period  Number MMR(a) 
2000–2002 9 1.2 
2003–2005 9 1.2  
2006–2010(a) 13 0.9  
(a) 2006–2010 is a 5-year period; previously 3-year 
reporting periods were used. 
In the UK, a data linkage study, which is a reliable method of obtaining information on the 
number of maternal deaths and their cause, identified suicide as the leading cause of 
maternal morbidity and mortality for the time period studied (CMACE 2011). A New South 
Wales-based data linkage study reported similar findings, with a large proportion of the 
deaths identified (32%) due to psychosocial-related morbidity (Cliffe et al. 2008). The serious 
and, in some cases life-threatening, consequences of mental health illness associated with the 
perinatal period have been afforded increasing prominence in the area of maternal morbidity 
and mortality research over recent years, and in this report. A significant proportion of 
maternal deaths occur among women with a previous psychiatric history (Austin et al. 2007) 
and evidence suggests that substance misuse and domestic violence often complicate deaths 
related to psychiatric illness and in a minority can be the primary cause (Austin et al. 2007; 
Oates 2003). The antenatal period is a time when many women will have contact with health-
care services, which presents an important opportunity to evaluate and monitor psychosocial 
wellbeing and provide access to appropriate mental health services. Although these deaths 
can be viewed as not strictly due to ‘obstetric causes’ they are a part of the spectrum of 
maternal morbidity and a significant cause of mortality in the perinatal period. If the aim of 
examining and reporting maternal deaths is to make improvements in maternity care that 
could lead to prevention of maternal deaths and to provide information that can be used to 
improve maternity services, then it is essential that deaths of women by suicide or assault in 
the perinatal period are included in systems of review. It is essential that maternity services 
are able to effectively identify and provide services to women at risk of harm from 
themselves or others. It is essential that opportunities to prevent the death of vulnerable 
women are not lost.  
There were 13 women who died from causes related to psychosocial morbidity between 2006 
and 2010: 9 of these women committed suicide; 2 were murdered by their partners; and 2 
were known substance users who overdosed on illicit drugs with unknown intent.  
Table 5.2: Indirect maternal deaths due to psychosocial morbidity by 
cause, Australia, 2000–2010 
Cause of death  2000–2002 2003–2005 2006–2010(b) 
Suicide 7 4 9 
Homicide .. 3(a) 2 
Overdose 1 2 2 
Other 1 .. .. 
Total 9 6 13 
(a)  Deaths due to homicide were previously reported in the ‘other category’ and not ‘psychiatric deaths’. 
(b)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
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There were 4 further deaths related to psychosocial morbidity that were classified as 
incidental. Of the incidental deaths, 3 women were murdered and 1 died of an overdose in 
early pregnancy; all of these cases were deemed unrelated to the pregnancy by the local 
STMMC. There was another death related to psychosocial morbidity that is reported 
elsewhere: a woman died from complications of labour after failing to attend maternity 
services during the antenatal period or at birth and was classified as an indirect death due to 
infection. 
Of the 9 women who committed suicide, 7 were by violent means including 5 who 
committed suicide by hanging. The method of suicide for 1 woman was not documented and 
1 was an overdose of illicit drugs. The women who died were aged between 19 and 40 with a 
median age of 32. Seven of the women died while they were pregnant, including all 3 who 
were victims of partners. Six women died in the postnatal period and the pregnancy status 
was not reported for 1 woman. Table 5.3 gives a summary of the women who died from 
causes associated with psychosocial morbidity in Australia between 1994 and 2010, and in 
the UK between 2000 and 2002. The 2006–2010 data support previous findings that a 
significant proportion of maternal deaths occur among women with a previous psychiatric 
history, or among those with current contact with mental health services.  
Table 5.3: Profiles of maternal deaths associated with psychiatric causes in Australia and  
the UK (adapted from Austin et al. 2007) 
 Australia 2006–2010 
(n = 13) 
Australia 1994–2002  
(n = 26) 
UK 2000–2002 
(n = 60) 
Age < 25 4 (31%) 7 (27%) 11/58 (16%) 
Ethnic/Indigenous status  Not reported At least 3 (12%) Indigenous 7/60 (12%) ethnic 
minorities 
Suicide by violent means  6 (46%) 17 (65%) 17/26 (65%)(a) 
Antenatal death  8 (62%) 17 (65%) 14/60 (23%) 
Prior psychiatric illness  8 (62%) 6 (23%) 34/56 (61%) 
Perinatal psychiatric episode  4 (31%) 13 (50%) 37/60 (62%) 
Receiving treatment 
perinatally  
3 (23%) 9 (35%) 37/60 (62%) 
Contact with a psychiatric 
service perinatally  
4 (31%) 8 (31%) 23/60 (38%) 
Psychiatric in-patient care 
perinatally  
3 (23%) 6 (23%) 10/60 (17%) 
Perinatal risk detection  Of the 8 women with a 
previous or current 
psychiatric disorder, 3 
(38%) were reported at 
the national level as in 
contact with mental 
health services 
Of the 19 women with a previous 
or current psychiatric disorder, 9 
(47%) were in contact with 
mental health services 
 
Of the 34 women 
with a previous 
psychiatric disorder, 
17 (50%) had been 
identified as ‘at risk’; 
10/17 had a 
management plan in 
place 
Note: Details were not available for 2 of the 28 suicide deaths. 
Of the 13 women who died between 2006 and 2010, 8 had a documented psychiatric history, 
8 were known substance users and4 had contact with mental health services during the 
perinatal period. Austin et al. (2007) suggest ‘that these deaths, in particular, may have been 
avoided if there had been adequate monitoring of the women’s mental health status’.  
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Case summary 
A 30-year-old nulliparous woman with a history of depression and borderline personality 
disorder revealed feelings of anxiety, suicidal ideation and an episode of attempted self-
harm to maternity staff during the antenatal period. Although she was referred for mental 
health care, she failed to attend any follow-up appointments. She went into spontaneous 
labour at term and gave birth to a healthy infant. During the early postpartum period 
family members raised concerns with maternity staff over her difficulty parenting the baby. 
Two days later she committed suicide by hanging. 
 
Case summary 
A 24-year-old nulliparous woman experienced a neonatal death. Medical records reported 
no known general practitioner. A mental health history was not obtained but a known 
history of ‘recreational drug use’ was recorded. The woman was found deceased at home 32 
days postpartum. Autopsy: mixed drug toxicity.  
Collecting information on maternal deaths due to psychosocial 
morbidity 
At present, the national maternal death data collection consists of limited information on 
psychosocial wellbeing. In 2013–14, a new national maternal death reporting form was 
piloted: the National Maternal Death Reporting (NMDR) form. The NMDR form is the result 
of a thorough process of consultation with relevant experts, both nationally and 
internationally. The NMDR form will collect more detailed information on psychosocial 
wellbeing, including details of antenatal and postnatal mental health screening, psychiatric 
history and previous contact with psychiatric or child protection services.  
Data linkage, as previously demonstrated in Cliffe et al. 2008 and Thornton et al. 2013, allows 
more accurate detection of all psychosocial-related maternal deaths, including late maternal 
deaths, which are particularly relevant to this group of women, given that the greatly 
increased rate of serious psychiatric morbidity extends into the first few months postpartum 
(Austin et al. 2011; Munk-Olsen 2006; Thornton et al. 2013) . 
Classifying maternal deaths due to psychosocial morbidity 
In Australia, each maternal death undergoes a through process of review and investigation 
in the form of a confidential death enquiry. As part of the confidential death enquiry, there is 
the opportunity to examine the circumstances surrounding each death on an individual basis 
and determine previous psychosocial morbidity. As discussed in ‘Chapter 2 Definitions, 
classifications and methods’, for national reporting purposes, Australia has classified deaths 
among women with a pre-existing psychiatric illness or a psychiatric illness that developed 
during pregnancy and was not due to direct obstetric causes as indirect. Deaths deemed 
unrelated to the pregnancy due to ‘external causes’ have been classified as incidental. This 
classification system was introduced in the 1997–1999 triennium and the classification for 
psychosocial deaths that occurred between 2006 and 2010 remained unchanged from that 
triennial report.  
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In general, the Australian classification system is intended to determine the causes and 
potential preventability of these deaths, with the aims of improving maternity mental health 
services and reducing maternal deaths.  
Summary 
Psychosocial morbidity is a leading cause of maternal death in Australia. The high 
proportion of deaths occurring in women with a known psychiatric history highlights the 
importance of antenatal and postnatal mental health screening. The adoption of antenatal 
psychosocial screening and implementation of the NPDI, which for the first time provides 
guidelines for the management of psychiatric illnesses in the perinatal period, are timely 
initiatives in preventing maternal deaths related to psychosocial morbidity. A more detailed 
national maternal death reporting form represents the potential for significant change and 
improved reporting in Australia. Improved reporting of these non-obstetric causes of 
maternal death could provide the evidence base required for further policy and service 
implementation for women with mental health morbidity. 
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6 Incidental deaths 
Incidental maternal deaths are deaths from causes unrelated to pregnancy that happen to 
occur in pregnancy or the puerperium. Internationally, cases of such incidental deaths are 
included in maternal mortality reporting, although only direct, indirect and unclassifiable 
maternal deaths are counted for statistical purposes. In addition to the 99 maternal deaths 
reported to the NPESU between 2006 and 2010, there were 26 incidental maternal deaths 
(Table 6.1).  
Table 6.1: Causes of incidental 
maternal deaths, Australia,  
2006–2010 
Cause of death  Number 
Medical causes 11 
Motor vehicle accident 7 
Homicide 3 
Accidental injury 2 
Undetermined 2 
Overdose 1 
Total 26 
The incidental maternal deaths from medical causes were the most common category and 
included deaths due to a variety of conditions such as asthma, sepsis, intracerebral 
haemorrhage and probable cardiac arrhythmia. Deaths resulting from motor vehicle 
accidents were the most common single cause, accounting for 7 of the 26 incidental maternal 
deaths, followed by 3 deaths due to homicide. These are additional to the 2 indirect deaths 
due to homicide reported in ‘Chapter 5 Deaths related to psychosocial morbidity’, where the 
deaths were able to be attributed to known partner violence.  
6.1 Accidental injury and motor vehicle accident 
The Injury and Prevention Research Unit, New Zealand provided a statement with regards 
to the prevention of accidental and motor vehicle injury in pregnancy. Motor vehicle 
accidents during pregnancy are the leading cause of traumatic fetal mortality and serious 
maternal injury morbidity and mortality in the US and presumably in other car-centric 
societies such as Australia. However, fetal death and injury due to maternal injury is a 
largely invisible problem and has not been enumerated in Australia. The problem remains 
hidden and under-reported because of the way fetal trauma is coded in vital statistics and 
the lack of pregnancy status recorded in crash and other injury surveillance systems. Linking 
crash data to fetal death and infant birth records is 1 proven way to get a better 
understanding of the problem, though no states do this on an ongoing basis. In addition to 
better tracking of the problem, a combination of prevention efforts is needed to deal with the 
issue including: increased occupant protection through high levels of proper maternal 
seatbelt use; less maternal driving to suit different lifestyles; lower driving speeds; and 
avoiding or limiting being in a vehicle during risky situations (poor roads, night, bad 
weather, impaired or distracted drivers). 
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Summary 
All maternal deaths occurring in pregnancy or the puerperium should be reviewed by a 
STMMC. Information on incidental maternal deaths is needed to inform prevention 
strategies. Motor vehicle accidents during pregnancy are a major cause of traumatic fetal 
mortality and serious maternal injury. Correct maternal seatbelt use is to be advocated. 
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7 Aboriginal and Torres Strait Islander 
women 
Good practice guidance 
Aboriginal and Torres Strait Islander women: 
• remain at 3 times the risk of maternal death as non-Indigenous women 
• have a greater burden of maternal mortality from chronic conditions 
• have sepsis as the most common specific cause of death in this reporting period and 
when deaths over a longer time period were considered 
• may not all have been identified among women who died. It is important to record 
accurately Aboriginal and Torres Strait Islander status in all data collections. 
Pregnancy and birth pose a greater risk for Aboriginal and Torres Strait Islander women 
than for non-Indigenous women. There were 14 Aboriginal and Torres Strait Islander 
women who died during their pregnancy, labour or in the postnatal period between 2006 
and 2010. Of these, 9 were maternal deaths, 4 were due to incidental causes and 1 was 
unclassifiable. The MMR for the 5 years 2006 to 2010 was more than 3 times higher for 
Aboriginal and Torres Strait Islander women than for the 75 non-Indigenous women (where 
Indigenous status was known), with MMRs of 16.4 and 5.4 deaths, respectively, per 100,000 
women who gave birth. The very small number of deaths increases volatility and limits the 
interpretation of the data. Caution should be used when interpreting these results. 
7.1 Indigenous women who died between 2006 and 
2010 
The 9 maternal deaths among Aboriginal and Torres Strait Islander women in the current 
reporting period comprised of 5 direct maternal deaths and 4 indirect maternal deaths. Table 
7.1 presents a summary of maternal deaths in Aboriginal and Torres Strait Islander women 
between 2006 and 2010. 
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Table 7.1: Maternal deaths among Aboriginal and Torres Strait  
Islander women, Australia, 2006–2010 
Age group Cause of death category Parity group(a) 
Direct     
<20 Hypertensive disorder M 
30–34 Obstetric haemorrhage GM 
20–24 Sepsis M 
35–39 Sepsis M 
≥40 Sepsis GM 
Indirect   
20–24 Suicide Not stated 
20–24 Cardiac condition M 
30–34 Cardiac condition Not stated 
35–39 Other cause Not stated 
(a) M = multipara; GM = grand multipara. 
The median age of the Aboriginal and Torres Strait Islander women and other Australian 
women who died was 32. In contrast, the median age of all Aboriginal and Torres Strait 
Islander women who gave birth between 2006 and 2010 was 24, compared with 30 for other 
Australian women. All 6 women for whom parity was known were parous, with 2 grand 
multipara(4 or more previous births).  
Trends in maternal mortality by Indigenous status 
The 9 maternal deaths of Aboriginal and Torres Strait Islander women that occurred during 
2006–2010 are fewer than the peak of 12 deaths reported during 2000–2002 (Table 7.2). There 
has been a tendency towards lower MMRs for Aboriginal and Torres Strait Islander women 
compared with other Australian women since reporting of Indigenous-specific MMR began 
in 1991 (Table 7.2). Past reports have included women where Indigenous status was not 
reported. These are collectively referred to as ‘Other Australian women’. Although, there are 
more deaths in the current 5-year reporting period, which is 2 years (67%) longer than for 
previous reports, the rates of maternal mortality are lower for both Aboriginal and Torres 
Strait Islander women and other Australian women. 
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Table 7.2: Trends in maternal mortality in Aboriginal and Torres Strait Islander women and other 
Australian women, 1991 to 2010 
 Aboriginal or Torres Strait Islander women  Other Australian women(a)  
Relative 
MMR(c)  
 Maternal deaths   Maternal deaths   
Period Direct Indirect MMR(b)  Direct Indirect MMR(b)  
1991–93 1 4 23.2  26 17 5.8  4.0 
1994–96 3 1 17.4  43 19 8.3  2.1 
1997–99 1 5 23.5  33 23 7.7  3.1 
2000–02 4 8 45.8  28 44 10.0  4.6 
2003–05 2 4 21.7  27 32 8.0  2.7 
2006–10(d) 5 4 16.4  35 52 6.2  2.6 
(a)  Other Australian women include women whose Indigenous status was not known. Previous reports have included women with missing 
Indigenous status together with those for non-Indigenous women. For consistency, this grouping has been applied to all periods. 
(b)  MMR is reported per 100,000 women who have given birth. The number of Aboriginal and/or Torres Strait Islander women or other women 
who gave birth is the sum of numbers reported in the Australia's mothers and babies series for the years referenced. 
(c)  Relative MMR is the ratio MMR for Aboriginal and Torres Strait Islander women and the MMR for other women who gave birth in Australia. No 
difference between groups will yield an MMR equal to 1.  
(d)  2006–2010 is a 5-year period; previously 3-year reporting periods were used. 
Fluctuation in the MMRs has been more marked for Aboriginal and Torres Strait Islander 
women than for other women. This reflects both the rarity of maternal death and the smaller 
population of Aboriginal and Torres Strait Islander women. Apart from the 2000–2002 
triennium, MMRs for Aboriginal and Torres Strait Islander women have been of a similar 
order in all time periods. Higher numbers of indirect maternal deaths were reported for both 
Aboriginal and Torres Strait Islander and other women in the 2000–2002 triennium 
compared with other reporting periods. The numbers of maternal deaths among Aboriginal 
and Torres Strait Islander women, or indeed for other women, is too small to detect 
statistically significant differences over time, even when reporting periods are combined. 
To compare the causes of death between Aboriginal and Torres Strait Islander women and 
other Australian women, the causes of maternal death reported between 1997 and 2010 have 
been classified to categories of maternal death used in the current report (Table 7.3). Sepsis 
(21% of maternal deaths), cardiac conditions (18% of maternal deaths) and psychosocial 
conditions (18% of maternal deaths) were the leading cause categories among Aboriginal and 
Torres Strait Islander women. In contrast the most common specific causes of death for other 
Australian women in this period were hypertensive disorders and non-obstetric 
haemorrhage (15.3% of maternal deaths), followed by cardiac conditions (15.0% of maternal 
deaths) and amniotic fluid embolism (12.0% of maternal deaths). ‘Other specified cause’ 
comprise a varied group of conditions. Hypertensive disorders and non-obstetric 
haemorrhage were combined as these conditions may co-exist.  
Cause-specific MMR (CS-MMR) is a measure of the risk of maternal death from specific 
conditions. These are shown for Aboriginal and Torres Strait Islander women and other 
Australian women in Table 7.3, expressed per million women who gave birth. The relative 
CS-MMR quantifies the effect of Indigenous status on the risk of mortality from each cause. 
The risk of maternal death from sepsis was more than eightfold higher among Aboriginal 
and Torres Strait Islander women compared with other Australian women over this time 
period. Higher risks of maternal death from cardiac conditions, psychosocial conditions, and 
hypertensive disorders and non-obstetric haemorrhage combined are also seen among 
Aboriginal and Torres Strait Islander women compared with other women.  
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Table 7.3: Cause of maternal death among Aboriginal and Torres Strait Islander women and other 
Australian women, 1997 to 2010 
  
Aboriginal or Torres Strait Islander women  Other Australian women(a)   
Maternal deaths   Maternal deaths   
Cause of maternal 
death Number % CS-MMR(b) 
 
Number  % CS-MMR(b) 
 Relative 
CS-MMR(c) 
Sepsis 7 21.2 44.5  23 8.8 5.6  8.6 
Cardiac condition 6 18.2 38.1  41 15.0 9.5  4.0 
Psychosocial 
condition 6 18.2 38.1 
 
30 10.9 6.9 
 
5.5 
Hypertensive 
disorders and non-
obstetric 
haemorrhage 5 15.2 31.8 
 
42 15.3 9.7 
 
3.3 
Other specified 
cause 4 12.1 25.4 
 
58 21.2 13.4 
 
1.9 
Obstetric 
haemorrhage  3 9.1 19.1 
 
25 9.1 5.8 
 
3.3 
Amniotic fluid 
embolism 1 3.0 6.4 
 
33 12.0 7.6 
 
0.8 
Thrombosis and 
thromboembolism 1 3.0 6.4 
 
21 7.7 4.9 
 
1.3 
Total 33 100.0 209.7  273 100.0 63.4  3.3 
(a)  In this table, ‘Other Australian women’ include women whose Indigenous status was not known. Previous reports have variously reported 
maternal deaths with unknown Indigenous status together with those for non-Indigenous women. This limits the choice of comparator group. 
The MMR for ‘Other Australians’ will be higher than for ‘Non-Indigenous women’. 
(b)  CS-MMR (cause-specific MMR) is derived using the deaths for the cause as the numerator and the number of women who gave birth as the 
denominator. It is reported per million women who gave birth. 
(c)  Relative CS-MMR measures the effect of Indigenous status on maternal mortality. This is derived by dividing the cause-specific MMR for 
Aboriginal and Torres Strait Islander women by the cause-specific MMR for other Australian women.  
(d)  Statistically significant differences in the CS-MMR for Aboriginal and Torres Strait Islander women suggest that their mortality relative to other 
Australian women is not due to chance. This can be inferred if the 95% confidence limits for the relative MMR do not include 1.  
Pre-existing and non-obstetric conditions are more common causes of maternal death for 
Aboriginal and Torres Strait Islander women than for other women. This is consistent with 
generally poorer health among Aboriginal and Torres Strait Islander women compared with 
the general population of women. Antenatal care early in pregnancy is particularly 
important for Aboriginal and Torres Strait Islander women to ensure that there is provision 
to detect and appropriately manage chronic disease, especially rheumatic heart disease, and 
services need to be aware of the higher rates of depression and suicide risk in Aboriginal and 
Torres Strait Islander women compared with non-Indigenous women.  
Remoteness as a risk factor for maternal death 
There was no substantial difference in maternal mortality between Aboriginal and Torres 
Strait Islander women resident in Major cities or Inner regional areas (15.4 per 100,000 women 
who gave birth) and those living in Outer regional, Remote or Very remote locations (13.8 per 
100,000 women who gave birth). Nor was there a trend evident. In contrast, maternal 
mortality increased with increasing remoteness among non-Indigenous women from 3.7 per 
100,000 women who gave birth and were resident in Major cities to 4.9 per 100,000 women 
who gave birth and were resident in Remote and Very remote areas.  
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In 2006–2010, 27% of Aboriginal and Torres Strait Islander women and 2% of non-
Indigenous women who gave birth lived in a Remote or a Very remote area, while 27% and 
72%, respectively, lived in Major cities. Small numbers limit interpretation and detailed 
reporting of remoteness area for Aboriginal and Torres Strait Islander women.  
Access to health services and health outcomes are generally poorer in rural and remote areas 
relative to metropolitan areas (Department of Health and Aged Care 2003). Access to health 
care and chronic ill health may be issues for Aboriginal and Torres Strait Islander women 
living in urban areas, as well as those living in remote settings. Potential information bias 
regarding place of usual residence exists for women who are temporarily relocated to attend 
hospitals in metropolitan areas in the later stages of their pregnancy until they give birth.  
Taking control of maternity care 
The threefold higher risk of maternal death faced by Aboriginal and Torres Strait Islander 
women compared with other women in Australia is 1 of a range of differential perinatal 
outcomes that communities, health services and health authorities are seeking to eliminate. 
In the National Maternity Services Plan, attention is focused on expanding the provision of 
culturally competent maternity services for Aboriginal and Torres Strait Islander women 
(Australian Health Ministers' Conference 2011). Cultural competence has been defined as a 
set of congruent behaviours, attitudes and policies that focuses on the capacity to improve 
health and wellbeing by integrating culture into the delivery of health services (NHMRC 
2006).  
Culturally competent Aboriginal and Torres Strait Islander maternity care integrates respect 
for, and recognition of, cultural diversity, partnership with Aboriginal and Torres Strait 
Islander communities and Aboriginal and Torres Strait Islander workforce into services with 
continuity of care and carer models, community-appropriate infrastructure, guidelines, 
communications, cultural education programs, evaluation tools and consumer engagement 
in clinical governance (Kruske 2011). These principles are exemplified in the 3 examples in 
Box 7.1 from the growing number of programs across Australia.  
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Box 7.1: Examples of Aboriginal and Torres Strait Islander culturally competent 
maternity services 
• The Anangu Bibi Family Birthing Program was founded following consultation with 
senior Aboriginal women in South Australia and set up in partnership with Aboriginal 
communities in Whyalla and Port Augusta. Aboriginal maternal and infant care 
workers take the lead role, working in partnership with midwives backed by general 
practitioners in an intercultural partnership and skill exchange to provide care during 
pregnancy, childbirth and in the postnatal period for Aboriginal mothers and families 
(Stamp et al. 2008). 
• Mawarnkarra Aboriginal Health Service developed a program that incorporates 
relevant cultural beliefs in the health education program for pregnant women and their 
families in response to gaps in service provision identified by the health team and 
community elders (McHugh & Hornbuckle 2011). 
• Congress Alukura is a long-standing Aboriginal community-controlled health service 
in Alice Springs that provides culturally appropriate antenatal, intrapartum and 
postnatal care by a team that includes a full-time general practitioner, midwives, 
women’s health nurse, Aboriginal liaison officer, educators and traditional 
grandmothers (Kruske 2011). 
Audit tools (Reibel & Walker 2010) and indicators (Kruske 2011) of cultural competence in 
maternity services are being developed and tested so that the extent and contribution of 
culturally competent maternity services can be evaluated (Australian Health Ministers' 
Conference 2011). This is, however, only 1 facet, and services are encouraged to develop an 
organisational culture that values learning and continuous quality improvement across all 
areas of practice and service delivery (McHugh & Hornbuckle 2011).  
Identifying Aboriginal and Torres Strait Islander women 
Aboriginal or Torres Strait Islander status has been collected for cases categorised as direct 
maternal deaths since 1970, and for indirect maternal deaths and incidental deaths since 
1991. For this report, Aboriginal or Torres Strait Islander status was not reported for 16 
women who died during pregnancy or within 42 days of giving birth, including 12 direct or 
indirect maternal deaths, representing 13% of maternal deaths. This is higher than the 
previous triennium 2003–2005 when 6 (8%) of the maternal deaths had no data reported on 
Indigenous status (Sullivan et al. 2007). This reflects in part the provisional nature of some of 
the data provided for this report.  
An Aboriginal or Torres Strait Islander woman is defined for Australian health data 
collections as a woman of Aboriginal or Torres Strait Islander descent who identifies herself 
as such. The third criterion for Aboriginality, namely that she is accepted by her community, 
is not included for pragmatic reasons. For this report, information on Indigenous status was 
collected using the National Maternal Death Reporting (NMDR) form 2006–2010, using the 
standard categories.  
The quality of Aboriginal or Torres Strait Islander status data, as measured by the proportion 
of clients with a not-stated response in specific data collections, has improved in most data 
collections since the AIHW’s 2007 data quality report (AIHW 2012a). Since the 2007 report, a 
number of activities have been, or are being, undertaken to improve the identification of 
Indigenous people in the community services’ data collections. These include modifying 
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client forms and client information management systems and the provision of staff training, 
including cultural awareness training, and training on how to collect Indigenous status data. 
Summary 
Aboriginal and Torres Strait Islander women are 3 times more likely to die during their 
pregnancy or the puerperium than other Australian women. Pre-existing and non-obstetric 
conditions are more common causes of maternal death for Aboriginal and Torres Strait 
Islander women than for other women. Sepsis, cardiac and psychosocial conditions were the 
leading cause categories of deaths among Aboriginal and Torres Strait Islander women 
between 2006 and 2010. Antenatal care early in pregnancy is particularly important for 
Aboriginal and Torres Strait Islander women to ensure that there is provision for early 
detection and appropriate management of chronic disease that may have an impact on 
pregnancy. 
The sociocultural, geographic and health service environments for many Aboriginal and 
Torres Strait Islander women are different to other Australian women. There are successful 
examples of culturally appropriate Aboriginal and Torres Strait Islander community 
maternity care programs that have been shown to improve the health of Aboriginal and 
Torres Strait Islander mothers and their babies. It is critical that Aboriginal and Torres Strait 
Islander status is adequately reported in key health data sets, so that essential information 
can be collected and used to inform research, with the ultimate purpose of improving the 
health of all Australian mothers. 
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8 Coronial review  
Good practice guidance 
• Maternal deaths should be reported to the coroner and where the cause of death is not 
clearly known autopsy should be advocated to establish the cause of death.  
• Guidelines for how to perform a maternal death autopsy are available from The Royal 
College of Pathologists, Guidelines on autopsy practice scenario 5: Maternal death 
(RCPATH 2010).  
• Jurisdictions are advised to develop documents to support families and clinicians 
during the process of consent for autopsy. 
• The role of the coroner and reporting requirements are not standardised across 
jurisdictions. 
 
This is the first Maternal Deaths in Australia report to include a specific chapter on the role of 
the coroner. The NMMAC was concerned about the number of deaths that it reviewed that 
were not examined by autopsy despite there being some uncertainty regarding the cause of 
death and, in some cases, not being appropriately referred to a coroner; this concern led to 
inclusion of this chapter.  
In Australia, the primary method of review for all maternal deaths is confidential enquiry. 
However, there are several models of reporting and investigation into maternal deaths other 
than confidential enquiry. Examples of other models of investigation include investigation 
by the hospitals in which the death occurs, such as by root cause analyses, and investigation 
by the coroner. These other enquiries can provide valuable information on individual cases 
to be used at confidential enquiry. Autopsies may be essential in accurately establishing the 
cause of death in some cases, and coronial review can establish valuable insights into the 
circumstances of particular deaths. Between 2006 and 2010, 80 of the 99 (80.1%) direct and 
indirect maternal deaths were referred to the coroner. There were autopsies for 72 (72.7%) of 
all cases (Table 8.1).  
Table 8.1: Maternal deaths by referral to coroner, by type of death and autopsy, 
Australia, 2006–2010 
Type of death Maternal deaths  Referred to the coroner Autopsy 
Direct 39 33 30 
Indirect 57 45 40 
Maternal deaths not further classified 3 2 2 
Total 99 80 72 
8.1 The role of the coroner 
Each state and territory has its own Coroners Act, which governs the powers and duties of 
the coroner. Accordingly, the specific duties and responsibilities of the coroner vary by 
jurisdiction (National Coronial Information System). In general, the role of the coroner is to 
investigate the circumstances surrounding a ‘reportable death’. At the conclusion of every 
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investigation, it is the task of the coroner to prepare a written finding to establish wherever 
possible the following: 
• identity of the deceased  
• circumstances surrounding the death 
• cause of death 
• particulars needed to register the death. 
The coronial process is not adversarial and is not intended to determine whether any person 
is guilty of any offence, but rather to investigate and discover facts (Turnbull 2010). As part 
of the coronial process, an autopsy may be performed to help explain the cause of death. 
Once a pathologist has all the results of the tests, a detailed report is prepared for the 
coroner, which outlines medical findings and conclusions (National Coronial Information 
System). The coroner takes this information into account when making a finding. In some 
circumstances, an inquest may be held. An inquest is a court hearing conducted by the 
coroner, in which the circumstances surrounding a death are examined. It is important to 
note that most deaths do not require an inquest. In Western Australia, an inquest or public 
hearing is only held in about 3% of cases (Turnbull 2010). 
Is a maternal death a reportable death? 
Coronial legislation varies by jurisdiction and, in turn, what constitutes a ‘reportable death’ 
varies by jurisdiction. A review of the relevant legislation demonstrates that generally 
legislation mandates that: 
• all reportable deaths are reported to the coroner 
• health professionals must provide all available information to the coroner’s office 
• the coroner’s role is to determine what happened, as well as to assign a cause of death. 
Across jurisdictions in general, a reportable death is a: 
• death that follows an injury or accident (not explicitly stated in New South Wales) 
• violent or unnatural death 
• death of which the cause is unknown  
• death which was unexpected  
• death in custody  
• death that has not been certified by a medical practitioner 
• death of a person who was detained or recently detained in mental health services 
(Victoria, New South Wales, South Australia, Queensland, Western Australia and 
Northern Territory, but not Australian Capital Territory or Tasmania). 
In some jurisdictions, health-care-related deaths are more specifically included: 
1. A death following anaesthetic (South Australia, Tasmania, Western Australia and 
Northern Territory) 
2. A health-care-facility-related death: 
• Queensland: ‘healthcare related death’ 
• Northern Territory: ‘a death following a medical procedure where the death is or 
may be causally related to the medical procedure’ 
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• New South Wales: ‘the person died where the person’s death was not a 
reasonably expected outcome of a health-related procedure’ 
• Australian Capital Territory: ‘a death within 72 hours of an operation of a 
medical, surgical, dental or like nature, or an invasive medical or diagnostic 
procedure’ 
• Victoria: ‘a death following a medical procedure where the death is or may be 
causally related to the medical procedure’. 
In April 2004, Australian Health Ministers agreed to all public hospitals reporting all sentinel 
events and that all states and territories would contribute to a national report on sentinel 
events (AIHW & ACSQHC 2007). Sentinel events are reported by the Productivity 
Commission in their annual Report on government services. Most cases of maternal death are 
likely to fall within the criteria for a reportable death. In the UK, the Royal Colleges of 
Obstetricians and Gynaecologists and of Pathologists both recommend that ‘an autopsy be 
performed on as many maternal deaths as possible to learn from the results’ (CMACE 2011). 
In Australia, the Royal College of Pathologists of Australasia is supportive of all maternal 
deaths being investigated by an autopsy, whether authorised by the coroner or not. 
Guidelines for how to perform a maternal death autopsy are available from The Royal 
College of Pathologists, Guidelines on autopsy practice scenario 5: Maternal death (RCPATH 
2010). It is important to note that if the case is reportable when death is declared (which 
includes when brain death is determined), the body becomes property of the coroner and it 
is an offence to perform any procedure on, or to interfere with, the body without permission 
from the coroner.  
Sentinel event reporting 
The national list of sentinel events, revised by the Australian Health Ministers’ Advisory 
Council (AHMAC) and the Standing Committee on Health (SCoH) in 2009 is as follows. A 
maternal death is the seventh sentinel event:  
1. procedures involving the wrong patient or body part resulting in death or major 
permanent loss of function 
2. suicide of a patient in an inpatient unit 
3. retained instruments or other material after surgery requiring re-operation or further 
surgical procedure 
4. intravascular gas embolism resulting in death or neurological damage 
5. haemolytic blood transfusion reaction resulting from ABO incompatibility 
6. medication error leading to the death of patient reasonably believed to be due to 
incorrect administration of drugs  
7. maternal death or serious morbidity associated with labour or delivery 
8. infant discharged to the wrong family. 
A survey of jurisdictional reporting practices  
In April 2012, the AIHW NPESU undertook a survey in each jurisdiction. The survey was 
completed by the Department of Health in each jurisdiction and aimed to establish which 
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methods of maternal death enquiry are used by each jurisdiction. A component of the survey 
focused on the role of the coroner and aimed to establish: 
• jurisdictional legislation or policy that mandates or recommends maternal deaths are 
reported to the coroner 
• any non-formalised reporting processes involved in coronial review of maternal deaths. 
No survey responses were received from the Australian Capital Territory and the Northern 
Territory. Table 8.2 summarises the jurisdictional reporting practices by identifying the 
relevant legislation, showing if there is mandatory reporting of maternal deaths to the 
coroner and highlighting any reported relationships between the Department of Health and 
the coroner’s office.  
Table 8.2: Coronial legislation and existing reporting relationships by jurisdiction 
State Coroner’s legislation 
Does this policy 
mandate referral of 
maternal deaths? Existing reporting structures/current relationship 
NSW Coroners Act 2009 No The Department of Forensic Medicine at Glebe reports maternal 
deaths to the Ministry of Health on a voluntary basis. 
Qld Coroners Act 2003 No The Chairpersons of gazetted state-wide quality assurance 
committees have an informal relationship with the State Coroner, 
and the chairperson of the Queensland Maternal and Perinatal 
Quality Council has met formally with the State Coroners in 2013 
and 2014. 
The Public Health Act 2005 was revised in early 2014 to mandate 
reporting of maternal deaths to the Department (the Maternal 
Death Statistics Collection). 
Vic Coroners Act 2008 Yes Notified automatically through coronial e-Medical Deposition 
Form (check box asking if pregnant in past 12 months). 
SA Coroners Act 2003 Yes Coroner's records are able to be accessed, excepting those 
where a criminal investigation is underway. 
Tas Coroners Act 1995 Yes All maternal deaths to be reported to the coroner. 
WA Coroners Act 1996 No The WA Health Coronial Liaison Unit was established in 2005 to 
improve communication between WA Health and the Office of the 
State Coroner  
ACT Coroners Act 1997 – – 
NT Coroners Act 2011 – – 
Each jurisdiction has a Coroners Act, which legislates for the role of the coroner. Jurisdictions 
reported differing practices with regards to maternal death review. Victoria and Tasmania 
have a mandatory reporting requirement for maternal deaths. Reporting of a maternal death 
to the coroner is not mandatory in New South Wales, Western Australia and Queensland. 
Some jurisdictions have established reporting relationships with the coroner’s office. For 
example, in New South Wales, the Department of Forensic Medicine, where all maternal 
death autopsies are undertaken, report maternal deaths to the Ministry of Health on a 
voluntary basis.  
The number of referrals to the coroner and the number of autopsies carried out varied in 
each jurisdiction between 2006 and 2010. The proportion of autopsies performed varied 
between 40% in Northern Territory to 100% in Western Australia (Table 8.3).  
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Table 8.3: Maternal deaths by referral to coroner, autopsy, state and territory of death, 
Australia, 2006–2010 
State and territory Maternal deaths 
Referred to the coroner  Autopsy 
Number %  Number % 
NSW and ACT 24 22 91.7  20 83.3 
Vic 30 23 76.7  16 53.3 
Qld 24 20 83.3  20 83.3 
WA 8 8 100.0  8 100.0 
SA 6 (a)5 83.3  5 83.3 
Tas 2 0 0.0  1 50.0 
NT 5 2 40.0  2 40.0 
Total 99 80 80.8  72 72.7 
(a) Includes 1 woman who had pathology review only with histology of the uterus, spleen and placenta. 
Summary 
Most cases of maternal death are likely to fall within the criteria for a reportable death. 
Reporting practices vary by jurisdiction, as do the number of autopsies undertaken. Maternal 
deaths should be reported to the coroner and the majority of cases should undergo autopsy. 
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9 Quality of maternal death reviews in 
Australia 
The current Australian maternal death reporting system involves several tiers of 
reporting/review as outlined in Chapter 2. The organisational structure, roles and 
responsibilities of State and Territory Maternal Mortality Committees (STMMCs) vary across 
states and territories. There is no standardised method of identifying and collecting data on 
maternal deaths, and no nationally agreed process of reporting or investigation. Data from 
the National Maternal Death Report Data Set, used to populate this report, reflect these 
inconsistencies.  
This chapter outlines the variations in the process of data collection and supply across states. 
Information used in this chapter was obtained from a national survey distributed to the 
Department of Health in each state and territory in July 2012. The aims of the survey were: to 
determine the most common sources of maternal death notification; identify legislation 
relevant to maternal deaths in each state and territory; and to establish which mechanisms of 
review other than confidential enquiry are routinely used. Survey responses were received 
from New South Wales, Victoria, Queensland, South Australia, Western Australia and 
Tasmania, with the majority completing all questions.  
9.1 Sources of maternal death notification  
Methods of maternal death notification vary across states and territories. Information from 
the survey responses is detailed here, noting that no information was received from the 
Australian Capital Territory and Northern Territory.  
In New South Wales, maternal deaths are notified through a number of methods such as: 
direct notification by hospitals; voluntary reporting by the local Department of Forensic 
Medicine; and dedicated searches of New South Wales admitted patient data such as the 
New South Wales Perinatal Data Collection and the National Coronial Information System. 
Additionally, the number of deaths for each year is assessed against ABS mortality data.  
In Victoria, maternal deaths are identified through direct notification by Health Services, 
Victorian Perinatal Data Collection Unit (birth forms), the Coroner’s Office, the Registrar of 
Births, Deaths and Marriages, and through media reports. In 2010, automatic electronic 
notification through coronial e-Medical Deposition Forms was introduced.  
Queensland Health conducts dedicated searches of hospital administrative data sets 
intended for the sole purpose of identifying maternal deaths. In 2012, the Minister for Health 
approved consideration of changes to the Public Health Act 2005 to mandate reporting of 
maternal deaths to the Department (working with the Queensland Maternal and Perinatal 
Quality Council).  
Tasmania Health Department are notified of maternal deaths through the following sources: 
health statistics; the Register of Births, Deaths and Marriages; and by local clinicians who are 
members of the state STMMC (Tasmanian Council of Obstetric and Paediatric Mortality and 
Morbidity Maternal Mortality), as well as the local hospital Morbidity and Mortality 
Committees.  
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Other jurisdictions have more informal processes of review. South Australia Health accesses 
multiple notifications including review of media articles, word of mouth, clinicians, 
pathologists and sentinel event reporting from hospitals. Although there is a tick box on 
death certificates to indicate if a woman has been pregnant in the last 3 months, this is not 
used as a source of notification to the STMMC in South Australia. Additionally, hospital 
separation discharge codes are reviewed to identify maternal deaths. No information was 
provided by Western Australia on the sources of maternal death notification.  
Relevant legislation pertaining to the reporting of maternal deaths is shown in Table 9.1. 
Only Victoria, Queensland and Western Australia reported a mandatory reporting 
requirement for maternal deaths. 
Table 9.1: Jurisdictional legislation pertaining to maternal deaths notification, 
Australia, 2012 
State and territory Legislation 
New South Wales Public Health Act 1982, section 23  
Victoria Public Health and Wellbeing Act 2008  
Queensland Public Health Act 2005 (revision)  
Western Australia Health Act 1911, Part XIII, section 336  
Tasmania Obstetric and Paediatric Mortality and Morbidity Act 1994  
The supply and sharing of information 
As outlined in Chapter 2, a standard set of information is requested from each state and 
territory STMMC and compiled into the National Maternal Death Report Data Set with 
expert input from the NMMAC. For this report, data were supplied to the NPESU using the 
National Maternal Death Reporting (NMDR) form 2006–2010: a standardised data collection 
form distributed to each state and territory health department. A subcommittee of the 
National Maternal Mortality Advisory Committee Report Working Group (NMMAC–RWG) 
(Appendix B) was established to develop this data collection form. The NMDR form 2006–
2010 was developed based upon the existing national maternal death reporting form, the 
New Zealand Perinatal and Maternal Mortality Review Committee (PMMRC) maternal 
death reporting form and the UK’s maternal death surveillance form. A number of concerns 
were raised by the RWG over the availability of data for the period 2006–2010. The RWG 
noted there were likely to be administrative and logistical barriers to the collection of the 
data and expressed significant concerns over the retrospective collection of data and the 
burden on the jurisdictional health services. On the advice of the RWG and NMMAC, it was 
agreed the proposed NMDR form 2006–2010 would be shortened to enhance usability and 
maximise likely data completion. As a result, the NMDR form 2006–2010 used to populate 
the National Maternal Death Report Data Set collects limited information on risk factors, 
clinical pathways and management of severe maternal morbidity.  
For this report, and in previous reporting periods (Sullivan et al. 2007), there were 
inconsistencies in the data supplied, which in part reflect issues relating to legislative 
barriers to the sharing of data and with timeliness of the process of review. For the current 
report, several jurisdictions did not undertake a clinical review of the deaths before 
supplying data, and other jurisdictions were unable to provide information obtained at 
clinical review or confidential enquiry for compilation into the National Maternal Death 
Report Data Set. Data provided by Western Australia has been subject to legislative privacy 
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restrictions and limited information was provided. Data as collected by the STMMC were 
not provided and data were sourced from perinatal and hospital administrative data 
collections. Classification of death as decided by the STMMC was subsequently supplied in 
2013. During the development of the report, the New South Wales Maternal and Perinatal 
Committee was in a period of suspension due to legislative committee restructuring and a 
number of cases were provided as not yet reviewed by the committee. In some instances, this 
resulted in very limited available information.  
Supply of data was variable, with data not available for all deaths. Data for 2006–2010 deaths 
were not received until late 2012 with a further resupply of data in 2013. Not all deaths at a 
jurisdictional level had been notified, reviewed and classified at the time of the data request 
for the report. Three deaths were excluded because not enough information was available to 
determine whether these deaths could be classified as maternal deaths. The publication time 
for the report has varied and is detailed in Table 9.2. The 5-year reporting period for this 
report was used to mitigate this delay in publishing data. 
Table 9.2: Timeliness of publication of Maternal deaths 
in Australia reports 
Maternal mortality reporting period  Year of publication 
1997–1999 2004 
2000–2002 2006 
2003–2005 2008 
2006–2010 2014 
The delay in publication time potentially compromises the immediate clinical relevance of 
data because maternal health care continues to evolve. The development of a nationally 
agreed process of review of maternal deaths, an agreement for the responsible sharing of 
data at the committee level and implementation of the proposed NMDR form 2014 are 
required to improve the quality and utility of the maternal deaths data collection. 
Methods of review other than confidential enquiry 
State and territory-based confidential enquiry is the primary method of review for all 
maternal deaths. Across Australia, there is a variety of reporting systems other than maternal 
death confidential enquiry that focus on patient deaths. These include the coronial system, 
the sentinel event program and patient safety incident reporting systems. All of these 
enquiries can be used to add value to the confidential enquiry. The coronial system was 
discussed in ‘Chapter 8 Coronial review’. 
A national list of core sentinel events was agreed with all jurisdictions at the Australian 
Health Ministers’ Conference in 2004: a maternal death is the seventh sentinel event (AIHW 
2007). A sentinel event report was published by the AIHW, in conjunction with the Safety 
and Quality in Health Care Council in 2007 (AIHW 2007). To date, there have been no 
subsequent publications.  
Patient safety incident reporting and investigation is now required in all health-care 
jurisdictions in Australia (ACSQHC 2009). The legislative and policy basis for this 
requirement varies between states and territories, as do the mechanisms in place for 
reporting (ACSQHC 2009). Broadly, the requirements in each jurisdiction mandate health-
care practitioners to report patient safety incidents. They mandate the use of a standardised 
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risk-adjustment tool to classify the severity of the incident reported (generally a ‘Severity 
Assessment Code (SAC)’), and specified actions for the investigation of the most severe 
patient safety incidents, usually through root cause analysis (RCA). Maternal death is 
classified as the highest severity of incident. Table 9.3 names the relevant policy and 
processes of review by state and territory. Although the states and territories consistently 
reported policy regarding incident reporting systems, they reported inconsistency in the 
utilisation of RCAs in investigating maternal deaths. Queensland Health estimates that less 
than 50% of maternal deaths undergo RCA. Victoria reported that they are unable to identify 
maternal deaths cases in the incident reporting system before 2010, and South Australia 
reported ‘unknown’ for the proportion of maternal deaths undergoing RCA.  
Table 9.3: Maternal death incident reporting system policy and review processes by state and 
territory, Australia, 2012 
 New South Wales Victoria Queensland South Australia Tasmania 
Maternal 
deaths incident 
reporting 
system policy  
Policy Directive on 
Incident 
Management 
NSW Health 
Victorian Health 
Incident 
Management 
Policy 
Clinical Incident 
Management Policy 
SA Health Incident 
Management 
Policy  
DHHS Incident 
Reporting and 
Management  
Responsible 
body 
Clinical Excellence 
Commission 
Quality and Safety 
and Patient 
Experience Branch 
of Department of 
Health 
Patient Safety and 
Quality 
Improvement 
Service, 
Queensland Health 
Safety and Quality 
Unit, SA Health  
Tasmanian 
Council of 
Obstetric and 
Paediatric 
Mortality and 
Morbidity Maternal 
Mortality 
Maternal death review in the United Kingdom and New Zealand 
The UK confidential enquiry process is considered internationally as the gold standard and 
the 2010 Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer, 2006–2008 
reports the following process of review (CMACE 2011). Confidential enquiries are carried 
out regionally, with a central coordination office overseeing the process. Notification usually 
occurs through a clinician involved in the case and then to a regional officer who follows up 
with a request for more detailed surveillance data. Each case undergoes a 2-stage review: 1 at 
the regional level and1 at the central level. National reporting is undertaken by the central 
office every 3 years.  
In New Zealand, a subgroup of the ministerially convened PMMRC, the Maternal Mortality 
Review Working Group (MMRWG), undertakes review of all direct and indirect maternal 
deaths (PMMRC 2007). On notification of a death, the national coordinator issues a 
nationally standardised maternal deaths reporting form to a local coordinator who is then 
responsible for gathering necessary clinical information from those involved in the case. 
Each maternal death is then reviewed by designated members of the MMRWG, who 
presents a summary of a case and findings to the working group (PMMRC 2012). The 
MMRWG reviews each case in detail including assessing the presence of contributory factors 
and potential avoidability. 
In New Zealand, local coordinators are requested to notify all maternal deaths. Deaths are 
also identified through the coroner and media reports. At the end of each year, known 
deaths are cross-referenced with the mortality collection of the Births, Deaths and Marriages 
Registry to ensure collection is complete. Since July 2007, there has been a mandatory 
reporting requirement for all maternal deaths to the coroner (PMMRC 2012). 
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The current Australian system of review does not have the same level of centralisation and 
continuity of reporting that occurs in the UK and New Zealand. In Australia, a secondary 
report-specific data set collected up to 7 years after a death has occurred is used to undertake 
national reporting. Assessments of potential avoidability are not undertaken consistently at a 
jurisdictional level. At the national level, only summary data on the maternal deaths is 
provided, which limits this type of assessment. The timeliness of reporting and lack of 
transfer of information between committees do not permit this type of national review. 
Overall, these factors limit the capacity for meaningful comparison of cases. The lack of a 
nationally standardised process of data collection and review has a significant impact on the 
quality and utility of the data collected in Australia.  
Future reporting of maternal deaths 
The NMMAC has advised that the NMDR form 2006–2010 will be used to collect information 
about maternal deaths occurring in 2011 and 2012. The use of the NMDR form 2006–2010 is 
in response to the NMMAC’s concern regarding the timeliness of maternal death data 
collection, as well as consideration of the burden of retrospective data collection on 
jurisdictional health services.  
Pilot National Maternal Death Reporting form  
The National Maternal Death Reporting (NMDR) form is intended for implementation in 
2015. The NMDR form has been developed by the NMMAC–RWG and has been based on 
the National Maternity Council’s draft form provided to the NMMAC in September 2011. 
The form has undergone several rounds of review by relevant national and international 
experts. The aim of this process of review has been to ensure that the national data collection 
tool is up to date, comprehensive and reflects the availability of information at the state and 
territory level. Although the form is intended for use at the national level, it may be used at 
the local level if the states and territories determine. Piloting commenced in South Australia 
and Queensland in 2013.  
Overall, this form will collect more detailed information on the underlying health status of 
women who die, the risk factors associated, and the details of labour and birth events. It will 
limit the capacity for variability in data provision and is in line with current international 
and national data development initiatives. The aim has been to present a form that will 
improve the quality and utility of the data collection that can ultimately be used in the 
development of policy, clinical guidelines and educational resources.  
Summary 
The care pregnant women in Australia receive is among some of the best in the world and 
the existing process of review is an example of good practice as well as in compliance with 
international standards. However, there are inconsistencies in the process of maternal death 
review and in turn there is:  
• inconsistency in the quality of data collected 
• under-utilisation of other patient death enquiry systems 
• delay in the process of confidential enquiry  
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• legislative inconsistency and barriers to sharing data between states, territories and 
federally. 
The WHO suggests that, in order to enhance patient safety, health-care services need an 
‘increased ability to learn from mistakes, through better reporting systems, skilful 
investigation of incidents and responsible sharing of data’ (WHO 2002). In order to achieve 
this in Australia, it is necessary to work in collaboration with state and territories to 
implement policy at a national level that aims to improve and standardise data collection. A 
mandatory reporting requirement for notification of maternal deaths and an agreement on 
the responsible sharing of data at the national committee level would support this. 
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Appendix A National Maternal Mortality 
Advisory Committee membership 
Dr Fadwa Al-Yaman Head, Social and Indigenous Group, Australian 
Institute of Health and Welfare 
Professor Marie-Paule Austin The Royal Australian and New Zealand College of 
Psychiatrists 
Dr Peter Chapman: proxy for 
Professor Jeremy Oats  
22/2/2012–28/5/2012  
Representative for Maternity Services Inter-
jurisdictional Committee 
A/Professor Amanda Dennis Chair, Tasmanian Council of Obstetric and Paediatric 
Mortality and Morbidity, Maternal Mortality 
Subcommittee 
Professor Jodie M Dodd Chair, South Australian Maternal and Neonatal 
Clinical Network 
Ms Kate Dyer A second representative from the Australian College of 
Midwives with expertise in maternal mortality and 
high-risk pregnancy 
Professor David Ellwood Chair, Australian Capital Territory Maternal Perinatal 
Data Collection 
Professor Cynthia Farquhar Chair, Perinatal and Maternal Mortality Review 
Committee New Zealand 
Professor Michael Humphrey Chair, Queensland Maternal and Perinatal Quality 
Council 
Dr Jenny Hunt Representative for the National Aboriginal 
Community Controlled Health Organisations 
(NACCHO)  
Ms Rebecca Jenkinson Consumer representative, The Maternity Coalition 
A/Professor Steven Katz Associate Professor, Australian and New Zealand 
College of Anaesthetists 
Professor Yee Khong The Royal College of Pathologists of Australasia 
Ms Ann Kinnear Executive Officer, Australian College of Midwives 
Ms Rachael Lockey Midwifery Co-Director Integrated Maternity Services, 
Northern Territory Department of Health and Families 
Dr Karin Lust Council Member, Society of Obstetric Medicine 
Australia and New Zealand 
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Dr Nhi Nguyen The College of Intensive Care Medicine 
Professor Jeremy Oats  
 
Victorian Consultative Council on Obstetric and 
Paediatric Mortality and Morbidity; Representative for 
Maternity Services Inter-jurisdictional Committee 
Professor Michael Permezel: proxy 
for Professor Jeremy Oats  
22/2/2012–28/5/2012 
Victorian Consultative Council on Obstetric and 
Paediatric Mortality and Morbidity  
A/Professor John Smoleniec New South Wales Perinatal and Maternal Mortality 
Committee 
Professor Elizabeth Sullivan 
(Chair) 
Director, National Perinatal Epidemiology and 
Statistics Unit 
Clinical A/Professor Barry Walters The Royal Australian and New Zealand College of 
Obstetrics and Gynaecology and Western Australian 
Perinatal and Infant Mortality Committee 
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Appendix B National Maternal Mortality 
Advisory Committee–Report Working 
Group membership 
Professor Cynthia Farquhar Chair, Perinatal and Maternal Mortality Review 
Committee, New Zealand 
Professor Michael Humphrey Chair, Queensland Maternal and Perinatal Quality 
Council 
Ms Ann Kinnear Executive Officer, Australian College of Midwives 
Dr Karin Lust Council member, Society of Obstetric Medicine 
Australia and New Zealand 
Professor Michael Permezel: 
proxy for Professor Jeremy Oats 
Victorian Consultative Council on Obstetric and 
Paediatric Mortality and Morbidity 
Chair, Victorian Consultative Council on Obstetric and 
Paediatric Mortality and Morbidity and Maternity 
Services Inter-jurisdictional Committee 
A/Professor John Smoleniec New South Wales Perinatal and Maternal Mortality 
Committee 
Professor Elizabeth Sullivan Director, National Perinatal Epidemiology and 
Statistics Unit 
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Appendix C National Maternal Mortality 
Advisory Committee–Clinical 
Classifications Working Group 
membership 
Professor Marie-Paule Austin The Royal Australian and New Zealand College of 
Psychiatrists 
Professor David Ellwood Chair, Australian Capital Territory Maternal Perinatal 
Data Collection 
Professor Cynthia Farquhar Chair, Perinatal and Maternal Mortality Review 
Committee New Zealand 
Professor Michael Humphrey Chair, Queensland Maternal and Perinatal Quality 
Council 
Professor Jeremy Oats  
 
Victorian Consultative Council on Obstetric and 
Paediatric Mortality and Morbidity; Representative for 
Maternity Services Inter-jurisdictional Committee  
A/Professor John Smoleniec New South Wales Perinatal and Maternal Mortality 
Committee 
Professor Elizabeth Sullivan 
(Chair) 
Director, National Perinatal Epidemiology and 
Statistics Unit 
Clinical A/Professor Barry Walters The Royal Australian and New Zealand College of 
Obstetrics and Gynaecology and Western Australian 
Perinatal and Infant Mortality Committee 
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Appendix D Data quality statement 
National Maternal Death Report Data Set 
for 2006-2010 
Summary of key issues 
• The National Maternal Death Report Data Set provides national information for use 
in preparing a national report on women who died while pregnant or within 42 days 
of termination of pregnancy, between 2006 and 2010. 
• Data sources, supply and quality varied by state and territory. 
• Legislative privacy restrictions and data approval processes differed by state and 
territory, and in some jurisdictions precluded full supply of maternal death data. 
• Not all states and territories had active maternal mortality committees or 
subcommittees for the period of deaths. This has limited the quality and 
completeness of data supplied. 
• National data were published less than 1 year after collection by the National 
Perinatal Epidemiology and Statistics Unit (NPESU) and within 3 years of the time 
frame for including maternal deaths of 31 December 2010. 
• Data collection for some jurisdictions was retrospective and not from existing 
collections. Retrospective data collection limited the quality and completeness of data 
supplied. 
• Methodology, definitions, classifications and reference periods for maternal death 
data collections differ significantly across states and territories, and comparisons 
between collections should be made with caution. 
Description 
The National Maternal Death Report Data Set is a set of national research data collated from 
state and territory sources to be used in the preparation of the national report. The data set 
contains information on the deaths of women reported to have died while pregnant or 
within 42 days of termination of pregnancy, between 2006 and 2010. Data were supplied by 
state and territory health authorities to the NPESU. The data supplied by states and 
territories were primarily compiled from state and territory maternal death data collections, 
or where not available, other data sources. Data in the National Maternal Death Report Data 
Set include data collected retrospectively and specifically by some states and territories to 
produce the maternal deaths report for 2006–2010. The state and territory health authorities 
receive clinical data on the women who died from patient administrative and clinical 
records, as well as from the state and territory maternal mortality committees or 
subcommittees where death reviews are undertaken. This information is usually collected 
through a variety of sources, including notifications from health professionals involved in 
the case, coronial reports and notifications from related data collections, including the 
jurisdictional register of births, deaths and marriages. States and territories use these data to 
determine cause of death, classification of death and for service planning, monitoring and 
internal and public reporting.  
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The organisational structure, roles and responsibilities of State and Territory Maternal 
Mortality Committees (STMMCs) vary across states and territories. There is no standardised 
method of identifying and collecting data on maternal deaths, and no nationally agreed 
process of reporting or investigation. Data from the National Maternal Death Report Data 
Set, used to populate this report, reflect these inconsistencies.  
States and territories supplied these data subject to national and jurisdictional ethics 
committee approvals. Ethics approval for this study was obtained from: the Australian 
Institute of Health and Welfare Human Research Ethics Committee (HREC); New South 
Wales Population Health HREC; The Consultative Council on Obstetric and Paediatric 
Mortality and Morbidity HREC; Queensland Health HREC; Department of Health Western 
Australia HREC; South Australia Health HREC; Health and Medical HREC, University of 
Tasmania; Australian Capital Territory Department of Health HREC; Northern Territory 
Department of Health and Menzies School of Health Research HREC; the National Coronial 
Information Service HREC, and the University of New South Wales HREC. 
Institutional environment 
The NPESU was established in 1979 to provide information and statistics in reproductive 
and perinatal health. The Unit is part of the University of New South Wales (UNSW) and is 
located at the Randwick Hospitals Campus, and since 1987 has been a collaborating unit of 
the AIHW. The AIHW is Australia’s national agency for health and welfare statistics and 
information. The role of the AIHW is to provide information on Australia’s health and 
welfare, through statistics and data development that inform discussion and decisions on 
policy and services.  
The AIHW is a major national agency set up by the Australian Government under the 
Australian Institute of Health and Welfare Act 1987 to provide reliable, regular and relevant 
information and statistics on Australia's health and welfare. It is an independent statutory 
authority established in 1987, governed by a management Board, and accountable to the 
Australian Parliament through the Health and Ageing portfolio. 
The AIHW aims to improve the health and wellbeing of Australians through better health 
and welfare information and statistics. It collects and reports information on a wide range of 
topics and issues, ranging from health and welfare expenditure, hospitals, disease and 
injury, and mental health, to ageing, homelessness, disability and child protection. 
The Institute also plays a role in developing and maintaining national metadata standards. 
This work contributes to improving the quality and consistency of national health and 
welfare statistics. The Institute works closely with governments and non-government 
organisations to achieve greater adherence to these standards in administrative data 
collections to promote national consistency and comparability of data and reporting. 
One of the main functions of the AIHW is to work with the states and territories to improve 
the quality of administrative data and, where possible, to compile national data sets based on 
data from each jurisdiction, to analyse these data sets and disseminate information and 
statistics. 
The Australian Institute of Health and Welfare Act 1987, in conjunction with compliance to 
the Privacy Act 1988 (Cwlth) ensures that the data collections managed by the AIHW are 
kept securely and under the strictest conditions with respect to privacy and confidentiality. 
For further information see the AIHW website www.aihw.gov.au. 
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Timeliness 
The Maternal Death Reporting Data Set is a report-specific ad hoc data collection used to 
prepare the intended national report. Data are published in the Maternal deaths in Australia 
series. National data were published less than 1 year after collection of the data by AIHW, 
and within 3 years of the time frame for including maternal deaths of 31 December 2010. 
Accessibility 
The NPESU provides a variety of products that draw upon the National Maternal Death 
Report Data Set including the Maternal deaths in Australia report series 
Data is also used in a number of other AIHW products including Australia’s health and the 
Australia’s mothers and babies series. Data is subject to strict confidentiality restrictions due to 
the small number of deaths and potential for identification and is not generally available on 
request. In accordance with the HREC approvals, these data will be kept for 7 years from the 
date of report publication and will then be destroyed. 
Interpretability 
The organisational structure including relevant legislation, policy and process for maternal 
death data collection varies by state and territory. The National Maternal Death Report Data 
Set reflects these variations. In all cases, the best available information was used to form the 
National Maternal Death Report Data Set. Data provided by Western Australia has been 
subject to legislative privacy restrictions and limited information was initially provided to 
NPESU. Data as collected by the Western Australian Perinatal and Infant Mortality 
Committee were not provided and data were sourced from the Department of Health, 
Western Australia perinatal and hospital administrative data collections. Classification of 
death as decided by the Maternal Mortality Committee was subsequently supplied at a later 
date. During the development of the report, the New South Wales Maternal and Perinatal 
Committee were out of term and a number of cases were provided to NPESU as not yet 
reviewed by the New South Wales Maternal and Perinatal Committee. For some cases, only 
very limited information was available. 
An overview of each state’s maternal death data collection process is outlined here: 
The New South Wales Ministry of Health is notified of maternal deaths through a variety of 
organisations and methods including: hospitals, the Department of Forensic Medicine at 
Glebe, Ministry of Health systematic searches of New South Wales population health data 
sets (e.g. Admitted Patient Data Collection and the New South Wales Perinatal Data 
Collection) and through the National Coronial Information system. The number of maternal 
deaths for each year is assessed against Australian Bureau of Statistics (ABS) mortality data, 
where available (deaths with an ICD-10 cause of death code commencing with an ‘O’) to 
maximise ascertainment.  
In Victoria, maternal deaths are identified through direct notification by health services, 
Victorian Perinatal Data Collection Unit (birth forms), the Coroner’s Office, the Registrar of 
Births, Deaths and Marriages and through media reports. In 2010, automatic electronic 
notification through coronial e-Medical Deposition Form was introduced.  
Queensland Health conducts dedicated searches of hospital administrative data sets 
intended for the sole purpose of identifying maternal deaths. In 2012, the Minister of Health 
approved consideration of changes to the Public Health Act 2005 to mandate reporting of 
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maternal deaths to the Department (working with the Queensland Maternal and Perinatal 
Quality Council). 
South Australia Health has no formal process of maternal death notification in place. The 
Maternal Mortality Committee accesses multiple notifications, including review of media 
articles, word of mouth, clinicians, pathologists and sentinel event reporting from hospitals. 
Although there is a tick box on death certificates to indicate if a woman has been pregnant in 
the last 3 months, this has never been a source of notification to the Maternal Mortality 
Committee of a maternal death. Hospital separation discharge codes are also reviewed as a 
quality check to identify maternal deaths, but to date this process has never informed the 
Maternal Mortality Committee of a maternal death the Maternal Mortality Committee was 
not already aware of. Similarly, sentinel event reporting has not identified a new maternal 
death to the Maternal Mortality Committee. 
Tasmania Health department are notified of maternal deaths through the following sources: 
health statistics, the Register of Births, Deaths and Marriages and local clinicians who are 
members of Tasmanian Council of Obstetric and Paediatric Mortality and Morbidity 
COPMM (state-wide) and local hospital Morbidity and Mortality Committees. 
Information on the process of notification and data collection were not provided by the 
Australian Capital Territory Department of Health.  
Northern Territory undertook a process of maternal death ascertainment and review 
specifically to supply data to the National Maternal Death Report Data Set. 
Relevance 
The National Maternal Death Report Data Set is a specification for data compiled primarily 
from state and territory maternal death data collections, or where not available, other data 
sources. Data was requested on the death of all women reported to have died while pregnant 
or within 42 days of termination of pregnancy in Australia in hospitals, birth centres and the 
community between 2006 and 2010. Information was collected from each state and territory 
health department through the completion of a standardised data collection form: the 
National Maternal Death Reporting (NMDR) form 2006–2010. Specifications for the NMDR 
form 2006–2010 were developed using nationally standardised data as entered into the 
National health data dictionary which has an repository, 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/181162 >. It includes data items 
relating to the mother, including demographic characteristics and factors relating to the 
pregnancy, labour and birth, details of death, classification of death and data items relating 
to the baby, including birth status, as well as any additional case summaries. 
A National Maternal Mortality Advisory Committee (NMMAC) was convened to oversee the 
process of data collection for the maternal death report. A subcommittee of the NMMAC, the 
National Maternal Mortality Advisory Committee–Report Working Group was established 
to oversee the development of NMDR form 2006–2010 and a system of maternal death 
classification. The NMDR form 2006–2010 was limited in the information that could be 
collected due to the retrospective data collection and advice from states and territories 
regarding availability of data. 
Accuracy 
Inaccurate responses may occur in all data provided to the NPESU. The NPESU does not 
have direct access to maternal mortality committee records to determine the accuracy of the 
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data provided. However, the NPESU undertakes validation on receipt of data. Data received 
from states and territories are checked for completeness, validity and logical errors. Potential 
errors are queried with jurisdictions, and corrections and resubmissions are made in 
response to these edit queries. Any cases without outstanding issues are reviewed by the 
NMMAC. The NPESU does not adjust data to account for possible data errors. 
Errors may occur during the processing of data by the states and territories or at the NPESU. 
Processing errors before data supply may be found through the validation checks applied by 
the NPESU. The data are corrected when verification of an error was supplied. 
The NPESU does not adjust the data to correct for missing values.  
Before to publication, data are referred back to jurisdictions for checking and review. Note 
that, because of data editing and subsequent updates of state/territory information, numbers 
reported may differ from those in reports published by the states and territories. 
Coherence 
The National Maternal Death Report Data Set is a one-off data set collected specifically for 
use in Maternal Deaths in Australia 2006–2010. Similar data sets have been compiled for 
previous reports in the Maternal Deaths in Australia series. Although definitions and some 
individual data elements have changed over time in response to expert review, changes in 
international definitions and coding relating to maternal deaths, in many cases it is possible 
to map these changes and make meaningful comparisons over time.  
State and territory health authorities compile statistics and publish reports on maternal 
deaths. Methodology, definitions, classifications and reference periods for these collections 
differ significantly across states and territories, and comparisons between states and 
territories should be made with caution. 
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Appendix E National Aboriginal Perinatal 
Reference Group membership  
State or 
territory 
NACCHO state affiliate organisation Person nominated 
NSW Aboriginal Health and Medical Research Council of NSW 
(AH&MRC) 
Jennifer Hunt 
Vic Victorian Aboriginal Community Controlled Health 
Organisation (VACCHO) 
Wendy Bissinger 
Qld Queensland Aboriginal and Islander Health Council 
(QAIHC) 
Kate Panaretto 
WA Western Australia Aboriginal Health Council Daniel McAullay 
SA Aboriginal Health Council of South Australia Inc. Karen Atkinson 
ACT Winnunga Nimmityjah Aboriginal Health Service (AHS) Emma Adams 
NT Aboriginal Medical Services Alliance Northern Territory 
(AMSANT) 
To be advised 
 
Note: The Tasmanian affiliate declined the invitation to nominate a representative. A 
representative from Northern Territory has not yet been nominated. 
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Glossary 
Aboriginal or Torres Strait Islander: A person of Aboriginal and/or Torres Strait Islander 
descent who identifies as an Aboriginal and/or Torres Strait Islander. See also Indigenous. 
acute: Coming on sharply and often brief, intense and severe. 
acute myocardial infarction (AMI): Term still commonly used to mean a heart attack, but 
more correctly refers only to those heart attacks that have caused some death of heart 
muscle.  
administrative data collection: A data set that results from the information collected for the 
purposes of delivering a service or paying the provider of the service. This type of collection 
is usually complete (that is, all in-scope events are collected), but it may not be fully suitable 
for population-level analysis because the data are collected primarily for an administrative 
purpose. An example is the Alcohol and Other Drug Treatment Services National Minimum 
Data Set.  
admission: An admission to hospital. In this report, the term hospitalisation is used to 
describe an episode of hospital care that starts with the formal admission process and ends 
with the formal separation process. In this report, the number of separations has been taken 
as the number of admissions; hence, admission rate is the same as separation rate.  
amniotic fluid embolism (AFE): Amniotic fluid embolism is a rare obstetric emergency in 
which it is postulated that amniotic fluid, fetal cells, hair, or other debris enter the maternal 
circulation, causing cardiorespiratory collapse. 
antenatal: The period covering conception up to the time of birth. Synonymous with 
prenatal. 
arrhythmia: A disturbed rhythm of the heart beat—too fast, too slow or irregular. 
assisted reproductive technology: Treatments or procedures that involve the in vitro 
handling of human oocytes (eggs) and sperm or embryos for the purposes of establishing a 
pregnancy. 
asthma: A common, chronic inflammatory disease of the air passages that presents as 
episodes of wheezing, breathlessness and chest tightness due to widespread narrowing of 
the airways and obstruction of airflow. The symptoms may reverse without treatment, but 
often treatment is required. Different medications can prevent the episodes or relieve them. 
atherosclerosis: A process in which fatty and fibre-like deposits build up on the inner walls 
of arteries, often forming plaques that can then cause blockages. It is the main underlying 
condition in heart attack, angina, stroke and peripheral vascular disease. 
birth status: Status of the baby immediately after birth. 
birthweight: The first weight of the baby (stillborn or liveborn) obtained after birth (usually 
measured to the nearest 5 grams and obtained within 1 hour of birth). 
blood pressure: The force exerted by the blood on the walls of the arteries as it is pumped 
around the body by the heart. It is written, for example, as 134/70 mmHg, where the upper 
number is the systolic pressure (the maximum force against the arteries as the heart muscle 
contracts to pump the blood out) and the lower number is the diastolic pressure (the 
minimum force against the arteries as the heart relaxes and fills again with blood). Levels of 
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blood pressure can vary greatly from person to person and from moment to moment in the 
same person.  
body mass index (BMI): The most commonly used method of assessing whether a person is 
normal weight, underweight, overweight or obese (see obesity). It is calculated by dividing 
the person’s weight (in kilograms) by their height (in metres) squared; that is, kg ÷ m2. For 
both men and women, underweight is a BMI below 18.5, acceptable weight is from 18.5 to 
less than 25, overweight is from 25 to less than 30, and obese is 30 and over. Sometimes 
overweight and obese is combined, and is defined as a BMI of 25 and over. 
caesarean birth: (also caesarean section or c-section) A method of birth in which a surgical 
incision is made into the mother’s womb via the abdomen to directly remove the baby.  
cholecystitis: Inflammation of the gallbladder. 
chorioamnionitis: An inflammation, usually from an infection, of the membranes 
surrounding the fetus. 
confidence interval (CI): A statistical term describing a range (interval) of values within 
which we can be ‘confident’ that the true value lies, usually because it has a 95% or higher 
chance of doing so. 
diabetes (diabetes mellitus): A chronic condition in which the body cannot properly use its 
main energy source, the sugar glucose. This is due to a relative or absolute deficiency in 
insulin, a hormone that is produced by the pancreas and helps glucose enter the body’s cells 
from the bloodstream and then be processed by them. Diabetes is marked by an abnormal 
build-up of glucose in the blood, and it can have serious short- and long-term effects.  
eclampsia: The occurrence of 1 or more convulsions not caused by other conditions, such as 
epilepsy or cerebral haemorrhage, in a woman with pre-eclampsia. The onset of convulsions 
may be preceded by a sudden rise in blood pressure and/or a sudden increase in oedema 
and development of oliguria. 
ectopic pregnancy: The development of a fetus at a site other than in the uterus. This may 
happen if the fertilised egg cell remains in the ovary or in the tube leading from near the 
ovary to the uterus (the Fallopian tube) or if it lodges in the free abdominal cavity. 
embolism: The condition in which an embolus becomes lodged in an artery and obstructs its 
blood flow. The most common form of embolism is pulmonary embolism, in which a blood 
clot is carried in the circulation to lodge in the pulmonary artery.  
epilepsy: A disturbance of brain function marked by recurrent fits and loss of consciousness.  
episiotomy: An incision of the perineum and vagina to enlarge the vulval orifice. 
fetal death (stillbirth): Death before the complete expulsion or extraction from its mother of 
a product of conception of 20 or more completed weeks of gestation or of 400 grams or more 
birthweight. The death is indicated by the fact that, after such separation, the fetus does not 
breathe or show any other evidence of life, such as beating of the heart, pulsation of the 
umbilical cord, or definite movement of voluntary muscles. 
gestational age: The duration of pregnancy in completed weeks calculated from the date of 
the first day of a woman’s last menstrual period and her baby’s date of birth, or via 
ultrasound, or derived from clinical assessment during pregnancy or from examination of 
the baby after birth. 
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gestational diabetes: A form of diabetes that is first diagnosed during pregnancy (gestation). 
It may disappear after pregnancy but signals a high risk of diabetes occurring later on. 
grand multipara: Pregnant woman who has had 4 or more previous pregnancies resulting in 
a live birth or stillbirth. 
haemorrhage (bleeding): The escape of blood from a ruptured blood vessel, externally or 
internally. 
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander. See also Aboriginal or Torres Strait Islander. 
induction of labour: Intervention to stimulate the onset of labour. 
influenza (flu): An acute contagious viral respiratory infection marked by fevers, muscle 
aches, headache, cough and sore throat. 
intrapartum: Occurring during childbirth or during the birth process.  
ischaemic heart disease: Also heart attack and angina (chest pain). Also known as coronary 
heart disease. 
live birth: The complete expulsion or extraction from its mother of a product of conception, 
irrespective of the duration of the pregnancy, which, after such separation, breathes or shows 
any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or 
definite movement of voluntary muscles, whether or not the umbilical cord has been cut or 
the placenta is attached; each product of such a birth is considered live born (WHO 
definition). 
Marfan’s syndrome: A hereditary condition that affects the musculoskeletal system and is 
often associated with abnormalities of the cardiovascular system and the eyes. Inherited as 
an autosomal-dominant trait, Marfan's syndrome affects men and women equally. Its major 
musculoskeletal effects include muscular underdevelopment, ligamentous laxity, joint 
hypermobility and bone elongation. 
maternal age: Mother’s age in completed years at the birth of her baby. 
maternities: (NZ/UK ) Defined as the number of pregnancies that result in a live birth at any 
gestation or stillbirths occurring at or after 24 completed weeks of gestation. 
median: The midpoint of a list of observations that have been ranked from the smallest to the 
largest. 
menarche: The start of the menstrual periods and other physical and mental changes 
associated with puberty. 
morbidity: Refers to ill health in an individual and to levels of ill health in a population or 
group.  
mortality: Death. 
multipara: Pregnant woman who has had at least 1 previous pregnancy resulting in a live 
birth or stillbirth. 
neonatal death: Death of a live born baby within 28 days of birth. 
non-Indigenous: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent. Compare with Other Australians. 
nullipara: A women who has not given birth before to the current pregnancy 
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obesity: Marked degree of overweight, defined for population studies as a body mass index 
of 30 or over. 
Other Australians: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent, and those for whom their Indigenous status is unknown. Compare with 
non-Indigenous. 
parity: Number of previous pregnancies resulting in live births or stillbirths, excluding the 
current pregnancy. 
perinatal: Pertaining to or occurring in the period shortly before or after birth (usually up to 
28 days after). 
phaeochromocytoma: A small vascular tumour of the inner region (medulla) of the adrenal 
gland. 
postnatal: Occurring after birth, with reference to the newborn.  
postpartum: Occurring after childbirth, with reference to the mother. 
psychosocial morbidity: Describes deaths in which a psychiatric condition contributed to the 
cause of death. 
puerperal psychosis: Covers a group of mental illnesses with the sudden onset of psychotic 
symptoms following childbirth. 
puerperium: The period of up to about 6 weeks after childbirth, during which the uterus 
returns to its normal size. 
rate: Is 1 number (the numerator) divided by another number (the denominator).The 
numerator is commonly the number of events in a specified time. The denominator is the 
population ‘at risk’ of the event. Rates (crude, age-specific and age-standardised) are 
generally multiplied by a number such as 100,000 to create whole numbers. 
relative risk: The relative risk compares 2 groups for their likelihood of an event. Another 
term for the relative risk is the risk ratio because it is the ratio of the risk in the ‘exposed’ 
divided by the risk in the ‘unexposed’. It is also known as the rate ratio. 
sepsis: Refers to a bacterial infection in the bloodstream or body tissues. This is a very broad 
term covering the presence of many types of microscopic disease-causing organisms. 
spontaneous vaginal birth: Birth without intervention in which the baby’s head is the 
presenting part. 
stillbirth: see fetal death. 
suicide: Deliberately ending one’s own life. 
Tetralogy of Fallot: Congenital heart defect that is classically understood to involve 
4 anatomical abnormalities of the heart. 
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Maternal deaths in Australia 2006–2010 is the 15th report 
on women who die during pregnancy and childbirth. 
Although maternal deaths are rare in Australia, they are 
catastrophic events when they do occur and require 
monitoring and investigation. The report includes 
information about the women, pregnancy, and cause 
of death as well as good practice guidance points for 
clinicians to inform practice improvement.
